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Abstract
Prostate cancer (PCa) is a major mortality cause for men around the world and
therefore there is a high demand for reliable diagnostic solutions. Prostate-specific
antigen (PSA) is currently the representative biomarker for pre-screening of PCa,
necessarily followed by biopsy examinations for confirmatory diagnosis. In the
biomedical market, equipment to detect PSA in its relevant clinical concentration
is already commercialized. These devices are accurate, but the bench-top systems
are bulky, expensive, have a long response time, and rely on optical labels. To
eliminate these drawbacks, point-of-care (POC) devices are under development,
aiming at cost-effective, precise, portable, disposable and environmentally friendly
designs with a fast response time. Most of the devices are utilizing conventional
biosensing principles. However, the miniaturization of these approaches directly
induces performance variations and a drastic decrease of the sensing accuracy. It
is noteworthy that no biomarker is ideal, and no definite diagnostic decision can
be based on a single biomarker. Thus, the detection of a combination of various
biomarkers is recommended to provide multi-variable information for accurate
diagnosis in the early stage of cancer development. Some biomarkers are more specific
for PCa than others, but of a relatively low concentration in the clinical samples.
Therefore, new biosensing concepts with multiplexing capability are under intensive
investigation.
Graphene, as an atomic carbon lattice, possesses superior electronic, optical and
plasmonic properties, which trigger a revolution in the microelectronics field.
Graphene is of atomic thickness but mechanically ultra-strong, and the carrier
transport is ballistic in the condition of high charge carrier concentrations. In
addition, this material is highly heat resistant, cheap, environmentally friendly and
biocompatible.
The aim of this thesis is to utilize graphene-based material for novel biosensors
towards PSA detection. Graphene oxide (GO) and reduced graphene oxide (rGO),
as derivatives of graphene, partially possess the promising properties of graphene.
In addition, they provide diverse functionalization possibilities for immobilization of
biomolecules and a wafer-scale preparation capability on arbitrary substrates. In the
framework of this thesis, GO flakes were chemically exfoliated by a newly developed
low-temperature exfoliation and desalination (LTEDS) method. The high-quality GO
flakes were characterized intensively using scanning electron microscopy (SEM),
transmission electron microscope (TEM), ultraviolet-visible (UV-VIS) spectroscopy,
X-ray diffraction (XRD) and Fourier-transform infrared (FT-IR) spectroscopy. The
graphene oxide and reduced graphene oxide ((r)GO) thin films were prepared in
wafer-scale using the techniques of gas-phase silanization, spin-coating, followed
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with patterning by photolithography and reactive ion etching. After a thermal
reduction, electronic characterizations of rGO thin films were carried out using
cyclic-voltammetry, current-voltage (I-V) characterizations and electrolyte-sensitive
field-effect transistor (ESFET) measurements. These combined electronic and
electrochemical characterizations aimed at analyzing the wafer-scale topographical
completeness, uniformity, and field-effect mobility of the rGO thin films.
The rGO thin films were utilized as functional layers in different biosensor device
configurations of surface plasmon resonance (SPR) spectroscopy, electrochemical
impedance spectroscopy (EIS) and ESFET. The biosensing performances and the
corresponding sensing mechanisms were analyzed and evaluated in detail. The
bipolar property of the rGO thin films allowed a tuning effect of the SPR intensity.
Concanavalin A (ConA) was detected using the rGO based SPR principle and a
limit of detection (LOD) as low as 0.01 µg ml−1 was achieved. Such a LOD was
not attainable by the standard gold SPR chips. Besides, the electronic biosensing
experiments were all carried out in a buffer solution with an ionic strength of 162 mM
and a corresponding short Debye-screening length (0.76 nm), which were similar to
physiological solutions (150 mM and 0.78 nm). The rGO based EIS and ESFET sensors
exhibited the outstanding biosensing capability to detect PSA in its relevant clinical
concentration range (4-10 ng ml−1).
The rGO based biosensors as developed and optimized in this thesis work
showed a highly sensitive PSA detection beyond the Debye-screening limitation
and demonstrated a great potential towards real biosensor applications for future
healthcare.
II
Zusammenfassung
Prostatakrebs (PCa) ist weltweit eine der Hauptursachen für Mortalität bei
Männern. Daher besteht ein hoher Bedarf an zuverlässigen diagnostischen Verfahren.
Prostataspezifisches Antigen (PSA) ist derzeit der repräsentative Biomarker für die
PCa-Voruntersuchung, dem bei Auffälligkeiten für eine sichere Diagnose weitere
Biopsieuntersuchungen folgen. Auf dem biomedizinischen Markt sind bereits Geräte
zum Nachweis von PSA in klinisch relevanten Konzentrationen kommerziell
erhältlich. Diese Systeme sind präzise, jedoch sind sie groß, teuer, haben eine lange
Analysezeit und beruhen auf optischen Markern zur Detektion der Biomoleküle.
Aktuell werden Point-of-Care (POC) Geräte entwickelt, die kostengünstig, präzise,
tragbar und umweltfreundlich sind und dennoch eine schnelle Analysezeit besitzen.
Die meisten dieser Geräte verwenden herkömmliche Biosensor-Prinzipien. Die
Miniaturisierung der klassischen Prinzipien führt jedoch zu Ungenauigkeiten,
die mit einer drastischen Verringerung der Zuverlässigkeit einhergehen. In
diesem Zusammenhang ist festzustellen, dass kein Biomarker ideal ist und keine
definitive diagnostische Entscheidung auf einem einzigen Biomarker basieren
kann. Daher werden Anstrengungen unternommen, Kombinationen verschiedener
Biomarker nachweisen zu können, um schon im Frühstadium der Krebsentwicklung
multivariante Informationen für eine genauere Diagnose bereitzustellen. Dabei sind
einige der neuen Biomarker spezifischer für PCa als andere, jedoch liegen sie alle nur
in relativ geringen Konzentrationen in den klinischen Proben vor. Aus diesem Grund
werden aktuell neue Biosensorkonzepte mit der Fähigkeit zur parallelen Detektion
mehrerer Biomarker entwickelt.
Graphen besitzt als atomares Kohlenstoffgitter herausragende elektronische, optische
und plasmonische Eigenschaften, die aktuell eine Revolution in der Mikroelektronik
auslösen. Graphen ist nur eine Atomlage dick, jedoch mechanisch ultrastark und
der Ladungsträgertransport ist bei hohen Ladungsträgerkonzentrationen ballistisch.
Außerdem ist dieses Material sehr hitzebeständig, billig, umweltfreundlich und
biokompatibel.
Das Ziel dieser Arbeit ist die Verwendung von graphenbasiertem Material in
neuartigen Biosensorkonzepten für den PSA-Nachweis. Graphenoxid (GO)
und reduziertes Graphenoxid (rGO), als Derivate von Graphen, besitzen zum
Teil auch diese vielversprechenden Materialeigenschaften. Darüber hinaus
bieten die funktionellen Gruppen im GO Material vielfältige Möglichkeiten
für die Immobilisierung von Biomolekülen und erlauben zudem eine
Wafer-skalige Herstellung von Sensoren auf beliebigen Substraten. Im Rahmen
dieser Arbeit wurden GO-Flocken durch eine neu entwickelte Methode zur
Niedertemperatur-Exfoliation von Graphit mit nachfolgender Entsalzung
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(LTEDS) hergestellt. Die qualitativ hochwertigen GO-Flocken wurden mittels
Rasterelektronenmikroskopie (SEM), Transmissionselektronenmikroskopie (TEM),
UV-VIS-Spektroskopie, Röntgenbeugung (XRD) und Fourier-Transform-Infrarot
(FT-IR) Spektroskopie intensiv charakterisiert. Die GO- und rGO-Dünnschichten
wurden im Wafer-Maßstab unter Verwendung einer Gasphasen-Silanisierung der
Wafer und Spin-Coating dünner Schichten hergestellt und mittels Photolithographie
und reaktivem Ionenätzen strukturiert. Nach der thermischen Reduktion in
leitfähige rGO-Dünnfilme und Strukturen wurden elektrische Charakterisierungen
mittels zyklischer Voltammetrie, Strom-Spannungs (I-V)-Kennlinien und
electrolytensensitiven Feldeffekt-Transistor (ESFET) Messungen durchgeführt.
Diese kombinierten elektronischen und elektrochemischen Charakterisierungen
zielten darauf ab, die topographische Qualität, Gleichmäßigkeit und
Ladungsträgerbeweglichkeit der rGO-Dünnfilme im Wafermaßstab zu analysieren.
Die rGO-Dünnfilme wurden als funktionelle Schichten in verschiedenen
Biosensorkonzepte wie Oberflächenplasmonenresonanzspektroskopie (SPR),
elektrochemische Impedanzspektroskopie (EIS) und ESFET-Messungen
verwendet. Die Eigenschaften dieser Biosensorkonzepte und die entsprechenden
Sensormechanismen wurden analysiert und detailliert ausgewertet. Der bipolare
Ladungsträgertransport innerhalb der rGO-Dünnfilme ermöglichte ein elektrisches
Abstimmen der SPR-Intensität. Concanavalin A (ConA) wurde unter Verwendung
des rGO-basierten SPR-Prinzips nachgewiesen, und eine Nachweisgrenze (LOD) von
nur 0.01 µg ml−1 wurde erreicht. Solch eine niedrige LOD war mit Gold-basierten
SPR-Sensoren nicht erreichbar. Außerdem wurden alle elektronischen Biosensor
Experimente in einer Pufferlösung mit einer Ionenstärke von 162 mM und
einer daraus resultierenden, sehr kurzen Debye Abschirmungslänge (0.76 nm)
durchgeführt, die einer physiologischen Lösung sehr ähnlich war (150 mM
und 0.78 nm). Die rGO-basierten EIS- und ESFET-Sensoren zeigten dabei eine
hervorragende Performance, um PSA im klinisch relevanten Konzentrationsbereich
(4-10 ng ml−1) nachzuweisen.
Die in dieser Dissertation entwickelten und optimierten, rGO-basierten Biosensoren
leisteten einen hochsensitiven PSA-Nachweis jenseits der typischen Limitierung
durch die Debye-Abschirmung von Ladungen und zeigten dadurch ein sehr großes
Potenzial für reale Biosensorkonzepte für die Gesundheitsversorgung der Zukunft.
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List of Used Acronyms
AC Alternating current
AFM Atomic force microscopy
APS 3-aminopropylsiloxane
APTES (3-aminopropyl) triethoxysilane
ATP 4-aminothiophenol
C-V Capacitance-voltage
cDNA Complementary DNA
CE Counter electrode
ConA Concanavalin A
CPE Constant phase element
CTC Circulating tumor cell
CVD Chemical vapor deposition
DC Direct current
DIW De-ionized water
EDC N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride
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FT-IR Fourier-transform infrared
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GO Graphene oxide
HSA Human serum albumin
I-V Current-voltage
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IDE Interdigitated electrode
IHM Improved Hummers’ method
ISFET Ion-sensitive field-effect transistor
LOD Limit of detection
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LTEDS Low-temperature exfoliation and desalination
MCH 6-mercapto-1-hexanol
MOS Metal-oxide-semiconductor
MOSFET Metal-oxide-semiconductor field-effect transistor
NHS N-hydroxysuccinimide
NP Nanoparticle
PBS Phosphate buffered saline
PBST Phosphate buffered saline with tween-20
PCa Prostate cancer
POC Point-of-care
PSA Prostate-specific antigen
PSAD PSA density
PSADT PSA double time
ProPSA Pro-forms of PSA
PSAV PSA velocity
fPSA Free PSA
tPSA Total (free and complexed) PSA
RE Reference electrode
(r)GO Graphene oxide and reduced graphene oxide
rGO Reduced graphene oxide
RIU Refractive index unit
RPA Random-phase approximation
SEM Scanning electron microscopy
SP Surface plasmon
SPR Surface plasmon resonance
ssDNA Single-stranded DNA
TEM Transmission electron microscope
TRP Thermal reduction protocol
UV-VIS Ultraviolet-visible
VDP Van der Pauw
WE Working electrode
XPS X-ray photoelectron spectroscopy
XRD X-ray diffraction
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1 | Introduction
Prostate cancer (PCa) [1–3] is the fifth leading cause of death from cancer in males
around the world, according to the GLOBOCAN database 2012 [4]. An alveolar
exocrine gland, the prostate is part of the male reproductive system responsible
for producing alkaline fluids that are critical for maintaining suitable chemical
environment for the sperms and also neutralize the acidity of the vaginal tract. PCa
tends to develop in men over the age of fifty [5]. Its progress is often slow and
patients with PCa may have no symptoms and eventually die of other unrelated
causes. But in many cases, the patients who are diagnosed with PCa rapidly manifest
life-threatening symptoms [6]. Therefore, it is highly necessary to carry out the PCa
screening in order to discover the cancer in its early stage. Aiming to reduce the
suffering as well as the mortality, the corresponding measures should be properly
tailored for the patients, by balancing the potential benefit of treatments and the
expected harms of the intervention. Meanwhile, the discussion with the patients about
the pros and cons should be repeated along the treatment with the newest available
information about the interventions.
The PCa progression is represented genetically and proteomically in and around
the prostate by an overexpression of abnormal nuclear proteins, such as cell-cycle
proliferation markers, structural proteins and some other molecules whose functions
have yet to be addressed [7, 8]. To strengthen the protection against the pathological
changes, antigens and specific inhibitors are activated. By examining and monitoring
the abnormal molecules, so-called biomarkers, the PCa can be identified in its very
early stage. This screening process is a critical challenge for pathologists, clinicians
and biosensor researchers to precisely address the disease level.
PCa screening
Plenty of effort has been made to analyze PCa related biomarkers in serum, tissue
and urine, which are summarized in table 1.1 [8]. The exact functional roles of these
biomarkers in relation with the level, progression and aggressiveness of the PCa are
still under investigation. Their sensitivity and specificity for diagnosing PCa must also
be further evaluated and validated for real clinical utility.
Among all the biomarkers in table 1.1, prostate-specific antigen (PSA) is the
most commonly used to identify the presence of PCa and to address the disease
aggressiveness and relapse after treatment [9]. This biomarker is a type of glycoprotein
produced by cells in the prostate gland (both normal cells and cancer cells). It is mostly
found in semen, but a small amount can also be found in the blood. The serum
PSA has been approved by the U.S. Food and Drug Administration since 1994 for
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Table 1.1: Prostate-specific biomarkers in body fluids.
Body fluids Prostate-specific biomarkers
Serum PAP, tPSA, fPSA, ProPSA, PSADT, PSAD, PSAV, EPSA, EPSA-2
Tissue GSTP1, AMACR, TMPRSS2-ETS gene rearrangement
Urine DD3PCA3/UPM3
identifying PCa. Most healthy men have serum PSA levels under 4 ng ml−1. However,
the range 4-10 ng ml−1 of the serum PSA is regarded as a “gray zone”, which implies
further PCa diagnosis tests for the patients. Indeed, the elevation of serum PSA is
frequently caused by benign prostatic hyperplasia, prostatitis, prostatic manipulation
or medical interventions, for instance, cystoscopy. In addition, ethnicity, age, relative
size of the prostate gland, dietary changes and physical activity of the patients have
been found to make the PSA levels fluctuate [10–13]. These above-mentioned issues
may induce an improper interpretation of the PCa screening, leading to false positive
or false negative diagnoses and resulting in inadequate treatments. A false positive
diagnosis means that a high PSA level is detected, but the patient has no cancer.
A false negative diagnosis corresponds to a case where a patient with PCa shows
low PSA levels. Therefore, in order to avoid diagnostic discrepancies with the use of
PSA as a biomarker, it is proposed to examine additional parameters: PSA velocity
(PSAV), defined as PSA changes over time (ng ml−1 per year); PSA density (PSAD),
defined as PSA level divided by the sonographic prostate volume; PSA double time
(PSADT), defined as the time for PSA level to double; the ratio of free PSA (fPSA)
to total (free+complexed) PSA (tPSA); or the ratio of pro-forms of PSA (ProPSA) to
fPSA. All these biomarkers were suggested after intensive investigation for accurate
PCa screening.
State-of-the-art of PSA tests
At present, PSA is the most popular biomarker used for PCa screening. The typical
sensing mechanism is making use of an immunoassay which generates an optical
signal to identify the PSA level. The sensing range and response time are dependent
on types, structures, and readout methods of the biosensor assay. The equipment
supplied for the PSA tests in clinical laboratories can achieve the required sensitivity
by covering the “gray zone” of PSA levels (4-10 ng ml−1), but they are generally bulky
and costly. In addition, the sample transportation and administration processes on
the clinical laboratories side lead to extra costs and long waiting time. Therefore,
the point-of-care (POC) devices are developed to provide portable, cost-effective
and instant test results for the convenience of both patients and clinicians. The
equipment available on the market for PSA tests for use in clinical laboratories and
POC testing are listed in table 1.2 and table 1.3, respectively. Nevertheless, the PSA
test results from POC devices are barely satisfactory, mainly because the PSA level
is not perfectly addressed due to technical limitations. For instance, the measured
PSA value may vary up to 20 % between two Tandem-R PSA assay from Hybritech
company [14]. The portable device concile®Ω100 Reader was directly compared with
the bulky clinical equipment: Immulite 2000®and Centaur®test systems from Siemens
Healthcare Diagnostics. Although the PSA sensing range covers 0.5-25 ng ml−1, it is
suggested that the CancerCheck®PSA on this POC device is only appropriate for
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detecting PSA concentrations below 2.5 ng ml−1 to identify the cases of low PCa
risk. From PSA values of 10 ng ml−1, the tests are proposed to be performed with
the standard assays by bulky equipment, because the diagnostic precision of POC
measurement is impaired [15].
Table 1.2: Commercialized equipment used in clinical laboratories for PSA tests.
Company Roche Diag-
nostics [16,
17]
Siemens
Healthcare
[18]
Ortho Clin-
ical Diag-
nostics [19,
20]
Beckman
Coulter [21]
Abbott Diag-
nostics [22]
Country Switzerland Germany USA USA USA
Equipment COBAS ana-
lyzers
ADVIA Cen-
taur, IM-
MULITE,
Dimension
systems
VIT-
ROS®ECiQ
3600 Immun-
odiagnostic
Systems, VIT-
ROS®5600
Integrated
Systems
Beckman Ac-
cess/Access
II Immunoas-
say system,
Hybritech To-
tal PSA assay
Architect,
AxSYM, IMx
Principle Electro-
chemiluminescence
immunoassay
Biomarker fPSA tPSA,fPSA tPSA, fPSA tPSA tPSA,fPSA
Range
(ng ml−1)
0.01-100 0.001-150 0.1-150 0-100
Sample vol-
ume (µl)
20 25-175
Time (min) 18 29
Table 1.3: Commercialized equipment for POC for PSA tests.
Company Mediwatch [23] Sekisui Diagnos-
tics [24]
concile [15, 25] True Diagnostics
[26]
Country UK USA USA USA
Equipment PSAwatch-
Bioscan
FaskPack®IP Au-
tomated System
concile®Ω100 TrueDx Reader™
Principle Au particles la-
beled immunoas-
say
Chemi-
luminescent im-
munoassay
Au particle la-
beled chromato-
graphic sandwich
immunoassay
Biomarker tPSA fPSA tPSA/fPSA PSA
Range
(ng ml−1)
0.5-25 0.05-20 0.5-25
Sample vol-
ume (µl)
35 30
Time (min) 10 12 20
Release year 2007 2014
Being hindered by the insufficient specificity, the PSA test is necessarily combined
with a biopsy to prognose the PCa screening. When the serum PSA reaches a level
above 4 ng ml−1, a further confirmatory diagnosis should be performed by digital
rectal examination, transrectal ultrasound or pathological analysis of prostate needle
biopsy [27]. For the biopsy, a tissue fragment is collected from the patient’s prostate
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by using a needle with a diameter of one millimeter. It cannot be guaranteed
that the tissue sample is taken from the cancerous lesions and there is a 30 %
probability of missing the cancer tissue. Although more advanced techniques, such as
MRI-ultrasound fusion biopsy examination are developed to perform a precise tissue
collection from the cancer lesion, it is still invasive, carries the risk of subsequent
infections, and is another source of physiological and psychological suffering for the
patients.
In order to avoid unnecessary biopsy, and reduce over-diagnosis and over-treatment
of early detected PCa caused by inaccurate PSA levels [28], biomarkers that
can diagnose PCa accurately are in high demand. There is a concerted effort
to identify and develop the tests of highly specific biomarkers of PCa that are
minimally invasive, using only body fluids such as blood, urine, and semen.
These three general biomarkers matrices directly relate to circulating tumor cell
(CTC), DNA, RNA/miRNA, prostasomes/exosomes, proteins and antigens, which
are over expressed and responsible for the cancer cell proliferation and metastasis
[7]. However, it is noteworthy that no biomarker is ideal. It is preferable to use a
combination of biomarkers to provide multi-variable information about the status
of PCa, leading to proper and precise treatments for the patients and avoiding
under-estimation or over-diagnosis.
Biosensing mechanism and strategy
Many other PCa biomarkers potentially display superior specificity than PSA, but
they are still being investigated to validate their utility for the real clinical application.
Besides, the concentration of these biomarkers in body fluids is comparably low
due to the presence of other unrelated matters. Therefore, new emerging sensing
technologies focus on developing biosensors with multiplexing capability, which
could be used for detecting several biomarkers simultaneously.
The typical biosensing principles, as described in figure 1.1, are based on
thermodynamics, mechanics, optics and/or electrochemistry mechanisms, with
a corresponding biosensing signal readout from calorimetry, micro-gravimetric
analysis, photometry and electrochemical measurements.
To improve the biosensing selectivity, bio-recognition structures or molecules are
typically immobilized on the transducer layers. The transducer elements can be
cement based materials, piezo ceramics (e.g. quartz, zinc oxide (ZnO), lithium niobate
LiNbO3), nanoparticles (e.g. gold (Au)), metal (e.g. Au, platinum (Pt), palladium
(Pd)), dielectric (e.g. silicon dioxide (SiO2), silicon nitride (Si3N4), aluminium oxide
(Al2O3), tantalum pentoxide (Ta2O5), aluminium anion (Al
– ), borate anion (B– ),
sodium (Na– ) silicates), crystalline (e.g. silver chloride (AgCl), silver bromide (AgBr),
silver sulfide (Ag2S), lanthanum trifluoride (LaF3)), heterogeneous (e.g. ion-exchanger,
polymers, ionophores) membranes, carbon based material (e.g. carbon nanotubes,
graphene, graphene oxide and reduced graphene oxide ((r)GO) and other two
dimensional materials (molybdenum disulfide (MoS2)). Based on the above basic
sensing mechanisms, plenty of biosensors have been investigated and corresponding
development toward PSA detection before 2007 can be found in a review paper [33].
The most recent biosensors for PSA detection are summarized in table 1.4.
The label-based biosensing is the major transduction modality for PSA detection
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Figure 1.1: The over expressed biomarkers: CTC, DNA, RNA/miRNA, prostasomes/exosomes,
proteins and antigens specifically bind with receptor biomolecules or structures on the surface
of the transducer of a biosensor. The binding activities of these biomarkers are recognized and
transformed by different formats transducing mechanisms into thermodynamic, mechanical, optical
and electrochemistry readout signals. The images of CTC, DNA, prostasomes/exosomes and antigens
are adpated from [29–32].
with optical readout signals, but this biosensing format has difficulties to realize
multiplex sensing. The recent research is weighted in favor of label-free detection,
making using of other transducing formats based on field-effect transistor (FET)
[34–40], mechanical resonators [41], piezoelectric effect [36], surface acoustic wave
[42], electrochemical impedance spectroscopy (EIS) [43], surface plasmon resonance
(SPR) [44] and memristors [45].
An ideal biosensor is required to response linearly over the relevant concentration
range, operate in complex media, have no or minimum cross-sensitivity, have no
false positive and false negative results. In terms of design, they must be robust,
reproducible, reliable, cost-effective, easy to handle, environmentally friendly, and
disposable. Towards POC tests, it is also essentially required that the devices are of
reduced sizes. Such a device miniaturization can be realized by taking advantages
of micro- and nano-scale transducers as integral components of the biosensors. With
size reduction, the size effect of nano-materials emerges [46] and leads to ultra-high
sensitivities for biosensing applications [45, 47–50].
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Table 1.4: Recent biosensors for PSA detection.
Sensing mech-
anism
Transducer Receptor
structure
Detec-
tion range
(ng ml−1)
Buffer Detection
time (min)
Year Ref.
Fluorenscence Nanoparti-
cle label
10−3-1 0.05 M Tris-
HCl buffer
> 180 2004 [51]
Fluorenscence Fluropoly-
mer micro-
capillary
film
0.9-60 Blood 13 2015 [52]
Field-effect
transistor
Si
nanowires
(NWs)
Nucleic
acid
> 9 · 10−4 1 µM phos-
phate
buffer
< 30 2005 [34]
Field-effect
transistor
In2O3 NWs Antibody > 5 PBS < 3 2005 [35]
Field-effect
transistor
Single wall
nanowires
Antibody > 5 PBS < 10 2005 [35]
Field-effect
transistor AlGaN/GaN
Antibody 10−2-103 PBS 0.1 2007 [36]
Field-effect
transistor
PE-
DOT:PSS
polymer
Antibody
labeled
with Au
NPs
10−3-100 0.1 M PBS 1440 2010 [37]
Field-effect
transistor
MoS2 Antibody 10−3-10−3 PBS 10 2014 [38]
Field-effect
transistor
Si NWs Aptamer 10−2-103 10 mM
phosphate
buffer
120 2018 [39]
Field-effect
transistor
MOSFET Molecu-
larly in-
mprinted
cavity
10−3-10−2 Diluted
human
plasma
30 2016 [40]
Mechanical
resonator
Si Antibody 1.5 · 10−6-
50
Serum 60 2007 [41]
Piezoelectric Quartz Antibody 1.5-40 150 mM
PBS
> 40 2007 [36]
Surface acous-
tic wave
LiTaO3 DNA ap-
tamer
10-103 1 µM PBS < 3.5 2015 [42]
Electrochemi-
cal enzymatic
redox cycling
Au NPs/
MnO2
NWs
Glucose
oxidase
(enzyme),
TMB (re-
dox termi-
nator)
1.2 · 10−3-
100
PBS 40 2014 [53]
Surface plas-
mon resonance
Au thin
film
Antibody 8.9-825 PBST 3.5 2015 [44]
Electrochemi-
cal impedance
spectroscopy
Au elec-
trode
Aptamer-
Molecularly
imprinted
cavity
0.1-100 Redox
markers in
10 mM PBS
2016 [43]
Memristor Si NWs Aptamer >
0.76 · 10−6
10 mM PBS 60 2016 [45]
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Graphene, graphene oxide and reduced graphene oxide transducers for
biosensing
Graphene and graphite have been studied theoretically since 1947 [54–56]. It was
believed that graphene and graphite cannot exist in the free state due to the structure
instability. Therefore, only theoretical models to describe the properties of various
carbon-based materials have been established in the past [57, 58]. In 2004, Andre Geim
and Konstantin Novoselov mechanically exfoliated the two dimensional material
graphene from a highly ordered pyrolytic graphite using a scotch tape [59]. This
discovery turned the illusion into reality and triggered a motion to employ graphene
towards real applications in the field of biosensors.
The graphene exhibits promising electrical [59, 60], optical [61–66], mechanical [67],
thermal [68] and biocompatible [69] properties. The bipolar property and high carrier
mobility of graphene make it a suitable material for electrochemical biosensing
applications. With the target biomolecules attached onto the graphene transducer
layer, the carrier (holes or electrons) concentration (Fermi level) is tunable and the
biosensing process is addressed in the form of a shift of the Dirac-point or a change
in the bipolar characteristic curve. Due to the excellent electronic properties, graphene
offers a promising sensitivity as a transducer layer in detecting single gas molecules
[47]. In terms of optical properties, the signals are tunable and can be controlled by
an external electric field. Such a method was applied by using infrared spectroscopy
for biosensing with graphene coated nanoribbons [70]. Biomolecules of different sizes
can be detected in the clinical concentration range. However, the carbon lattice of
graphene only provides the binding by pi-pi stacking to attach the linker molecules
for immobilizing the specific probe biomolecules. As a result, the binding strength
and diversity of further surface functionalization is massively weakened and limited
[71].
Two derivatives of graphene drew tremendous attention in recent years: graphene
oxide (GO) [71, 72] and reduced graphene oxide (rGO) [73–75]. Both of them preserve
the electronic and optical properties similar to graphene and can be cost-effectively
prepared in wafer-scale [71]. Furthermore, the tertiary alcohols and ethers functional
groups that remain on the carbon basal plane even after the reduction treatment,
provide a high yield of covalent binding of receptor biomolecules. This is obtained by
various means of chemical interactions to selectively capture the target analytes (PCa
biomarkers) from different complex matrices.
A prerequisite for later commercialization of biosensors is a confirmed device
robustness and reproducibility with reliable sensing results. In this work, the
biosensing capability of the established (r)GO transducer layers in SPR, EIS and
electrolyte-sensitive field-effect transistor (ESFET) configurations for PSA detection
is addressed. The essential role of the rGO thin films in the biosensing processes
is intensively investigated for further optimization of the exfoliation process
of GO flakes, reduction treatments and configuration design of devices. This
enables a straightforward detection of prostate-specific biomarkers in their clinical
concentration ranges with reproducible and reliable readout signals.
This thesis is arranged as follows:
• In Chapter 2, a fabrication process flow of GO thin films on 4-inch wafers is
described, using chemically exfoliated GO flakes as the source material. Various
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state-of-the-art spectroscopy and microscopy techniques were carried out to
illustrate the structural details of the produced GO thin films.
• In Chapter 3, the reduction methods to transform the insulating GO thin films
into conductive rGO thin films are summarized. After a thermal reduction
treatment, the uniformity of resistance as well as the field-effect mobility of
the rGO thin films on 4-inch wafers were studied to understand the biosensing
performances in later chapters. The reduction method was tested in order to
protect the functional oxygen groups to a maximum degree.
• In Chapter 4, the (r)GO thin films are employed as functional layers on
conventional Au based SPR devices to investigate their sensing mechanism
and tunability of the SPR signals with and without externally applied electrical
fields.
• In Chapter 5, the rGO thin films are utilized as the transducer layers on
top of interdigitated electrodes (IDEs) in impedance spectroscopy. PSA-specific
aptamers and antibodies served as receptor biomolecules in different buffer
concentrations to analyze and address the essential role of the rGO thin films in
the biosensing process for PSA detection.
• In Chapter 6, the rGO thin films are applied as transducer layers on top of IDEs
in an ESFET configuration for PSA detection. The bipolar properties of rGO play
a key role in the ESFET sensing. Moreover, the possibility of immobilizing metal
nanoparticles were examined with their impact on the biosensing process.
• Chapter 7 presents the conclusions and outlook. Novel findings and concepts
elaborated in this thesis are discussed and related to latest findings in the field
of biosensing with graphene based materials.
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2 | GO Based Devices: Material
Synthesis and Nanofabrication
In this chapter, GO and rGO, which are utilized as a source material for
the preparation of biosensor devices in this thesis, are presented. Firstly, the
fundamental properties of pristine graphene are introduced as the predecessor
of other carbon forms. The production methods of pristine graphene towards
massive device production is reviewed. Secondly, the fundamental properties
of GO and rGO flakes are introduced and the low-temperature exfoliation
and desalination (LTEDS) synthesis method based on the improved Hummers’
method (IHM) is discussed in detail. The GO flakes produced by LTEDS were
characterized by scanning electron microscopy (SEM) and transmission electron
microscope (TEM). Evidence of the upgraded process is shown by ultraviolet-visible
(UV-VIS) spectroscopy, X-ray diffraction (XRD) and Fourier-transform infrared (FT-IR)
spectroscopy characterizations. Thirdly, the preparation procedure of GO thin films
via gas-phase silanization and a spin-coating technique is described and discussed.
Afterwards, the spectroscopic ellipsometry was used to characterize the topography
of the formed thin films, which are used after a reduction treatment as an alternative
transducer layer for biosensing. Fourthly, a nanofabrication process of GO thin film
based electronic devices is described and the obtained GO pattern was characterized
by atomic force microscopy (AFM), SEM and optical microscopy.
2.1 Fundamentals of Graphene
Graphene was mechanically exfoliated for the first time from bulk graphite in 2004
[59]. It can be observed under an optical microscope on a 285 nm thick SiO2 substrate,
due to the optical contrast [61]. Graphene is a single atomic carbon lattice, in which
the carbon bonds are sp2 hybridized. The out-of-plane pi bonds that contribute to
a delocalized network of electrons, are responsible for the electrical conduction of
graphene and lead to weak interactions among the graphene layers or between
graphene and a substrate. Graphene exhibits extraordinary electronic properties
[59], optical properties [61], mechanical properties [67], with a breaking strength of
42 N m−1 and a Young modulus value of 1.0 TPa, as well as high thermal stability
up to 700 ◦C [68]. Possessing an ultra-high surface to volume ratio, various defects
within the sheets and highest ratio of edgy carbon atoms compared to similar
carbon materials such as nanotubes, graphene has an increased chemical reactivity,
which results in a high potential of functionality. Nowadays, wafer-scale graphene is
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generally produced by chemical vapor deposition (CVD) [76] or by high temperature
decomposition [77]. Larger-scale fabrication has been realized by a roll-to-roll method
[78]. With an extra step to transfer graphene to a target substrate, the application
potentials based on graphene can be further realized [47, 79–84]. Since these properties
promote graphene as a promising material for various applications, particularly as a
transducer in biosensors, the intrinsic electronic and optical properties are introduced
in detail in this section.
Massless Dirac Fermions
Intrinsic graphene acts as the mother of all graphitic forms by being wrapped up into
0D fullerenes, rolled into 1D nanotubes or stacked into three dimensional graphite
[59]. It serves as the basis to study other allotropes of carbon, as shown in figure 2.1(a).
Graphene is a two dimensional single layer of carbon atoms with a hexagonal packed
structure, as shown in figure 2.1(b). The structural unit cell consists of two different
atoms A and B which are arranged in a triangular lattice with a carbon-carbon
distance a ≈ 1.42 Å. The lattice can be defined by two vectors a1 and a2:
a1 =
a
2
(
3,
√
3
)
, a2 =
a
2
(
3,−
√
3
)
(2.1)
For this periodic lattice, the Fourier transform can be applied to obtain the
corresponding reciprocal space (also known as momentum space). The reciprocal
lattice vectors can be written as:
b1 =
2pi
3a
(
1,
√
3
)
, b2 =
2pi
3a
(
1,−
√
3
)
(2.2)
In the reciprocal lattice, the first Brillouin zone is a primitive cell which contains
exactly one lattice point and it is used to define the properties of a lattice [85]. In
the case of graphene, as shown in figure 2.1(c), the two points K and K′, located at
the corners of the graphene Brillouin zone, are the so-called Dirac points (also called
Dirac cones) [60, 86]. Their positions in momentum space are as follows:
K =
(
2pi
3a
,
2pi
3
√
3a
)
, K′ =
(
2pi
3a
,− 2pi
3
√
3a
)
(2.3)
The other 4 Dirac cones can be obtained by adding some reciprocal lattice vectors
to K and K′. Considering that the electrons hop to the nearest and second nearest
neighbor atoms, the energy bands derived from the tight-bonding Hamiltonian can
be expressed as follows [54]:
E± (k) = ±t
√
3 + f (k)− t′ f (k)
f (k) = 2 cos
(√
3kya
)
+ 4 cos
(√
3
2
kya
)
cos
(
3
2
kxa
) (2.4)
where t is the nearest neighbor hopping energy and t′ is the second nearest neighbor
hopping energy, which represent the hopping between the different lattice and within
the same lattice, respectively. The plus and minus signs apply to upper pi and lower
pi∗ bands, respectively.
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Figure 2.1: (a) On top, graphene, the mother of all graphitic forms [87]. Fullerene (left), nanotubes
(center) and graphite (right) are obtained by cutting and folding graphene. (b) Lattice structure of
graphene made of two interpenetrating triangular lattices. (c) First Brillouin zone of graphene lattice,
where the Dirac cones are located at the K and K′ points [60].
In condensed matter physics, a surface in the reciprocal space that separates occupied
and unoccupied electron states is called a Fermi surface. In the case of graphene, the
Fermi surface is defined by K and K′. By expanding the full band structure (equation
2.4) close to the Dirac point K (or K′) with the vector k = K + q while |q|  |K|, the
dispersion relationship of energy and momentum can be obtained:
E± (k) ≈ ±υF|q|+O
(
(q/K)2
)
(2.5)
where q is the momentum relative to the Dirac points, and νF is the Fermi velocity
with the value:
νF = 3ta/2 ' 1 · 106 m s−1 (2.6)
Different from the free electron case with the E (q) = q2/ (2m), the energy in graphene
as shown in equation 2.5 has a linear relationship with the momentum of the particles.
From the quantum mechanics point of view, these particles are defined as massless
Dirac fermions. Within the semi-classical approximation, the cyclotron mass can be
deduced as:
m∗ =
√
pi
υF
√
n (2.7)
where n is the electronic density. Experiments have confirmed the existence of such
massless Dirac quasiparticles in graphene [88], while plenty of effort was made in
order to comprehend their properties [59, 60, 63, 68, 87, 89–91].
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Electronic Properties
The electron orbitals of the carbon atoms in graphene are s, px, py and pz orbitals.
The electron configuration for a single carbon atom in the ground state is 1s22s22p2.
After forming the carbon lattice as graphene, the electron configuration of the carbon
atom becomes 1s22s12p3 [92]. The 1s2 electrons are inert and plays no contribution
for the chemical bonding formation. The 2s1 and two of the 2p3 electrons (2px
and 2py) orbitals hybridize to form three in-plane sp2 orbitals, corresponding to
σ-bonds. The σ-bonds are responsible for maintaining the chemical bonding of carbon
atoms and determine the mechanical properties of the graphene. The 2pz orbitals are
perpendicular to the plane of carbon lattice and responsible for most of the unusual
electronic properties of graphene. Each pz orbital contributes one electron per carbon
atom. The pz orbitals of carbon atoms combine to form the out-of-plane pi bonds,
which subsequently hybridize to form pi bands and pi∗ bands [93]. In the pi-pi∗ system,
the cosine-like energy bands of the sublattices that are made of atoms A (or B) intersect
at E = 0 and result in the conical sections of the energy spectrum as shown in figure
2.2(a). The minus band, as represented in equation 2.4, is fully occupied, while the
plus band is empty. These two bands touch at the K points, which implies graphene
is a zero-gap semiconductor. In a pronounced electric field, the Fermi level can be
tuned towards either the valence or the conductance bands as shown in figure 2.2(b).
This electronic property of graphene is known as bipolar behavior, in contrast to
conventional monopolar semiconductors. The bipolar property means that graphene
can behave as either an n-type or a p-type semimetal with the assistance of an
external electronic field, not requiring doping elements to offer mobile carriers.
The concentration n of electrons and holes can be modulated continuously as high
as 1013 cm−1, with the mobility µ exceeding 15 000 cm2 V−1 s−1, which is barely
influenced by temperature [87]. The Dirac fermions in graphene are also insensitive
to the defects in the graphene lattice. This implies that the carriers can travel freely
thousands interatomic distances even at room temperature without being scattered,
which is defined as ballistic transport on submicron scale (up to 0.3 µm at 300 K) [87].
Figure 2.2: Energy landscape and Fermi level of graphene. (a) Energy landscape of graphene with
t = 2.7 eV and t′ = 0.2t [60] and a close-up of the energy bands at one of the Dirac points. (b) The
Fermi level is tuned into conductance and valence bands by external applied voltages.
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The energy spectrum and the electronic properties rapidly evolve with the number
of layers and approach the three dimensional limit of graphite at 10 layers
[94]. Only mono- and bilayer have a simple energy spectrum and behave as
zero-gap semiconductors. For 3 and more layers, the spectrum becomes complicated,
while several charge carriers appear, and the conduction and valence bands start
overlapping [59, 94, 95]. Due to its structural and electronic flexibility, there are plenty
of possibilities to tailor graphene by external metal atoms, molecules and interactions
among the graphene layers. Such excellent electronic properties allow graphene to be
utilized in various application fields.
Optical properties
The linear dispersion of the Dirac fermions determine the optical properties of
graphene. These quasiparticles can completely transmit through a classical forbidden
region without being localized, a fact known as the Klein paradox [96, 97]. The
dynamic conductivity G0 of Dirac fermions in graphene is a constant:
G0 = pie2/2h ≈ 6.08 · 10−5Ω−1 (2.8)
while e is the charge of an electron and h is the Planck constant. This universal
conductivity infers that the optical transmittance and reflectance are also constants:
T ≡ (1 + 0.5piα)−2, R ≡ 0.25pi2α2T (2.9)
where α = G0/piε0c is the fine structure constant. As a result, the opacity of graphene
is equal to:
1− T ≈ piα = 2.3 % (2.10)
This value was extracted experimentally with incident white light onto free-standing
and undoped graphene [61, 62]. The absorption spectrum is flat from 300 nm to
2500 nm, with a peak (above 10 %) around 275 nm in the ultraviolet region due
to resonant excitons which are induced by van Hove-like singularities [98, 99].
During the interband excitation generated by an ultrafast optical pumping, the carrier
population in conductance and valence bands are in non-equilibrium states. The
possible relaxation mechanisms, as depicted in figure 2.3(a), are generally associated
with:
i) Carrier-carrier intraband and phonon emissions in the 100 femtosecond scale.
ii) Electron-hole interband recombination and cooling of hot phonons in the
picosecond scale.
Furthermore, the linear dispersion of the Dirac electrons enables ultrawide band
tunability in optics [100]. At the Dirac point, the electron energy is:
E ≈ h¯νFk‖ (2.11)
where k is the electron momentum. An external electrical field or chemical doping
tend to tune the Fermi energy to:
EF ≈ h¯νFkF (2.12)
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where kF = (pin)
1/2, and n is the concentration of the injected or the doped carriers.
Such a Fermi-level tuning effect induces immediately an optical gap of 2EF for
interband and intraband transitions as shown in figure 2.3(b). The Pauli blocking
of photon absorptions in the case of graphene is shown in figure 2.3(c).
Figure 2.3: (a) Possible relaxation mechanisms for the non-equilibrium electron population [64]. (b)
The Fermi level is raised up EF = h¯νFkF by an external electronic field or chemical doping with
kF = (pin)
1/2, while n is the concentration of doped carriers. The optical gap of a size 2EF is open.
For an energy smaller than this value, the vertical transitions are forbidden [64]. (c) In graphene: Pauli
blocking of photon absorptions.
The imaginary part = {rp} of the Fresnel reflection coefficient for p-polarized light
describes the energy-loss probability as well as the wave vector k‖ and the frequency
ω dependent optical excitations, when graphene is excited by a fast electron [101].
The optical excitations include the emergence of a plasmon band. In an electrostatic
view, rp is given as:
rp =
1
1− jω
2pik‖σ
(2.13)
where σ is the graphene conductivity. In the event of finite graphene structures with
a much larger size than the Fermi wavelength λF = 2pi/kF, the k‖ dependence plays a
negligible role such that the graphene conductivity can be expressed as random-phase
approximation (RPA) conductivity [78, 102]:
σ (ω) ≡ σ
(
k‖ = 0,ω
)
=
−e2
pih¯
j
ω+ jτ−1
−∞∫
∞
|E|d fEdE +
E
|E|
1− 4E
2
h¯2 (ω+ jτ−1)2
 dE (2.14)
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where fE is the electron distribution as a function of the energy E and τ is the finite
electronic relaxation time. The first term inside the integral represents the intraband
transition (marked as path 1) and the second term describes the interband transition
(marked as path 2) across the optical gap 2EF as shown in 2.3(b).
The plasmon dispersion relationship can be deduced by placing equation 2.14 into the
pole of equation 2.13 (ksp = jω/ (2piσ)). The plasmon wavelength is obtained with:
λsp =
2pi
< {ksp} = λ0 4αε1 + ε2 EFh¯ω (2.15)
where λ0 is the wavelength of the incident light, α is the fine structure constant, ε1
and ε2 are the dielectric parameters of the materials on both sides of the graphene.
The plasmon dispersion relation only applies to the short in-plane wavelengths and
the electron-hole excitations can be neglected between the induced charges with
a separation distance larger than nanometers. The polarization of the interband
transition generates a plasmon shift, which agrees with the description of local-RPA
conductivity [64]. In recent years, graphene plasmons have become extraordinarily
interesting, especially in the field of bio-plasmonic applications [63–66]. The surface
plasmons (SPs) along graphene’s surface are confined to a volume which is
approximately 106 times smaller than the diffraction limit and in favor of strong
light-matter interaction [103]. Based on the semimetallic characteristics of graphene
[59, 60], the externally applied electric field can tune the Fermi level towards either
the conductance band or the valence band, resulting in a sign switch of carrier
type and a drastic change in carrier concentration. The aforementioned electric field
has a strong tuning effect in the plasmon mode [104], the optical parameters [105],
the quantum pathways of inelastic light scattering [106] and the band-gaps [107].
Moreover, the field enhancement [104] and interaction strength of SPs in graphene at
the quantum level is increased by one degree, while the efficient decay rate exceeds
the natural decay rate by six orders of magnitude with reduced dimensionality [103]
and the resonant extinction cross section is much larger than the geometrical cross
section of graphene. This electric field can be applied as a gating voltage or generated
by the attachment of external molecules. With the assistance of an applied electric
field, graphene electro-plasmonic, label-free biosensors achieve a tunable sensitivity
in the mid-infrared regime [70]. Taking advantage of the above-mentioned powerful
properties, graphene has been applied as a linker layer on Au based SPR based
biosensor platforms. Its amplifying capability to boost the sensitivity during the
detection of biomolecules has been verified [108].
2.2 Fundamentals of (Reduced) Graphene Oxide
The promising high field-effect mobility, excellent mechanical properties, high
thermal stability and good biocompatibility enable graphene to be a competitive
candidate comparable to silicon or III/V heterojunction based devices for biosensors
and bioelectronic applications. However, the preparation of pristine graphene is
generally highly expensive, a high-quality wafer-scale transfer of CVD graphene to
arbitrary substrates is still challenging [109, 110] and probe molecule immobilization
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on a pure carbon lattice is based on physi-absorption, which is not always effective.
Therefore, chemically exfoliated GO [71, 72] and rGO [73–75] were intensively
exploited due to their similarity to graphene and tested out as an alternative to
overcome the dilemma that graphene is facing towards wafer-scale and robust device
preparation.
The exfoliation methods [111–113] and their potential applications [114, 115] are still
under discussion. Generally, the exfoliation process uses graphite as the starting
material. Mono and/or multi atomic carbon layers are generated due to the
degradation in the Van der Waals forces between the neighboring carbon layers. The
sp2 C−C bonds that build up the carbon hexagonal lattice are partially hybridized
and tetrahedrally coordinated by sp3 C−C and/or C−O bonds. It has been proven
that the surface of GO flakes is covalently functionalized with the following chemical
groups: ketones and phenols on the basal plane and carboxyl, anhydrates, lactones,
lactols and pyrenes at the edges [73], as shown in figure 2.4.
Figure 2.4: Schematic of a GO flake with various oxygen functional groups: ketones and phenols on
the basal plane and carboxyl, anhydrates, lactones, lactols and pyrenes at the edges [73].
Thanks to the various functional groups, GO flakes are dispersible in various solvents
for large-scale production of sensor devices on various substrates. In order to take
advantage of the extraordinary electronic and mechanical properties of pristine
graphene, the area of the pure carbon lattice network should be preserved as far as
possible during the exfoliation process. Until now, the area size of the same fingerprint
of graphene on GO flakes has reached nanoscale dimensions [112]. The electronic
resistances of these GO flakes are comparably high because the carriers are not able
to travel along the flake basal plane to realize conductivity within the microscale.
Different reduction methods have been developed to remove the oxygen functional
groups in order to enlarge the pure carbon lattice and smooth the carrier transport by
transforming insulating GO into conductive rGO [75]. It was proven that the carbon
lattice cannot be fully recovered to that of graphene [73]. The carriers can only hop
among localized sp2 states along the basal plane rather than traveling ballistically, due
to the disordered carbon lattice and residual functional groups. However, thanks to
these functional groups, the rGO surface can be functionalized with diverse metal
nanoparticles and/or be covalently decorated with external functional molecules,
resulting in a remarkable potential for molecular sensing. This is a powerful merit
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of rGO compared to graphene in practical application fields. In this work, a GO
dispersion was prepared by improving the process of IHM [111] and GO flakes
of different sizes were subsequently selected for device fabrication. A wafer-scale
fabrication method was developed to prepare rGO nano-film based devices which
were further investigated in detail. Their potential application fields are highlighted
in the next sections.
2.3 Low-Temperature Exfoliation and Desalination
(LTEDS) Method
The work described from section 2.3 to section 2.5 was published as
“Front-End-of-Line Integration of Graphene Oxide for Graphene-Based Electrical
Platforms” [116]. The images used in this thesis are partially adapted from this
paper with the journal’s permission. This paper as well as experiments described
in this chapter represent a shared work. Chemical synthesis and characterization
of the GO material was done in a parallel thesis whereas patterning and electrical
characterization was done in this thesis. For a better comprehension of this section,
both parts are summarized.
The IHM as shown in figure 2.5(a) uses H3PO4/H2SO4/KMnO4 instead of
HNO3/H2SO4/KMnO4 to initially provide a water-free equilibrium condition. The
ions SO 2–4 intercalate between the graphite layers and reduce the Van der Waals
forces at the outer zone. Subsequently, the oxidant MnO –4 reacts with the carbon
lattice by predominantly breaking the in-plane sp2 bonds and replaces them by
out-plane sp3 C−C, C−O, or C−O bonds. Stepwise, the matrices of monolayer,
bilayer, and/or multi-layer GO flakes are chemically exfoliated. The generated oxygen
functional groups are in the forms of ketones and phenols on the basal plane, while
carboxyl, anhydrates, lactones, lactols and pyrenes can be found at the edges [73].
In order to use these final product GO flakes in application fields, full exfoliation
is expected to generate mono- and/or multi-layer flakes rather than graphite-oxide
flakes. Meanwhile, a gentle and slow process is also required to preserve as much
of the carbon hexagonal lattice as possible, because the oxidation degree and the
percentage of hybridized sp3 carbon significantly restrict the transport of carriers
along the carbon basal plane compared to pristine graphene [60, 63, 74, 117]. Mainly,
the functionalization rate of the oxide groups, the generation rate of defects, and
the formation of CO2 within the carbon lattice can be suppressed by decreasing the
process temperature [112]. Instead of using 50 ◦C as in the IHM protocol, the LTEDS
developed in the framework of this thesis lowers the exfoliation temperature down to
20 ◦C (figure 2.5(b)). The very strong oxidant KMnO4 is the most critical reactant for
the exfoliation of graphite. In the highly acidic environment, MnO –4 diffuses between
the interlayer sheets and undergoes a redox reaction with the carbon atoms, so that
the required manganese oxide gets formed. Considering all the reported GO synthesis
protocols, there are currently no solutions to avoid the over-oxidation which creates
irreversible structural defects inside of the carbon lattice. To protect the hexagonal
honeycomb structure from this destructive effect, the key direction is minimizing the
mass of KMnO4, excessing the amount of graphite educts and lowering the reaction
temperature. The advantage of a 20 ◦C reaction temperature, is that it maintains the
17
active efficiency of the exfoliation and realizes a trade-off between the generation rate
of defects and the adequate percentage of functional groups.
After the exfoliation, the GO matrix contains highly-concentrated acids, which have to
be removed by a sophisticated cleaning procedure. This is a critical part of the protocol
because the residual ions and manganese oxide adhere to the GO flakes and influence
their properties negatively. In the newly established LTEDS protocol, the cleaning
procedure was upgraded to diminish this side effect and obtain a clearer fingerprint
of the oxygen functional groups compared to the IHM. The LTEDS protocol contains
the following precise steps:
i) The GO acid matrix was mixed with 400 ml milliQ water through a cone
separatory funnel, followed by pipetting 4 ml hydrogen peroxide into the
mixture to degas the CO2 and to dissolve the manganese esters and other
manganese-oxo-complexes. The milliQ water is a type of ultrapure water, which
typically has a resistivity value of 18.2 MΩ cm at 25 ◦C. The solution can be
generated by either the partial or complete hydrolysis of cyclo organo sulfate to
organo sulfate [118]. All of the above processes were carried out at 8 ◦C to avoid
a rapid temperature rise. Afterwards, the solution was allowed to sediment at
room temperature for one day to obtain a rough GO matrix. The supernatant
acid was removed and the bottom part was then mixed with fresh de-ionized
water (DIW) again by stirring. The solution was then allowed to sediment again
at room temperature for 5 days forming 3 distinct immiscible phases, as shown
in figure 2.5(c). The middle phase was extracted for later-on-treatment because
the bottom portion of the heavier products mainly consisted of graphite oxide
flakes and the supernatant acid.
ii) For further treatment, the extracted solution was centrifuged at two different
speeds, 100 rpm and 150 rpm sequentially for 60 min each and formed 3 distinct
immiscible phases, as shown in figure 2.5(d). A large portion of the ions,
primarily K+, Mn +2 , SO
2–
4 and a lower amount of the PO
3–
4 , were removed
in this step.
iii) The middle phase was extracted and mixed again with DIW by stirring,
followed up by centrifugation at 5000 rpm. With this procedure, the solution
was separated into two phases. Removing the supernatant acid, the bottom GO
layer was mixed again with DIW. This procedure had to be repeated two times
until the pH range was within 2 to 4.4. Afterwards, the GO was mixed with
hydrogen chloride 25 % and centrifuged at 5000 rpm for 50 min. To further clean
away the residual ions, the GO was dissolved in DIW again and transferred
into the dialyzing sack for one night, as shown in figure 2.5(e). After dialyzing,
the final GO product was mixed with ethanol and centrifuged two times at
5000 rpm for 50 min. The GO product was redispersed in diethyl ether to remove
ethanol completely and finally dried in the desiccator for 48 h. Afterwards, GO
flakes were dissolved in DIW and centrifuged again two times at 1000 rpm. The
supernatant was a GO flake dispersion with a final pH of around 2.9. This GO
solution can be used for later preparation of GO thin films.
The images in figure 2.5(f)-(g) expose the differences of the final GO flakes synthesized
by the IHM and the LTEDS protocols. In comparison to the IHM, the GO flakes
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generated after LTEDS were capable of freeing the functional groups from the residual
ions and CO2. The improved quality of GO flakes by LTEDS was further verified by
different characterization tools.
Figure 2.5: Synthesis procedure of GO flakes [116]. (a) The chemical exfoliation procedure of the IHM:
with mesh graphite as source material, the H2SO4 and H3PO4 with the assistance of the oxidant
KMnO4 diffuse and intercalate between the carbon stack stepwise to realize the exfoliation. (b) The
exfoliation temperature is maintained at 20 ◦C by a cooling system such that the lateral size of the
carbon honeycomb lattice is preserved for a smooth carrier transport. (c)-(e) Additional cleaning steps
after the chemical exfoliation were developed to remove the residual components resulting in an purer
product. (f)-(g) Illustrative lattice images to compare the final GO flakes between the standard IHM
process and the LTEDS process. The former image indicates that ions still remain within the oxidized
functional groups on the GO flakes in the case of IHM. The latter image shows that in the LTEDS
process the low exfoliation temperature suppresses the destructive power of the oxidants to restrict the
size and density of defects in the GO lattice, meanwhile the additional cleaning steps provide better
efficiency in removing residual ions.
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2.4 Characterization of LTEDS
2.4.1 Topographical Characterization
The SEM image of the GO flakes exfoliated by LTEDS is shown in figure 2.6(a).
To investigate and comprehend its potential for the wafer-scale applications, TEM
characterizations were carried out by drop casting the GO flake solution onto a TEM
grid to form a thin film. As it can be seen in figure 2.6(b), the exfoliated GO flakes are
amorphous without periodic carbon lattice. According to the distinguishable contrast
of the gray scale of the TEM image, the carbon amorphous thin film are formed with
oval GO islands. It is however not a single complete mono-, double- or multi-layer, but
it is decorated with small GO islands on its basal plane. As indicated by the distance
of the discrete GO islands, the ballistic transport of the carriers should be limited to
intervals of 25 nm or even larger.
Figure 2.6: Topographical characterization of GO flakes [116]. (a) SEM image of GO flakes. (b) TEM
image of a GO thin film.
2.4.2 UV-VIS Spectroscopy and Fluorescence Spectroscopy
Characterizations
UV-VIS spectroscopy is a technique to measure the collective electronic transitions
of the atoms and molecules from ground states to excited states in the UV-VIS
spectral region. The absorption peaks provide the qualitative analysis of functional
groups of molecules, impurities and conjugation of compounds. In molecules, there
are four possible transitions σ-σ?, n-σ?, pi-pi? and n-pi?, for which the corresponding
absorption energies are successively increasing. GO flakes generated by IHM and
LTEDS were prepared in DIW of the same concentration and pH and characterized
via UV-VIS spectroscopy. The obtained spectra are shown in figure 2.7(a). The black
curve is the bulk spectrum of the original mesh graphite, which was also dissolved in
DIW. For both GO flake solutions by IHM and LTEDS, there is a sub-shoulder at about
300 nm corresponding to n-pi? (plasmon peak) states which originate from carboxyl
groups [111]. Moreover, an absorbance peak that appeared at 237 nm corresponds
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to the electron transition between pi-pi? states within a flake. The intensity of the
absorption spectra is quantitatively proportional to the pi-pi? and the σ-σ? states
within the amorphous carbon lattice. The peak broadening is related to the fact
that the tetrahedral sp3 states get formed during the high temperature treatment.
Comparing the latter two spectra, the absorption intensity of the LTEDS GO solution
at 237 nm was much higher and the peak was sharper. This was due to the fact that
more sp2 intact carbon lattices within GO flakes prepared by LTEDS were preserved
in terms of higher rate of pi-pi? vibrations states compared to those from the IHM.
This is because the high process temperature of IHM favors the forming of MnO –4 ,
which resides on the surface of the carbon sheets and reacts with the cyclo- manganese
oxide and manganese oxide, resulting in more intrinsic defects tetrahedral sp3 states
and consequently decreases the amount of pi-pi? states. The result confirmed that the
IHM process, with its higher temperature, is fast but not effective enough to preserve
the hexagonal carbon formation. The GO flakes produced by LTEDS present better
characteristics in order to be utilized as a high-quality transducer material.
The GO flakes exfoliated by LTEDS were additionally characterized by fluorescence
spectroscopy. The obtained excitation-emission matrix is shown in figure 2.7(b). The
GO aqueous solution shows a very broad absorption spectrum. Dependent on the
incident excitation wavelength, the emission energy is smaller (red-shift) than the
excitation energy by following the so-called principle “Stokes shift”. In other research
works, both a blue-shift [119] and a red-shift [120] of GO fluorescence had been
observed. The fluorescence of GO flakes with typical C:O ratio around 2 to 4 has
been reported within the range from the visible to near infrared. Based on the
semiconductor electronic band structure and molecular orbital concepts, the oxygen
functional groups, sp2 carbon lattice and some sp3 oxidized sites of the GO flakes
greatly contribute to the generation of the fluorescence. The fluorescence is present
due to the electron-hole recombination from the bottom of the conductance band
and surrounding localized electronic states to the valance band. More specifically, the
emission species of visible fluorescence is generated from the non-oxidized atoms
and the boundary of the oxidized carbon atoms [121]. Therefore, the fluorescence
of GO flakes can be tuned in terms of the density of oxygen functional groups by
different reduction methods and/or the distribution of carrier populations by external
electronic fields.
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Figure 2.7: (a) UV-VIS spectroscopy characterization of GO flakes in DIW shows the absorption spectra
for the original graphite and GO flakes exfoliated by IHM and LTEDS. (b) The excitation-emission
matrix of the GO flakes in aqueous solution.
2.4.3 XRD and FT-IR Spectroscopy Characterizations
XRD is used to identify the crystallinity of materials. The X-rays interact with the
crystal lattice by striking the electrons and the emanating secondary spherical waves
from the electrons are formed. The destruction and construction of these waves
generate the diffraction patterns. The crystallization of the measured sample can
be deduced by analyzing the angle and intensities of the diffraction patterns. These
diffraction patterns follow the Bragg’s law: 2d sin θ = nλ, where d is the spacing
between diffracting planes, θ is the angle of incidence, n is an integer and λ is the
wavelength of the incident X-ray. XRD is able to address the complete extent of the
carbon lattice after the chemical exfoliation process. This characterization tool is used
to compare the final flakes’ quality between the two protocols, namely, the IHM and
LTEDS. The results are shown in figure 2.8(a). The angle of incidence of the X-ray
ranged from 5° to 70° and all of the curves are normalized. The shifts in the specific
reflections and the overall diffraction patterns clearly prove a better synthesis-quality
of GO flakes by LTEDS. The strong (002) peak at 2θ = 26.5° corresponds to
an interlayer spacing of approximately 0.34 nm in the graphitic layers. For both
exfoliation protocols, the (001) peak that appeared at around 2θ = 10.6° represents
the exfoliated graphene oxide with an interlayer spacing of approximately 0.83 nm
due to the presence of functional groups that bound on both sides of the carbon basal
plane and physical-absorbed water molecules [114]. This value corresponds to other
reported values, for example: the interlayer distance for a dry multi-GO flake was
observed by XRD to be approximately 0.639 nm [122] and for a hydrate multi-GO
flake the measured distance was 1.2 nm [123]. The vanishing (002) peak and the arise
of the fingerprint at 2θ = 32°− 37° for both IHM and LTEDS manifest that ordered
carbon lattices of graphite were partially transformed into out-of-plane disordered
carbon lattices. Diffraction peaks at 2θ = 41°− 43° indicate the displacement degree of
the sheets along the stacking direction for GO flakes. This implies that the basal plane
in the mesh graphite had slipped out of the alignment. The residual ions remaining
within the GO flakes by IHM lead to a broad peak at this position. LTEDS achieved
sharper peaks, which indicate a better cleaning procedure of the amorphous carbon
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material. More importantly, in comparison with other reported results, diffraction
peaks of LTEDS GO emerged at 2θ = 65°, 75° and 83°, which were clearly distinct and
indicated that after the strong oxidation a larger portion of carbon lattice GO flakes
were preserved by the low process temperature and advanced cleaning process.
In addition to XRD, FT-IR spectroscopy was used for a quantitative comparison
of GO flakes synthesized by the IHM and the LTEDS protocols. This technique
measures the IR absorption and transmission of the samples with incident infrared
light. The obtained spectrum represents the molecular fingerprints of the sample. As
shown in figure 2.8(b), the normalized spectra depict the influence of the additional
parameters in combination with the cleaning procedures. In the standard IHM, the
molecular vibration bounds were relatively weak and not clearly distinctive because
of the residual impurities on the GO flakes after the cleaning procedure. After
the first enhanced cleaning step using only the dialysis, this feature was improved
minimally. The spectrum of the second cleaning step in LTEDS showed an improved
purity of the exfoliated GO. The several washing described in the section 2.3 had a
remarkable effect. The stretching vibration of the hydroxyl group O−H was confirmed
at 3434.6 cm−1 and the stretching vibration of the carboxylic group was detected at
1720 cm−1. Characteristic absorption bands could be clearly identified in the FT-IR
spectrum of the GO, which could be attributed to the asymmetric C−O stretching
vibration with a characteristic doublet state at 1050 cm−1 and 1100 cm−1. Moreover,
bands of medium intensity could be assigned to the symmetric and asymmetric C−H
vibrations at 2912.4 cm−1 and 2850.1 cm−1. The epoxide group could be identified by
the weak band of the asymmetric C−H vibration of the epoxy ring at 2921.4 cm−1.
Additionally, the stretching vibration of the oxirane R−O−R functional was detected
at around 1230 cm−1. The systematic cleaning steps via LTEDS largely improved
the quality of GO compared to the IHM. In addition, the carboxylic and hydroxyl
functional groups of the high-quality GO by LTEDS were identifiable in the IR
spectrum. This proves the efficiency for further chemical functionalization of the GO.
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Figure 2.8: (a) XRD diffraction patterns of graphite and graphene oxide samples by IHM, pre-LTEDS
and LTEDS within the diffraction angle range: 5° to 70° [116]. The shifts in the specific reflexes and
the overall diffraction patterns clearly proves the synthesis enhancement of LTEDS. (b) FT-IR spectra
of GO flakes prepared by IHM and LTEDS: the C−O vibration peaks clearly illustrate the uncovering
of the doublet.
2.5 Wafer-Scale Fabrication of rGO Devices
2.5.1 GO Thin Films Preparation
Toward the purpose of wafer-scale fabrication, 4-inch glass or SiO2/Si wafers were
thoroughly cleaned with freshly prepared Caro’s acid (H2O2 30 %). Afterwards,
the wafers were activated by O2 plasma (t = 5 min, 230 W) and functionalized
by (3-aminopropyl) triethoxysilane (APTES) gas-phase silanization. The Au coated
surface was positioned at an angle of about 85° with respect to the outlet valve of
the desiccator to provide a maximum contact area between the substrate and the
silane-saturated gas stream. Then, the pressure inside the desiccator was reduced
to 130 mbar such that a continuous gas flow of the silane over the substrate was
ensured. The reaction time was 2 h. In this process, the surface −OH groups
replace the −O−CH2−CH3 ethoxy-group by SN2 reaction forming the corresponding
3-aminopropylsiloxane (APS) on wafer surface [124, 125]. After the silane coating, the
wafer was washed with ethanol. The −NH2 groups on the other end of the APS
layer, which are freestanding in the ambient air, covalently immobilize GO flakes by
reacting with the −COOH groups. 5 ml GO solution pH = 2.9 prepared by LTEDS
were applied and spin-coated onto the wafer surface.
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The detailed process information is given in figure 2.9(a)-(d) and each process step
was confirmed with a contact angle measurement. The static contact angle of a
bare glass wafer is 30.5°. After being treated with O2 plasma, the glass surface is
functionalized by −OH groups with a static contact angle below 10°. Uniform APTES
molecules self-assemble all through the glass wafer surface by a gas-phase silanization
technique. In this process, the −OH groups on the glass surface covalently bond to
the −COOH groups of APTES in the manner of dehydration at 60 ◦C in a vacuum
desiccator. The static contact angle of the formed APTES layer is 67.5°. An average of
static contact angles is approximately 65° which indicates a successful formation of an
APTES layer all through the 4-inch wafer. The freestanding −CH3 groups of APTES
molecules subsequently immobilize GO flakes by reacting with −COOH groups of
the carbon basal plane in the manner of dehydration at room temperature. The GO
dispersion was adjusted to be acidic so that face-to-face interaction among flakes was
dominant [126] with a pH value of 2.9 for the GO solution. The static contact angle of
the formed GO thin film is 44.8°.
This spin-coating step was repeated multiple times to prevent pinholes within the
GO layer. Because they were in hydrate states, the flakes were positively or negatively
charged depending on the types of functional groups on the carbon basal plane. The
amount, distribution and variety of functional groups on the carbon basal planes
were random so that the positive- and negative-charge centers on a single flake
were most probably separated. At least one layer of polar water molecules remained
around these charge centers in the manner of electrostatic interaction. Consequently,
the GO flakes, as dipoles, stacked up by Van der Waal interactions during the multi
spin-coating process. In order to get rid of the water molecules, but not influence the
thin film intrinsic properties, the GO on the substrate was baked in the ambient air at
90 ◦C for 30 s in between the sequential spin-coating steps.
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Figure 2.9: Schematics of the GO thin film preparation on glass substrate in wafer-scale. This protocol
also applies to the Si/SiO2 substrate [116]. (a) The static contact angle of a bare glass wafer is 30.5°.
(b) After being treated with O2 plasma, the glass surface is functionalized by −OH groups with static
contact angle below 10°. (c) Uniform APTES molecules self-assemble all through the glass wafer surface
by a gas-phase silanization technique. In this process, the −OH groups on the glass surface covalently
bind to the −COOH groups of APTES in condensation reaction at 60 ◦C in a vacuum desiccator.
The static contact angle of the formed APTES layer is 67.5°. An average of static contact angles is
approximately 65° which indicates a successful formation of an APTES layer all through the 4-inch
wafer. (d) The freestanding −CH3 groups of the APTES molecules subsequently immobilize GO flakes
by reacting with the −COOH groups on the carbon basal plane in a condensation reaction at room
temperature, while the pH value of the GO solution is 2.9. The static contact angle of the formed GO
thin film is 44.8°.
2.5.2 Wafer-Scale Ellipsometry Characterization
Unlike AFM characterization that provides information within the micro/nano- scale,
ellipsometry is an effective and efficient tool to measure up to the millimeter scale
and it is able to offer a macro view of the topographical uniformity of a thin film
over a 4-inch wafer [127]. Ellipsometry is a contact-free optical technique, which is
based on the change in polarization of the reflected light after interaction with the
material. It is used for investigating the film thickness, refractive index, dielectric
parameters, surface roughness, composition, crystallinity, uniformity and many other
material properties. For spectroscopic ellipsometry, the wavelength of the incident
light broadly ranges across the infrared, visible and ultraviolet regimes. As shown in
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figure 2.10(a), the incident light upon the sample surface can be decomposed in its
s-plane and p-plane components which are oscillating in a perpendicular and parallel
direction to the plane of incidence. After being normalized to the initial amplitude
of the s-plane and p-plane components of the incident light, the s-plane and p-plane
components of the reflected light can be denoted as Rs and Rp. The output signal of
the ellipsometry measurement is the reflectance ρ, defined as:
ρ =
Rp
Rs
= tan (Ψ) ej∆ (2.16)
in which tan (Ψ) and ∆ are the amplitude ratio and phase difference of the s-plane
and p-plane components of the reflected light, respectively. The thickness of APS and
nano-GO thin films by different spin-coating times was determined subsequently by
spectroscopic ellipsometry measurements [128] using the multi angle measurement
method at 50°, 60° and 70°, as shown in figure 2.10(b).
Figure 2.10: Characterization of GO thin film preparation on wafer-scale. (a) Ellipsometry setup: The
incident light upon the sample surface can be decomposed into its s-plane and p-plane components
which are oscillating perpendicular and parallel to the plane of incidence, respectively. The amplitude
ratio tan (Ψ) and phase difference ∆ of the reflected light are measured versus the incident wavelength
at a set angle of incidence θ. (b) GO thin film thickness after 1 time spin-coating and 4 times spin-coating
on a 4-inch wafer, which can be extracted from their ellipsometry measurements [116].
For both 1 time and 4 times spin-coating, 3 wafers with 9 points on each were
measured geometrically along the wafer radium to extract the statistical values of
the thicknesses of SiO2, the APS layer and the GO thin film. The APS layer was
about 1 nm, while the mean thicknesses of nano-GO thin films were 2.95± 0.35 nm
and 6.43± 0.40 nm by 1 time and 4 times spin-coating, respectively. The thickness
of mono-layer GO flakes was observed to range from 0.4 nm to 1 nm [74, 129–131],
which was highly dependent on the oxidation functionalization of the carbon basal
plane during the exfoliation process. From the ellipsometry results, it can be seen that
the spin-coating technique formed a stack of GO. Additionally, the refractive indexes
of each dielectric layer SiO2, APS and nano-GO thin film were extracted by fitting
them with the Cauchy equations:
nλ = n0 + 102
n1
λ2
+ 107
n2
λ4
kλ = k0 + 102
k1
λ2
+ 107
k2
λ4
(2.17)
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where λ is expressed in nanometers.
2.5.3 Nanofabrication of GO Devices
To characterize the electronic properties of the generated GO thin films, IDEs were
prepared by standard photolithography, metal evaporation and a lift-off process on
a 4-inch glass wafer, as shown in figure 2.11(a). The electrode was a bilayer stack:
top layer was 270 nm Au and bottom was 30 nm Ti, which acted as an adhesion
layer. Overall, there were 72 chips over the entire wafer. Each chip was 7 mm× 7 mm
in size as shown in figure 2.11(b) and consisted of a set of 4× 4 drain IDEs-array
sharing a common source-electrode bar as shown in figure 2.11(c). The resistance
and capacitance of each drain electrode were designed to be equal for an accurate
comparison of measurement results amongst channels. The width and length of
a single drain electrode was 5 µm and 100 µm, respectively, while the separation
distance of the neighboring electrodes was 5 µm. In the case of the 10-finger electrodes,
the effective channel length and width of the IDEs were 5 µm and 900 µm, respectively
[132–134]. Following the same procedure as introduced in section 2.5.1, a GO thin
film was formed on top of the prepared IDEs. Afterwards, the GO thin film was
patterned by a second step of standard photolithography followed with O2 etching.
The detailed procedure is shown in figure 2.11(d)-(g). The photoresist patterns serve
as masks to reserve the GO thin film during the O2 reactive ion etching process, while
the unprotected thin film was completely etched away.
After a thorough cleaning by acetone and isopropanol, the GO patterns fabricated
from 2 times spin-coating were topographically characterized. The SEM image of
the obtained GO-IDEs chip is shown in figure 2.12(a). A single GO-IDEs channel
was characterized by optical microscopy and SEM, as shown in figure 2.12(b)-(c).
The contrast of gray levels demonstrates that the surface was relatively smooth.
Furthermore, the GO pattern was characterized by AFM, as shown in figure
2.12(d)-(e). The extracted thickness was 5.13 nm in average, which is coherent with the
values obtained by the ellipsometry characterization after 1 and 4 times spin-coating.
The roughness of the GO thin film was determined by means of the root mean square
average of the height derivation Rq = 1.39 nm and the arithmetic average of the
absolute values of the surface height derivation Ra = 0.95 nm.
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Figure 2.11: Preparation of GO devices. (a) GO devices on a 4-inch glass wafer. (b) The size of a
single chip is 7 mm× 7 mm. (c) Schematic three dimensional illustration of interdigitated electrodes
on a single chip: 16 channels share a common-source electrode, which is located in the middle of
the chip. Each channel has 10 IDE fingers: the effective channel length and width are 5 µm and
900 µm, respectively. (d) IDEs consist of 30 nm Ti and 270 nm Au, and are prepared by standard
photolithography, metal evaporation and lift-off processes on 4-inch glass wafers. (e) A GO thin film
is formed by the spin coating technique. (f) Photoresist patterns serve as masks, which only cover
IDEs fingers after a standard photolithography technique. (g) The GO thin film is preserved by the
photoresist mask and the region without protection is etched away by O2 plasma. The photoresist is
removed by acetone and isopropanol later in the process.
29
Figure 2.12: Topographical characterization of GO devices [116]. (a) SEM image of a GO-IDEs array on
a single chip. (b) Microscopic image of a patterned GO thin film. (c) SEM image of a patterned GO thin
film. (d) AFM characterization of a GO pattern (2 times spin-coating) indicates that the mean thickness
of GO thin film is 5.13 nm with roughness Rq = 1.39 nm and Ra = 0.95 nm. (e) AFM characterization
of a patterned rGO thin film over drain-source electrodes.
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2.6 Conclusion
In this chapter, GO flakes were chemically exfoliated by a LTEDS method using low
exfoliation temperature (20 ◦C) and additional desalination steps. The quality of GO
flakes generated by LTEDS and conventional IHM were compared by UV-VIS, XRD
and FT-IR characterizations. The UV-VIS characterization showed a higher absorption
intensity at 237 nm for GO flakes by the LTEDS method, which is quantitatively
proportional to the pi-pi∗ vibration states. It indicated that a higher proportion of
fine carbon lattice of GO flakes was preserved by the LTEDS method. The XRD
characterization displayed a sharper diffraction peak at 41-43° for GO flakes by
LTEDS. This result indicated larger displacements of atomic layers in the exfoliated
GO flakes. The XRD peaks at 65°, 75° and 83° that appear in the case of the GO
flakes produced by LTEDS were distinct features that manifest a higher density of
oxidative functional groups and a more efficient removal of the physiosorbed ions
from the carbon lattice. In addition, the FT-IR characterization results demonstrated
more details of the fingerprints of oxygen functional groups after the exfoliation.
The stronger IR adsorption at 3434.6 cm−1 (−OH stretching vibration), 1726.4 cm−1
(C−O stretching vibration), 2921.4 cm−1 and 2850.1 cm−1 (C−H symmetric stretching
vibration) clearly proved that the ions were efficiently removed from the GO flakes by
the LTEDS method. These characterization results concretely proved that the LTEDS
method generated high-quality and clean GO flakes for device preparation.
A reproducible wafer-scale process for GO based devices was subsequently
established, making use of gas-phase silanization, spin-coating, standard
photolithography and O2 reactive ion etching techniques. The GO thin films
were formed on the bare Au and SiO2/Si (or glass) substrates with APS as linker
layers. Characterized by ellipsometry and AFM, the thickness of the linker layer
APS was 1.01± 0.40 nm, while the thicknesses of the nano-GO thin films were
2.95± 0.35 nm and 6.43± 0.40 nm in the condition of 1 time and 4 times spin-coating,
respectively. The ellipsometry results particularly proved that the GO thin film
is topographically uniform at a 4-inch wafer-scale. This fabrication method is of
significant importance for a massive, cost-effective production of GO thin films in the
various application fields, especially towards biosensing.
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3 | Reduced Graphene Oxide (rGO)
Devices
In this chapter, the electronic properties and surface characterizations of rGO thin
films are investigated in detail. Firstly, the reduction methods, which transform
the insulating GO thin films to conductive rGO, are summarized and commented.
Secondly, a thermal reduction treatment was applied to the GO-IDEs devices which
were described in the previous chapter. The electronic properties, such as the contact
between the rGO thin films and the IDEs, the completeness of the rGO thin films, and
the resistance uniformity over a 4-inch wafer-scale were verified by current-voltage
(I-V) and cyclic voltammetry characterizations. Especially, the bipolar characteristics,
the field-effect mobility and the sheet resistance of the rGO thin films extracted
by FET and four-point measurements are studied. Thirdly, the reduction degrees
were characterized and analyzed by Raman spectroscopy and X-ray photoelectron
spectroscopy (XPS).
3.1 Reduction Methods
The oxygen functional groups on the carbon basal plane of chemically exfoliated
GO allow the covalent immobilization of GO thin films on various substrates.
However, the oxygen functional groups on the carbon basal plane of the thin films
significantly obstruct the carrier hopping among the sp2 localized carbon area,
preventing advanced conductivity over microscale distances [59, 71]. To utilize GO
as functional material, with a conductivity similar to that of the graphene, various
reduction methods are summarized in this section. These reduction methods are
utilized to remove the sp3 oxygen functional groups, while preserving the carbon
lattice as completely as possible. The principle of all reduction methods is to break
down the sp3 bindings existing in different forms and recover the sp2 C−C bindings
by the following routes:
• The chemical reduction makes use of different types of chemical reactants to
remove oxygen groups, such as hydrazine [135–137], strong alkaline media
[138], substituted borohydrides [139, 140], sulfuric acid [141], ascorbic acid [142],
and alanine [143]. A chemical reduction is more functional in a liquid phase
because the chemical reactions take place on both basal planes of the carbon
lattice. However, this reduction method is not preferable because extra ions
or molecules tend to attach onto the GO surface and act as contaminants or
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dopants. This tends to influence the intrinsic properties of the carbon lattice
[107].
• The optical reduction consists of irradiating GO with photons, whose energy is
larger than the chemical bond energy between the oxygen functional groups and
the carbon basal plane, thus restoring C−C bonds [144–146].
• The thermal reduction method works by annealing the carbon lattice [147, 148].
This method has been revealed to induce the formation of carbonyl and ether
groups at the atomic level. Nevertheless, this method is able to reduce a bulky
thin film composed of several carbon sheets.
• The hydrogen reduction consists of triggering a chemical reaction between
the hydrogen and the functional oxygen groups under specific reaction
temperatures. This causes the conjunction of the carbon lattices and the removal
of the sp3 oxygen groups [149]. The high efficiency of this reduction method has
been proven [73]. Therefore, this method is of interest for researchers to generate
rGO which behaves similarly to pristine graphene.
Considering the GO thin films are stacks of multiple GO flakes, the thermal treatment
could be the optimal method to transform the insulating GO to conductive rGO thin
films. Indeed, the thermal treatment is affecting the bulk of the thin films, whereas
the other methods are limited to their surface.
During this process, the oxygen functional groups are removed from the carbon basal
plane and subsequently decomposed as CO or CO2. These gases are accumulating
to form a relatively huge pressure between the neighboring GO sheets. The pressure
values range from approximately 40 MPa at 300 ◦C to 130 MPa at 1000 ◦C [150]. As
reported, the Young’s modulus of pristine graphene is as high as 1 TPa [67] and the
carbon lattice is thermally stable up to 700 ◦C [68]. Therefore, the pressure induced
by CO or CO2 has no destructive effect to the carbon lattice, but the reduction
temperature must be kept below 700 ◦C. Since 400 ◦C is the maximum achievable
temperature by the vacuum oven at disposition, a reduction temperature of 350 ◦C
was chosen to carry out the thermal treatment to the GO devices. In this thesis, the
thermal reduction at 350 ◦C for 10 h in the vacuum oven, followed by an annealing at
600 ◦C for 20 s in the ambient air, is defined as the thermal reduction protocol (TRP).
The annealing is used to change the electrical contact between the thin films and the
IDEs as explained in the next sections.
3.2 Electronic Characterization
To apply rGO thin films as transducers for electronic devices, their uniformity
concerning electronic performance and device stability has to be clarified beforehand.
The TRP was used as the reduction protocol. The device structures used for the
electronic characterization is shown in figure 3.1(a), in which large-scale GO thin
films were prepared on top of 10-finger IDEs without further patterning. The length of
each finger electrode was 100 µm while the width of each electrode and the separation
distance of neighboring electrodes were both 5 µm.
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After the mild reduction at 350 ◦C for 10 h, the obtained rGO thin films formed a
Schottky contact [151] with the IDEs beneath. This was deduced from the I-V curve,
which was not linearly crossing the origin. In order to convert the Schottky contact
into an ohmic contact, the devices were subsequently annealed at 600 ◦C for 20 s in
ambient air. The ohmic contact is confirmed by linear I-V characteristic curves of all
16 channels as shown in figure 3.1(b), where the characteristic linear relation between
the current I and voltage V is observed.
Figure 3.1: I-V characterization of a multi-layer rGO thin film (prepared by 8-times spin coating). (a)
The configuration of the IDEs chip: in total 10 finger electrodes with a finger length of 100 µm, a finger
width and a separation distance of neighboring electrodes of 5 µm. (b) The linear I-V characteristic of
16 channels of one IDEs chip shows that the ohmic contacts are formed between the rGO thin films and
the IDEs after the thermal reduction at 350 ◦C for 10 h in the vacuum oven and subsequent annealing
at 600 ◦C for 20 s in ambient air [116].
3.2.1 Cyclic Voltammetry Characterization
For the rGO thin films prepared by the TRP, cyclic voltammetry measurements were
carried out to confirm the formation of complete rGO thin films without pinholes on
the top of the IDEs. The measurements were performed with an Ivium potentiostat
with a three-electrode configuration as shown in figure 3.2(a).
The rGO/IDEs or bare IDEs serve as working electrode (WE) while a Pt wire and an
Ag/AgCl electrode are used as counter electrode (CE) and reference electrodes (REs),
respectively. A series of sweeping voltages is applied to the WE against the RE and
the output current is measured between the WE and the CE. The measured current
represents the intensity of charges transferred between the redox markers K3/K4
(K3Fe(CN)6/K4Fe(CN)6) and the WE. It reflects the electrochemical properties on the
WE surface [152, 153]. Therefore, the cyclic voltammetry measurement can be used
as an electroanalytical technique to analyze the coverage quality of rGO thin films on
top of the IDEs.
The electrolyte solution in the fluidic cell for the measurements was prepared by
mixing 0.5 mM K3 with 0.5 mM K4 in 10 mM phosphate buffered saline (PBS). The
PBS consisted of 0.01 M phosphate buffer, 0.0027 M KCl and 0.137 M NaCl with
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a pH value 7.4, where 0.01 M phosphate buffer contained 0.0075 M Na2HPO4 and
0.0025 M NaH2PO4. The voltages were applied on the WE starting from −0.2 V
and sweeping forwards and backwards between −0.2 V and 0.6 V with a scan rate
of 50 mV s−1. After 15 sweeping cycles, the results for rGO/IDEs and bare IDEs
(Au) were summarized. An exemplary measurement is shown in figure 3.2(b). The
results of the measurements show no peaks that correspond to Au electrodes for
the rGO devices. This proves that the rGO thin film covers the IDEs completely
without pinholes. It also confirms the topographic results obtained by AFM and SEM
characterizations in chapter 2.
Figure 3.2: Cyclic voltammetry measurement of a rGO thin film. The rGO thin film was transformed
from the prepared GO thin film with the TRP. (a) The measurement setup: the configuration of the
electrodes was as follows: the WE of the impedance analyzer was connected to the common-source
electrode and the drain electrode of the chip. An Ag/AgCl electrode and Pt electrode served as REs
and CE. Both were immersed in the measurement cell filled with K3/K4 redox solution. (b) The scan
ranged from −0.2 V to 0.6 V and started at −0.2 V with a scan rate of 50 mV s−1 [116]. The obtained
result shows the difference between the rGO thin film and the bare IDEs. It indicates that the rGO thin
film is compact and complete without pinholes.
3.2.2 Wafer-Scale Resistance Uniformity of rGO Thin Films
The uniformity of the resistance over a 4-inch wafer was investigated to ensure that
the chips are reproducible and, hence, usable for biosensing. In total 10 chips with 16
channels each were measured. The obtained results are shown in figure 3.3(a) with
the distribution of measured chips as shown in figure 3.3(b).
In total 11 channels showed defective IDEs and were therefore excluded from these
measurements. There were 149 conductive channels with the following resistances:
• 16 channels ranged from 1.44 · 104Ω to 8.07 · 105Ω (10.8 %).
• 131 channels from 1.14 · 106Ω to 9.54 · 106Ω (87.9 %).
• 1 channel was 7.72 · 108Ω (0.7 %).
• 1 channel was 2.83 · 109Ω (0.7 %).
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In conclusion, 93 % of the channels for this exemplary wafer were functional. Those
defective channels were created during the metal microelectrode fabrication but were
not caused by the nonuniformity of the rGO thin films. It is noteworthy that 87.9 %
of the channels showed a resistance variation within one order of magnitude, which
refers to a relative uniform rGO thin film with respect to electronic properties.
To have an overview of the impact of the reduction duration, another thermal
reduction was carried out. The temperature was kept at 350 ◦C but the time was
reduced from 10 h to 4 h in a vacuum oven. As for the first reduction, the samples
were subsequently annealed at 600 ◦C for 20 s in the ambient air. The resistances of
a single chip with 16 channels are shown in figure 3.3(c). This result reveals that
the reduction for 10 h leads to a decrease in resistance of approximately 2 orders
of magnitude. In addition a smoothing of the resistance derivation among channels
is observed, compared to the reduction procedure for 4 h. This suggests that longer
reduction times would produce even better electronic uniformity. Besides the duration
of the reduction, further reduction tests can be carried out by applying different
temperatures.
Figure 3.3: Resistance uniformity characterization of rGO thin films (8-times spin coating) with
10-finger IDEs configuration. (a) Resistance mapping of rGO thin films (160 channels) on a 4-inch
wafer after TRP [116]. (b) The wafer-scale distribution of chips with rGO thin films on 10-fingers IDEs.
(c) Resistance distribution of an rGO thin film (16 channels) after vacuum reduction at 350 ◦C for 4 h
(against 10 h for the TRP) and subsequent annealing treatment at 600 ◦C for 20 s in ambient air.
3.2.3 rGO Thin Films Based ESFET
An ion-sensitive field-effect transistor (ISFET) device was firstly introduced by
Piet Bergveld in 1970 [154]. The device proposed at that time combined a
metal-oxide-semiconductor (MOS) transistor and a glass electrode to measure ion
activities in electrochemical and biological environments. In line with the aim of
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this thesis towards biosensing, the rGO thin films were employed as transducers in
ISFET devices configuration which were operated in direct contact with the electrolyte
solution. Such devices are denoted as ESFET in this thesis. The obtained bipolar
characteristic curves for the rGO thin films provide a straightforward evaluation of
the reduction method and its influence on the electronic properties of the rGO thin
films.
3.2.3.1 Fundamentals of ESFET
The ESFET, as a potentiometric device, consists of drain, source and gate electrodes
as shown in figure 3.4(a) [84, 155]. The transducer layer is located between the drain
and source electrodes. An external Ag/AgCl electrode is placed above the transducer
layer and immersed inside the buffer solution to apply a gate voltage through the
electrolyte to the transducer layer. The critical function of the Ag/AgCl electrode is
to maintain a constant potential which is independent from the ionic composition of
the buffer solution. Similar to typical metal-oxide-semiconductor field-effect transistor
(MOSFET), the Fermi level and the carrier concentration of the transducer layers
can be modulated by the gate voltage Vgs, resulting in a current change Ids in the
drain-source channel.
The rGO-IDEs employed for the ESFET characterization were also thermally reduced
by the TRP. The device consisted of 16 channels in a 4× 4 array layout with a
common-source electrode located in the middle of the chip. Each channel had 10
IDEs fingers, while the effective channel length and width were 5 µm and 900 µm,
respectively. The separation distance of the neighboring fingers was 5 µm. The
ESFET characterization measurements were carried out with a Keithley 4200-SCS
parameter analyzer. The buffer solution was 10 mM PBS. The Ag/AgCl electrode
served as the gate electrode to apply sweep voltages from −0.8 V to 0.8 V against
the source electrode, while the step voltages were applied between the drain and
source electrodes ranging from −0.1 V to 0.1 V with 0.1 V as the step size. The
obtained bipolar characteristic curves are shown in figure 3.4(b). Since the Dirac
points are located at the position where the valence and conductance bands meet,
they correspond to the minimum on each Ids-Vgs characteristic bipolar curve (blue
and black curves). It can be seen that the Dirac points do not lie perfectly at Vgs = 0,
but are slightly shifted to the right. This fact states that the rGO thin film is initially
p-doped. The possible reason for this could be the impurity doping by the substrate
and/or the modulation of the residual oxygen functional groups [84, 156]. The left
and right arms of the bipolar curve correspond either to the holes or the electrons as
the dominant carriers in rGO thin films which is not necessarily doped by impurity
elements to realize the conductivity. The applied gate voltage tends to tune the Fermi
level of the rGO thin film either into the conductance band or the valence band.
This changes the type of carrier to electrons or holes respectively. The concentrations
of the carriers increase when the difference between the Dirac point and the gate
voltage increases. It is shown that electrons’ concentration is increasing much faster
than the holes’ concentration by the gate voltages. As indicated in the bipolar curves,
the concentrations of two carriers are highly dependent on the applied drain-source
voltage. Furthermore, a stronger tuning effect is observed for a drain-source voltage
Vds = −100 mV compared to Vds = 100 mV.
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Figure 3.4: (a) Schematic of the ESFET configuration with an rGO thin film as a transducer layer and an
Ag/AgCl RE immersed into the buffer solution as the electrolyte gate contact. (b) Bipolar characteristic
curves of an rGO thin film in an ESFET device configuration.
In principle, each arm of the bipolar curve can be described in a first approximation
by the characteristic equation of a MOSFET in its linear regime:
Ids = Cgµ
W
L
[(
Vgs −Vt
)
Vds − 12V
2
ds
]
(3.1)
where Cg is the gate capacitance per unit area, µ is the field-effect mobility in the
channel, L and W are the effective channel length and width, Vt is the threshold
voltage in saturation mode. This equation can also be used as an alternative way to
estimate the field-effect mobility of the rGO transducer layer [157–162].
3.2.3.2 Solid-Liquid Interface
In order to find the relationship between the drain-source current Ids and the
gate-source voltage Vgs, the condition at the interface of the rGO transducer layer
and electrolyte has to be understood. In aqueous solutions, the rGO surface is
negatively charged due to the oxygen functional groups being hydrolyzed by the
water molecules. The ionic binding of the solute molecules are also broken, resulting
in positive and negative charged ions. These ions are surrounded by the polar
water molecules via electrostatic interactions. The charged rGO surface attracts the
water-surrounded ions and forms an ionic layer. This layer acts as a barrier for the
attractive force, which becomes too weak to attract further ions. This ionic layer is
called the electrostatic double layer (EDL) as shown in figure 3.5 [163]. The surface
potential Ψ decreases exponentially inside the EDL towards the bulk solution.
According to the Gouy-Chapman model, the EDL consists of a Stern layer and a
diffuse layer in series. The Stern layer is formed by the non-mobile ions, which are
strongly adsorbed by chemical binding on the rGO surface and are arranged in a
condensed manner. Further away from the rGO surface, the ions are attracted by the
Coulomb force and form a diffuse layer, in which the ions are mobile. The thickness
of the EDL is the so-called Debye length, which depends on the solvent permittivity
εs = ε0εr, the concentrations of the solute ions ni,∞ (m−3) and the valence of the solute
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Figure 3.5: Descriptive schematic of the solid-liquid interface between rGO thin films and the buffer
solution. The EDL is made of two layers, the so-called Stern layer and the diffuse layer, building up on
the rGO surface.
ions Zi by following the equation:
κ−1 =
√
εskBT
∑i ni,∞Z2i e
2
(3.2)
The ionic strength of the solution is defined as:
I =
1
2∑i
ni,∞
NA
Z2i (3.3)
where NA is the Avocadro constant. The ionic strength is a measure of the
concentration of ions in that solution. As one of the main characteristics of a solution,
the ionic strength significantly affects the dissociation constant and the solubility of
different salts, the rate of reaction of the proteins, and the effects of ions on the zeta
potential of biomolecules [164, 165].
The Debye length or the ionic strength can be used to calculate the capacitance of the
EDL, which is formed at the interface of the rGO thin film and the buffer solution,
using the following equation:
Cg =
ε0εr A
d
(3.4)
with the vacuum permittivity ε0 = 8.854 · 10−12 F m−1, the relative permittivity of the
solution, the area of rGO thin film A, and the thickness of the EDL d, the so-called
Debye length.
3.2.3.3 Field-Effect Mobility in rGO Thin Films
Knowing the capacitance of the EDL and the geometrical parameters of the rGO-IDEs
channel, the field-effect mobility µ of the rGO thin film can be estimated from the
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obtained bipolar characteristic curve [166]. By rewriting equation 3.1, the field-effect
mobility of holes and electrons can be deduced as the following equation:
µ =
∆Ids
∆Vgs
L
WCgVds
(3.5)
where, Ids is the drain-source current, Vds is the drain-source voltage, L and W are the
channel length and width, Cg is the gate capacitance, Vgs is the gate source voltage.
The field-effect mobility of rGO flakes and thin films prepared by different reduction
treatments as described in the scientific literatures is summarized in the table 3.1.
The Debye length of the EDL formed at the interface of the rGO thin film and
10 mM PBS was approximately 0.76 nm, deducing from equation 3.2. Subsequently,
the capacitance of the EDL can be obtained from equation 3.4: Cg = 8.85 nF,
using the relative permittivity of water εr = 78 and the area of the rGO thin film
A = 100 µm× 100 µm. The bipolar characteristic curves of an rGO thin film, shown
in figure 3.4(b), provide the values of ∆Vgs and ∆Ids. Therefore, the hole and electron
mobility are calculated:
µh =
∆Ids
∆Vgs
L
WCgVds
= 0.326 cm2 V−1 s−1
µe = 0.092 cm2 V−1 s−1
(3.6)
with the channel length L = 5 µm, the effective channel width W = 900 µm, and the
drain-source voltage Vds = 100 mV.
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3.2.4 Resistivity of rGO Thin Films
Van der Pauw (VDP) structures [168] were designed to extract the sheet resistivity
of the rGO thin films. There are various types of VDP structures: circle, clover
leaf, square, rectangle, Greek cross, and six- or eight-contacts Hall bars. Amongst
these structures, the Greek cross shown in figure 3.6(a) is able to maintain the
measurement error below 1 % with a sample geometry a/w > 1.02 [169]. Thus,
the Greek cross structure was chosen for the sheet resistivity measurements with a
geometry parameter a/w = 1.1 > 1.02. Considering the amorphous rGO thin films,
the separation distance of the diagonal electrodes of the Greek cross is designed to
be 5 µm, which is the same value as the separation distance of the IDEs used for
the electronic biosensors. It is meant to supply a precise resistivity for analyzing the
electronic biosensors.
The rGO thin film is patterned into the shape of the designed Greek cross by using
the fabrication procedure described in chapter 2. The obtained rGO pattern was
verified with SEM characterization and the result is shown in figure 3.6(b). The VDP
measurement was carried out with a Keithley 4200-SCS semiconductor analyzer to
extract the sheet resistivity [170]. This method involves applying a current bias and
measuring the generated voltages using the 4 contacts of the designed Greek cross,
with eight measurements as indicated in figure 3.6(c).
Figure 3.6: Sheet resistivity measurement of an rGO thin film. (a) Schematic of the rGO thin film
patterned in the shape of a Greek cross, with the geometry parameter a/w = 1.1 > 1.02. (b) The
SEM characterization which was used to extract the rGO thin film (8-times spin coated) resistivity by
four-point measurement. (c) 8 VDP measurements to extract the sheet resistivity.
The 4 contacts are labeled clockwise as 1, 2, 3, 4. The measurements take place with
the contact connection as follows:
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1. Common ground.
2. Current bias supply with either positive or negative values.
3. Voltmeter.
4. The same setting parameters as contact 3.
The same procedure was repeated at every side of the rGO Greek cross and in total 8
voltages were collected: V1 −V8. The sheet resistivity can be calculated as follows:
ρ =
ρA + ρB
2
(3.7)
with
ρA =
pi
ln 2
fAts
V1 −V2 + V3 −V4
4I
ρB =
pi
ln 2
fBts
V5 −V6 + V7 −V8
4I
(3.8)
while ts is the thickness of the rGO thin film, V1 − V8 are the voltages measured by
a voltmeter, I is the current. The parameters fA and fB are the geometrical factors
related to the two resistance ratios QA and QB:
QA =
V1 −V2
V3 −V4
QB =
V5 −V6
V7 −V8
(3.9)
The relationship between Q and f is as follows:
Q− 1
Q + 1
=
f
0.693
arccosh
(
e0.693/ f
2
)
(3.10)
To guarantee the measurement precision, the input current was 10 nA so that the
voltage difference at two contacts was less than 100 mV. In this experiment, the
thickness of the rGO thin film was 4.5 nm. The factors fA and fB are geometrical
factors related to the sample symmetry. In the condition of near-perfect symmetry,
such as with the Greek cross VDP structure, both factors can be considered as equal
to 1 [170]. Based on the experimental results, the obtained sheet resistivity of rGO was
calculated to be in the range of 0.03Ωm to 0.06Ωm after being treated by the TRP.
3.3 Reduction Characterization
To investigate the reduction degree after the thermal treatment, Raman spectroscopy
and X-ray photoelectron spectroscopy were used to characterize the GO and rGO thin
films. In this section, GO and rGO thin films were prepared on Si/SiO2 substrates.
The TRP was used as defined in the previous section, unless specified otherwise.
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3.3.1 Raman Spectroscopy Characterization
Raman spectroscopy is an optical, non-destructive technique to quantitatively detect
vibrations in molecules [171]. This technique is based on light scattering. Depending
on the incident energy, the incident photons can be absorbed, scattered or completely
transmitted, as shown in figure 3.7(a). The incident photons distort the electron clouds
around the nuclei and excite the molecule into a short-lived, virtual energy state,
which is determined by the frequency of the incident photons. When only the electron
clouds are distorted, elastic Rayleigh scattering takes place where the energy of the
incident photon matches the difference between the two energy levels. At the same
time the energy of the scattered photon does not change compared to the incident
photon energy, as shown in figure 3.7(b). Most of the photons are scattered based
on Rayleigh scattering. Only one out of 106 to 108 scattered photons is scattered
inelastically. This phenomenon is the so-called Raman scattering. In this scattering
process, the motions of the nuclei (phonons) are induced such that the energy can be
transferred from the molecule to the photon or vice versa (Stokes shift or anti-Stokes
shift) as shown in in 3.7(b).
In principle, the incident light is monochromatic and the Rayleigh scattered light is
filtered out. Only the Stokes-scattered (corresponding to Stokes shift) Raman light is
recorded. The Raman spectrum is plotted with the number of the collected photons
(y-axis) versus their energy shift referring to the incident energy (x-axis), which is
labeled as Raman shift in the unit of ∆cm−1. In practice, the unit of Raman spectrum
is labeled as cm−1 for the sake of convenience.
Figure 3.7: Principle of Raman spectroscopy. (a) Interaction types of incident photons with target atoms.
(b) Two possibilities of Raman scattering: Stokes and anti-Stokes scatterings for emitted photons of
energy smaller and larger than the energy of the incident photons, respectively. The vibrational state
of the molecules can either absorb energy from the incident photons or transfer energy to the incident
photons.
The Raman spectrum can reflect the evolution of the electronic structure as well as
electron-phonon interactions [172, 173]. In graphene, there are six phonon branches
named iLO, iTO, oTO, iLA, iTA, oTA as shown in figure 3.8(a) [174, 175]. Their name
is defined based on three characteristics:
• The phonon branches can either be optical (O) or acoustic (A) phonons.
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• One of each of these two kinds of phonons are out-of-plane (o) of the carbon
lattice and the other four are in-plane (i).
• The direction of the zone-center mode of the phonons either vibrates along or
perpendicular to the carbon-carbon bonds, which are known as transverse (T)
and longitudinal (L) modes.
Mainly because the photon excited electrons interact with iTO and iLO, the phonon
energies significantly disperse at the Γ and K points, as shown in figure 3.8(b). This
effect induces the main characteristic Raman peaks of pristine graphene and defected
graphene [175] as shown in figure 3.8(c)-(d). A detailed explanation about the Raman
scattering process [176] is given in figure 3.8(e):
i) The G band is located at approximately 1580 cm−1. It is a doubly-degenerate
in-plane sp2 C−C stretching mode. The incident photons excite a virtual
electron-hole pair, which is scattered by iTO or iLO of low momentum at the
Γ point in the center of the first Brillouin zone. Subsequently, the electron and
hole recombine and emit a photon, whose energy is smaller than the energy of
the incident photon.
ii) The 2D band is located at approximately 2700 cm−1. It originates from the
in-plane breathing-like mode of the carbon lattice. The virtual electron-hole pair
is created by an incident photon at the Dirac cone K point in the first Brillouin
zone. The electron (or hole) is scattered by one iTO phonon to the K’ point and
scattered back to the K point by a second iTO phonon to recombine with a
hole (or electron). This scattering routine is a so-called double resonant. Also,
both electrons and holes can be scattered by iTO phonons from the vicinity of K
point to K’ point and recombine afterwards by emitting a photon. This scattering
routine is a so-called triple resonant.
iii) The D band is located at approximately 1350 cm−1. It is induced by the disorders
in the carbon lattice, such as sp3 defects, grain boundaries, vacancy sites and
edges, which are responsible for the momentum conversion. The photon-excited
electron is scattered by an iTO around K point to K’ point and scattered back by
the above-mentioned defects. Since only one phonon participates in this process,
the energy shift is half of the value compared to the 2D band process.
iv) The D’ band is located at approximately 1620 cm−1, normally observed as a
shoulder peak of the G band. In contrast to the three bands mentioned above
attributed to intervalley scattering, the D’ band originates from intravalley
scattering. It requires a defect for scattering and involves the electronic states
around both K and K’ points.
For chemically exfoliated GO, the carbon lattice consists of sp3 oxygen functional
groups and vacancy sites. This results from the destructive power of the gases
generated during the chemical exfoliation process (CO and CO2), which are formed
in-between the neighboring carbon layers. These differences with pristine graphene
can be evaluated through the Raman peaks of GO and rGO flakes. The Raman
characteristic bands show the oxidation degree of the carbon lattice after the chemical
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Figure 3.8: Principle of graphene Raman spectra: (a) Diagram of phonon dispersion in graphene [174].
(b) iTO and iLO phonons at Γ point in the center of Brillouin zone and at Dirac cone K (K’) points
[174]. (c)-(d) Raman spectra of pristine graphene and n-doped graphene [177]. (e) Raman scattering
processes that are responsible for the characteristic peaks: G, D, D’ and 2D bands [174].
exfoliation and how the reduction treatment helped recovering the carbon lattice.
As depicted by the Raman scattering processes in graphene, the D and D’ bands
represent the disorder degree and the defect percentage of the carbon lattice. The G
and 2D bands describe the crystalline quality of the carbon lattice. The crystalline
size of the carbon lattice, in the order of magnitude of nanometers, can be extracted
by following the equation: 1/La = (ID/IG) [178]. It is also important to note that the
flake stacking during the spin-coating process is also responsible for the introduction
of additional Raman peaks for both GO and rGO thin films, which are discussed in
the following.
In this work, the Raman characterizations of GO and rGO thin films were carried
out with the excitation wavelength of 633 nm at room temperature. The obtained
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Raman spectra for GO and rGO thin films are shown in figure 3.9(a)-(b). The detailed
Figure 3.9: Raman spectra of (a) GO and (b) rGO thin films [116]. The evolution of the characteristic
Raman peaks (D band, G band, 2D band and D” bands) demonstrates how the carbon lattice is
recovered with the thermal reduction. The GO thin film was prepared by gas-phase silanization and
the spin-coating technique as described in chapter 2. The rGO thin film was transformed from the
prepared GO thin film with the TRP.
information about the position, intensity and full width at half maximum (FWHM)
of the characteristic Raman peaks for both GO and rGO thin films are summarized in
table 3.2.
Table 3.2: Peak position, FWHM and intensity of Raman
characteristic peaks for GO and rGO thin films.
[cm−1]
Peak position FWHM
[%]
Intensity
GO rGO GO rGO GO rGO
D 1325 1330 110 90 95.7 61.7
D” 1527 1581 207 76 18.1 28.4
G 1601 1608 56 44.5 64.5 76
2D 2638 2622 139 134.6 2.4 7
A Gaussian-Lorentzian algorithm was used for the spectrum deconvolution to extract
the characteristic Raman peaks. For both GO and rGO thin films, three typical peaks
D, G and 2D bands appear with an extra D” band. The existence of the D” band
can probably be attributed to the phonon density of states in the finite size crystals of
graphite [179]. For GO, the G peak attributed to the in-plane sp2 C−C stretching mode
(E2g [180]) is located at 1601 cm−1 while the 2D peak induced by the second-order
overtone of different in-plane breathing-like mode is at 2638 cm−1. The disorder
induced D peak (A1g) is present as 1325 cm−1 and the D” band appears at 1527 cm−1.
After thermal reduction, larger areas of sp2 carbon lattices were recovered for rGO, so
that the G peak, at 1608 cm−1 and the second order 2D, at 2622 cm−1 show a stronger
intensity compared to GO thin films. The intensity of the D” peak at 1581 cm−1
relates to the increase of phonon density states. The intensity of the D peak at
1330 cm−1, which is disorder induced, drastically decreases. This is due to the removal
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of sp3 oxygen functional groups from the carbon basal plane by thermal reduction.
Furthermore, the FWHM of the G, D, 2D and D” bands become narrower for rGO thin
films when compared to GO thin films after the reduction process [175, 181, 182]. In
addition, more Raman peaks of rGO thin films gradually emerge within the spectral
regime between 1690 cm−1 and 2150 cm−1. They correspond to the M-band region and
combination modes, which were observed in earlier reports for the case of few-layer
graphene. This is due to the interlayer bonding and relaxation of the selection rules
[183]. More pronounced combination modes were observed between 1800 cm−1 and
2150 cm−1, which originate from the intravalley double resonance scattering processes
in graphene. Such results indicate the strong commonalities between the quilted rGO
thin films and other forms of graphene such as incommensurate bilayer graphene
(IBLG) and stacked graphene layers [184, 185].
3.3.2 X-Ray Photoelectron Spectroscopy Characterization
XPS is an optical technique to analyze the surface chemistry of materials in ultra-high
vacuum. X-rays stimulate the electrons in the irradiated atoms to let them escape
from the analyzed material within a depth of less than 10 nm from the surface. These
released electrons correspond to the binding energies of the electron configuration of
the atoms and are collected by the XPS detector. The incident X-ray energy is known
as EX-ray = 1486.7 eV, and the binding energies of the electrons is calculated with:
Ebinding = EX-ray − (Ekinetic + φ) (3.11)
where Ekinetic is the electron energy measured by the XPS detector and φ is the work
function of the detector, which is attributed to the absorption of the photoelectrons.
The number of collected electrons versus their binding energies is plotted as XPS
spectra, which are unique for each element. Therefore, the XPS spectrum can be used
to characterize and identify the chemical compositions of the analyzed materials.
Furthermore, the bonding energies of the electrons vary according to the chemical
bonding environments. The resulting XPS spectrum can be used to distinguish the
types of bindings within the same elements. Both GO and rGO are of the same
chemical composition (C, O and H) but contain different portions of oxygen functional
groups. The XPS is an ideal characterization tool to address and compare the amount
of different oxygen functional groups in these two thin films in order to evaluate the
influence of the thermal reduction treatments.
For GO and rGO, three characteristic XPS peaks are expected: the C−C bonds at
284.5 eV, the C−O bonds at 286.4 eV, and the C−O bonds at 288.3 eV [182, 186, 187].
The degree of reduction can be reflected by the C/O ratio, in terms of the intensity
ratio of the sp2 hybridized C (284.6 eV) and C−O groups (286.0 eV), carbonyl groups
(287.8 eV) and carboxyl groups O−C−O (289.0 eV).
The XPS spectra as shown in 3.10(a)-(b) were obtained after the Shirley background
correction referring to the binding energy of the C 1s electron (284.6 eV). It was
observed that the amount of C−C bonds increased from 70.6 % to 74.4 %, which
means that more of the sp2 carbon lattice was restored after the thermal reduction. In
addition, the amount of oxygen bonds C−O and C−O bonds decreases from 22.1 %
51
to 18.8 % and 7.3 % to 6.8 %, respectively. This shows that the amount of hybrid sp3
oxygen functional groups was clearly diminished. These XPS results reveal that the
thermal reduction was efficient to transform GO into rGO resulting in a larger area of
the sp2 carbon lattice and less sp3 defects. In particular, it shows that rGO thin films
still possess a certain amount of functional groups, which are in favor of biomolecule
immobilization for biosensor applications.
Figure 3.10: XPS spectra of GO and rGO thin films [116]. The GO thin film was prepared by
gas-phase silanization and the spin-coating technique as described in chapter 2. The rGO thin film
was transformed from the prepared GO thin film by the TRP.
3.4 Conclusion
In this chapter, the I-V and cyclic voltammetry characterizations proved that the rGO
thin film obtained with the TRP formed an ohmic contact with the IDEs and that the
rGO thin films were complete without pinholes. These two facts are the prerequisites
so that the rGO thin films can be utilized into electronic devices. Furthermore, the
TRP generated 98.7 % (147 channels out of 149 channels) of channels with a resistance
between 1.44 · 104Ω and 9.54 · 106Ω. Most importantly, the resistance value of 87.9 %
of the conductive rGO channels were within only one order of magnitude. This result
demonstrates the efficiency of the TRP. The established protocol shows a scalability
for mass fabrication of rGO devices with further optimization.
The bipolar characteristic curves of the rGO thin film were measured in the
ESFET device configuration. These curves provided the possibility to deduce
the field-effect mobilities for holes and electrons with 0.326 cm2 V−1 s−1 and
0.092 cm2 V−1 s−1, respectively. In addition, the sheet resistivity was extracted by
four-point measurements using Greek-cross VDP structures and is between 0.03Ωm
and 0.06Ωm. These parameters are important, because they characterize the
reduction degree and serve as criteria to optimize the reduction conditions. The
obtained bipolar characteristic curves, field-effect mobility and sheet resistivity
indicated that the TRP removed the oxygen functional groups effectively and restored
the sp2 lattice partially. In addition, Raman spectroscopy and XPS characterizations
were used to address the reduction degrees by TRP and confirmed that the reduction
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was efficient. Therefore, the obtained rGO thin films were ready to be employed as
transducers in the biosensor devices to detect PSA biomarkers.
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4 | rGO Based SPR Platforms
In this chapter, SPR biosensors with GO and rGO thin films as functional layers are
presented. Firstly, the general principle of SPR is introduced and the state-of-the-art
of graphene as a functional layer in SPR for biosensing is summarized. Secondly,
(r)GO thin films were prepared on Au thin films with a glass wafer as substrate.
These devices were employed as SPR biosensors with covalently immobilized PSA as
the receptor biomolecules for detecting the target biomolecule lectin concanavalin A
(ConA). The biosensing performance of the GO and rGO functional layers based SPR
platforms in terms of SP enhancement are compared and discussed in detail. Thirdly,
the rGO thin film based electronic SPR biosensors are investigated, and the tuning
mechanism of the SPR signal by externally applied voltages is discussed.
4.1 State-of-the-Art of Graphene Based SPR Platforms
SPs are coherent, collective oscillations of charges at the interface of metals and
dielectric materials [188]. They can be excited either by photons or electrons. SPR
varies sensitively to dielectric changes in the vicinity of the interface, in a depth
approximately half the wavelength of the incident light. This optical phenomenon
enables label-free and real-time monitoring of the dynamic activity of biomolecular
interaction. The real application SPR based biosensor was first demonstrated by
Liedberg et al. in 1983 [189]. A typical SPR biosensor consists of a bilayer stack,
namely a biorecognition layer and a metal thin film on a transparent substrate, as
depicted in figure 4.1(a). Typically, a biorecognition layer is required to provide a
high density of functional groups and a large three dimensional surface area for
high-grade biomolecule immobilization. The biosensing process is addressed by the
intensity changes of SPR, which is induced by the attachment of biomolecules. As
depicted in figure 4.1(b), the angle of incident light to achieve a minimum value of
reflectance is shifted by the change in dielectric parameter of the biomolecule layer
∆εbio, which can be induced by the density and/or the type of biomolecules attached
on the biosensor surface. This effect is utilized as SPR biosensing principle.
Graphene is utilized as a layer between the biorecognition element and the metal
layer. This system shows improvements that are attributed to the promising optical
and plasmonic properties of graphene. As a two dimensional atomic carbon lattice,
graphene confines the SPs within a volume which is six orders of magnitude smaller
than the diffraction limit of the light [87, 103]. In addition, the field enhancement [104]
and the interaction strength of SPs in graphene at the quantum level is increased by
one order of magnitude compared to conventional metal thin films. The resonant
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Figure 4.1: (a) Schematic of an SPR chip. A biorecognition layer is immobilized on an Au thin film
with a glass as substrate. Through a prism, an incident light irradiates the glass side and stimulates
SPs at the interfaces of the biorecognition layer and Au thin film. (b) A plot of the angle of incident
light versus the SPR signal (reflectance), based on a typical five-layer system. The increase of dielectric
parameter of biomolecule layer εbio leads to the shift of reflectance. The SPR biosensing principle is
based on this effect.
extinction cross section is much larger than the geometrical cross section as well.
These properties are all in favor of enhancing the strong light-matter interaction [103].
Especially, the bipolar property of graphene [59, 60] enables a tuning effect in the
plasmon mode [104], the optical parameters [105], the quantum pathways of inelastic
light scattering [106], and the band-gaps [107], with the assistance of externally
applied bias voltages or the attachment of charged molecules. Therefore, graphene
becomes prominent in the field of bio-plasmonic applications [64–66]. The amplifying
capability of graphene as a functional layer on Au-based SPR biosensors was verified
to boost the sensitivity for the detection of biomolecules [63, 68, 89–91, 108]. The
sensing regime can be tuned by graphene based infrared spectroscopy with the
assistance of an applied electric field in the mid-infrared regime [70].
However, graphene as a linker layer restricts the immobilization of probe biomolecules
to pi-pi stacking. Unlike graphene, chemically exfoliated GO [71, 72] and its derivative
product, rGO [73–75] possess oxygen functional groups on both sides of the carbon
basal plane. This offers the possibility of (r)GO thin film formation on various
substrates, but also enables the diverse and robust immobilization of biomolecules.
Meanwhile, these two materials maintain a carbon lattice similar to pristine graphene
in nanoscale [112] so that the previously mentioned plasmonic characteristics are
partially preserved.
Plenty of effort is dedicated to investigate the biosensing performance of Au-based
SPR using GO flakes or layers to enhance the SPR intensity [190–197]. These
works proved that the sensitivity improved when compared to conventional Au
based SPR platforms. GO flakes or layers as an insulating material are generally
reduced to conductive rGO for the purpose of restoring the carbon lattice which also
generates the opto-electro-plasmonic properties [111]. It was found that the optical
properties of a few layers of rGO are similar to monolayer exfoliated graphene while
also being tunable by the reduction treatment [198]. In addition, rGO exhibits an
infrared-absorption which is highly superior to that of GO thin films [199]. This is
due to the coupling of the electronic states and the asymmetric stretching mode of the
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oxygen atoms aggregated at the edges of the defects. Such optically-active regimes of
rGO include the infrared regime, in which the excitation wavelength of a typical SPR
setup is located [200]. The comparison between the SPR enhancements of these two
materials and the potential for simultaneous optical and electronic biosensing with
(r)GO thin films as functional layers of SPR platform is of high interest.
4.2 (r)GO SPR Platforms
4.2.1 Preparation of (r)GO Based SPR Platforms
The (r)GO SPR chips were prepared as follows:
i) The glass wafers were thoroughly cleaned with freshly prepared Caro’s acid
to remove all contaminants and washed with DIW and dried under a nitrogen
(N2) flow. Afterwards, the glass wafers were directly transferred into an electron
beam evaporator to deposit the metal layer, which consisted of 3 nm Ti and
47 nm Au thin films. A schematic of the obtained wafers is depicted in figure
4.2(a).
ii) 4-aminothiophenol (ATP) linker layers, as depicted in figure 4.2(b), were
prepared on the Au surface by gas-phase silanization. This linker layer was used
to covalently immobilize GO flakes to form a uniform thin film. Prior to the
silanization process, the Au wafer was cleaned by O2 plasma (230 W) for 5 min,
in order to remove the adsorbates on the Au surface.
iii) The wafer was then transferred into a desiccator, which was inside a N2 flooded
glovebox to proceed to the gas-phase silanization. The silane ATP was placed
onto a glass slide, which was then transferred inside of the preheated desiccator
(60 ◦C). The Au wafer was positioned at an angle of about 85° with respect to the
outlet valve of the desiccator to provide a maximum contact area between the
substrate and the silane-saturated gas stream. Then, the pressure inside of the
desiccator was reduced to 130 mbar, such that a continuous gas flow of the silane
over the substrate was ensured. The process was carried out at 60 ◦C for 30 min
and an ATP linker layer was formed on the Au surface, as shown in figure
4.2(b). Afterwards, the glass wafer was washed with ethanol (98 %) and DIW,
and dried under a N2 flow to remove physically absorbed impurities during the
silanization process.
iv) The wafer with the silane ATP was then transferred into a second preheated
desiccator to carry out a grafting procedure at 85 ◦C for 1 h to remove leaving
groups. Eventually, the ATP linker layer was formed with the amino groups on
the surface.
v) The GO flakes were chemically exfoliated by following the LTEDS technique
presented in chapter 2.3 and the centrifugation speed in the last step was
500 rpm instead of 1000 rpm. The generated GO solution were applied by
spin-coating onto the ATP-functionalized Au surface to form uniform GO thin
films, as shown in figure 4.2(c).
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vi) The rGO thin films were prepared following the TRP to remove the oxygen
functional groups and partially restore the sp2 hybridized carbon lattice of the
GO thin films. In the following sections, the rGO thin films were reduced using
this method unless specified otherwise.
After the preparation process, the 4-inch wafer was diced into chips of the size
1.25 cm× 1.25 cm which are suited for the commercial Reichert SPR setup for
biosensing. To protect the (r)GO chips during cutting, a layer of photoresist was spin
coated on the 4-inch wafer. Then, in order to remove the protective photoresist, the
chips were first immersed in acetone for 30 min at room temperature, then in fresh
acetone and afterwards in isopropanol for 5 min. Finally, the chips were dried by N2.
Figure 4.2: Schematics of a GO thin film preparation on Au surface with a glass wafer substrate. (a)
The Au surface is cleaned by O2 plasma to remove the impurities and adsorbates. (b) A uniform ATP
layer is generated on the glass wafer surface by gas-phase silanization in a vacuum desiccator. In this
process, the thiol (−SH) groups of ATP bind to the Au surface. (c) The freestanding −NH3 groups of
the ATP molecules bind to the GO flakes by reacting with the −COOH groups of the carbon basal
plane in a condensation reaction at room temperature. The pH value of the GO solution is 2.9.
4.2.2 Fundamentals of (r)GO Based SPR Platforms
A Kretschmann configuration was used for the GO and rGO thin film based SPR
biosensor platforms [201]. A six-layer system was established by adding a (r)GO layer
into the typical five-layer system (prism, glass substrate, metal thin film, biomolecule
layer and analyte solution), as shown in figure 4.3. The final six layers are:
• Layer 1: prism of refractive index np
• Layer 2: glass substrate of refractive index ng.
• Layer 3: conductive gold layer of refractive index nc.
• Layer 4: dielectric layer, GO or rGO, of refractive index nd.
• Layer 5: biomolecule layer of refractive index nbio.
• Layer 6: analyte solution of refractive index ns.
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The dielectric layer can immobilize PSA, which act as receptor biomolecules to
detect the target biomolecule ConA. The objective of this section is to compare the
performance of GO and rGO as functional layers in SPR biosensor platforms.
Figure 4.3: Schematic of the GO or rGO thin film based SPR biosensor platform. The typical five-layer
system used for SPR sensing (prism, glass substrate, gold layer, biomolecule layer, analyte solution)
is expanded by an additional layer from either GO or rGO coating, giving six layers: prism, glass
substrate, conductive gold layer, dielectric layer (GO or rGO), biomolecule layer and analyte solution
with refractive indices np, ng, nc, nd, nbio and ns respectively. The wavelength of the incident light is
780 nm with an angle of incidence ranging from 58° to 85°.
In a typical SPR setup, a monochromatic plane-polarized light from a near-infrared
LED illuminates the back surface of the biosensor chip, while the reflected light is
detected by a diode array detector [202]. For the Reichert SPR setup used in this work,
the incident wavelength λ was 780 nm and the angle of incidence α ranged from 58° to
85°. In a typical five-layer system, the incoming light Ei induces an evanescent wave Er
at the metal and dielectric interface with the wave vector k and an amplitude decaying
exponentially, perpendicular into both medium sides [203]:
Er = Ei exp
(
jωt− jkxx− jkyy
)
(4.1)
where Ei and ω are the amplitude and the angle frequency of the incident light, kx
and ky are the wave vectors along the x and y axis at the interface plane, while the
wave vector kz along the z-axis is 0.
The SPR is activated by the evanescent wave at the metal and dielectric interface. The
characteristic curve of the light angle of incidence α and the reflectance (rp = |Er/Ei|2)
is employed to address binding of biomolecules, which results in a change in the
dielectric parameter of the biomolecule layer ∆εbio on the sensor surface. At a certain
angle of incidence α, a minimum value of reflectance appears as a dark strip on the
diode array detector. The SPR sensorgram is recording the change in α in real-time.
The relationship between α and ∆εbio can be described by an abstract multi-layer SPR
system consisting of nlay layers between the prism and the analyte solution. Each layer
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has a specific dielectric constant ε, refractive index n (ε ≡ n2), thickness d, and wave
vector ky along the y direction. The subscripts p, s, and i correspond to the prism,
solution, and layer i, respectively. The reflectance rp versus the angle of incidence
α can be calculated with the following equation, which is obtained by repeatedly
applying the Fresnel equations [203]:
rp(α) =
(
M11 + M12
kys
εs
)
kyp
εp
−
(
M21 + M22
kys
εs
)
(
M11 + M12
kys
εs
)
kyp
εp
+
(
M21 + M22
kys
εs
) (4.2)
where the factors Mij are obtained from the transfer matrix M:
M = ∏
i∈{1,nlay}
Mi =
[
M11 M12
M21 M22
]
(4.3)
with each matrix Mi defined as:
Mi =
 cos
(
kyidi
) −jεi
kyi
sin
(
kyidi
)
−jkyi
εi
sin
(
kyidi
)
cos
(
kyidi
)
 (4.4)
and the wave vector kyi obtained with the Snell’s law between layer i and i− 1:
k2yi = n
2
i−1
(
2pi
λ
)2( n2i
n2i−1
− sin2 α
)
(4.5)
In the six-layer SPR system with an additional (r)GO thin film as functional layer on
top of the Au metallic layer, M becomes:
M = Mglass ·MAu ·MGO/rGO ·Mbiolayer (4.6)
The sensitivity S of an SPR biosensor can be defined as the first derivation of the angle
of incidence α for the minimum reflectance with respect to the dielectric parameter
εbio of the bimolecule layer.
S =
dα
dεbio
∣∣∣∣
rp,minimum
(4.7)
The above deduction enables a comparison of the sensing performances of the SPR
biosensor platforms with GO and rGO functional layers, in the condition of knowing
the thicknesses and dielectric parameters of the (r)GO films d(r)GO and ε(r)GO.
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4.2.3 Biosensing Mechanism of (r)GO Based SPR Platforms
In this section, the thicknesses and dielectric parameters of the (r)GO thin films
were extracted by AFM and ellipsometry measurements. Afterwards, the sensitivity
corresponding to the binding activity of target biomolecule was simulated for both
(r)GO SPR platforms based on the six-layer model established in section 4.2.2.
The AFM characterization was carried out to extract the thickness of the GO thin films.
As shown in figure 4.4, the thickness of the thin films was approximately 8 nm. The
GO flakes used to prepare the GO thin films for the SPR experiments were of larger
lateral area and thickness, which lead to higher thin-film thickness compared to that
obtained in chapter 3. Since the oxygen functional groups are partially removed by
the thermal reduction, the rGO thin films tend to slightly collapse and their thickness
should be smaller than 8 nm. The evanescent light propagates until approximately half
of the incident light wavelength (390 nm) in the plane perpendicular to the conductive
layers [203]. Therefore, both thin films are within the range of the evanescent light field
and can be used to detect the target biomolecule bindings.
Figure 4.4: AFM characterization of a GO thin film showing an average thickness for the GO pattern
of approximately 8 nm.
The dielectric parameters were extracted by ellipsometry. The principle of this
characterization tool was introduced in chapter 2.5.2. The two parameters Ψ and ∆
were directly measured versus the incident wavelength at a fixed angle of incidence
θ. Ψ and ∆ are the amplitude ratio and phase difference of the s-plane and
p-plane components of the reflected light, respectively. In this study, the ellipsometry
characterization was carried out with the incident wavelength ranging from 300 nm
to 800 nm at multiple angles of incidence θ: 50°, 55°, 60°, 65° and 70°. Hereby,
the measurements in multiple angles provided a more precise analysis than the
measurement at a single angle. A proper layer model can be chosen to fit Ψ and
∆ so that the dielectric parameters and thicknesses of both thin films can be extracted
after the fitting.
A five-layer model was chosen for the fitting as shown in figure 4.5(a). It consists of
a Si file layer (data in lookup table), a SiO2 Cauchy layer, an APS Cauchy layer, a
(r)GO thin film as Cauchy layer and air as a fixed dielectric constant layer. The fitting
parameters of each layer are shown in figure 4.5(b).
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The experimental and fitting curves of Ψ and ∆ versus the incident wavelength are
shown in figure 4.5(c)-(d). From the fitting data, the refractive indices (n = n + jk) as
well as the dielectric parameters ( ε ≡ n2 = ε′ + jε′′) can be deducted. The dielectric
parameter for Si substrate and air were nSi = 3.872± 0.016j and nair = 1, respectively.
The thickness of SiO2 was measured to be dSiO2 = 156.15± 2.00 nm while its refractive
index was nSiO2 = 1.464. The thickness and refractive index of the APS layer was
measured as dAPS = 1.01± 0.40 nm and nAPS = 1.422± 0.0001j [204]. The thicknesses
of GO and rGO thin film, obtained by AFM characterization, were dGO = 8 nm and
drGO = 6.8 nm, respectively.
Figure 4.5: Ellipsometry measurements. (a) A layer model is chosen to extract the target material
parameters. It consists of Si, SiO2, APS, (r)GO thin film and air. The layer types are file layer, Cauchy 
layer, Cauchy layer, Cauchy layer and fixed d ielectric c onstant l ayer ( nk), r espectively. ( b) T he fitting 
parameters of each layer used to extract the dielectric parameters and optical indices for (r)GO thin 
films. ( c)-(d) M ulti-angle e llipsometry c haracterization o f t he G O t hin fi lms (t hickness 8 nm ) an d the 
rGO thin films (thickness 6.8 nm) after being treated by the TRP. The angles of incidence are 50°, 55°, 
60°, 65° and 70°. The experimental ellipsometry results are fitted with the 5-layer model to extract the 
refractive indices and dielectric parameters of the (r)GO thin films.
The deduced dielectric parameters of (r)GO thin film are plotted in figure 4.6(a). This
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result manifests a clear change in the complex dielectric parameters of the GO thin
film after the TRP. At the incident wavelength 780 nm of the SPR setup, the dielectric
parameters of GO and rGO thin films are: εGO = 1.72 + 0.55j, εrGO = 1.59 + 1.10j.
In the following, a simulation software “WinSpall” was used to analyze the SPR
biosensor performance with (r)GO as functional layers, based on the layer structures
shown in figure 4.6(b). For both cases, the sequential layers between the prism
and water layers were glass substrate, Au thin film, (r)GO thin film and biolayer
(ConA/PSA). All the parameters used for the simulation by WinSpall are listed in
figure 4.6(c). The thicknesses and dielectric parameters of the prism (dprism = ∞,
nprism = 1.76), glass (d = ∞, εglass = 1.76), Au (εAu = −12.45 + 1.3j) and water
(d = ∞, εwater = 1.78) were adapted from the WinSpall tutorial materials. The Au
thin film deposited by electron beam evaporation in this study was approximately
50 nm thick. The thicknesses and dielectric parameters for (r)GO thin films were the
values obtained by the AFM and ellipsometry (at λ = 780 nm) characterizations.
The performance of (r)GO based SPR biosensors were compared before and after the
attachments of the ConA/PSA biolayer (dConA/PSA = 10 nm, εConA/PSA = 2.11) [203].
The simulated results of the angle of incident light versus the SPR signal (reflectance)
for (r)GO based SPR biosensors are shown in figure 4.6(d). It clearly manifests that
the angle of incidence α corresponding to the minimum value of the reflectance shifts
is larger for rGO SPR biosensing compared to the case of GO.
Furthermore, to predict the real biosensing process, the sensitivity as defined in
equation 4.7 was compared for both biosensors with a variable thickness or dielectric
parameters of the biolayer. The simulated results are shown in figure 4.7(a)-(b). It
appears that the sensitivity is larger for rGO compared to GO based SPR biosensors
in the condition of constant dielectric parameters and variable thickness of the biolayer
or vice-versa.
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Figure 4.6: GO and rGO thin film based SPR biosensor. (a) The dielectric parameters of (r)GO thin films
ε = ε′ + ε′′ are extracted by spectroscopic ellipsometry measurements. (b) The layer structures applied
for the simulations. (c) All the parameters used for the simulation. (d) The simulated plots of the angle
of incident light versus the SPR signal (reflectance) for (r)GO SPR biosensors.
Figure 4.7: Simulated sensitivity of GO and rGO based SPR platforms (a) as a function of the thickness
and (b) as a function of the dielectric parameter of the biolayer.
64
4.3 (r)GO Based SPR Platforms for Biosensing
The SPR setup for the biosensing experiments is shown in figure 4.8. The main
components were an autosampler, a Y-valve, an SR7000DC SPR instrument, an
electronic flow cell, a solvent reservoir and waste bottles. Prior to each biosensing
process, the SPR was cleaned by six different substances in this sequence: DIW, 20 %
ethanol, sodium dodecyl sulfate 0.5 %, glycin, DIW, 20 mM NaOH.
The autosampler maintained the temperature at 4 ◦C to preserve the activity of the
agents. All the agents were degassed for 10 min before being injected into the flow
cell. This was to avoid the formation of air bubbles, which would add strikes to the
output SPR signals. In this study, both channels of the flow cell were used for the
biosensing because the receptor biomolecules were incubated outside of the flow cell.
The reference chips were used to extract the selectivity of (r)GO SPR biosensors.
Figure 4.8: The SPR setup (Reichert, Inc.) consisted of an autosampler (maintained at 4 ◦C to preserve
the activity of agents), a Y-valve, an SR7000DC SPR instrument, a flow cell, a solvent reservoir and
waste bottles.
4.3.1 Non-Electronic (r)GO Based SPR Platforms for Lectin
Detection
The biosensing process took place inside the flow cell. 1 µl matching fluid (refractive
index: 1.515) was pipetted beforehand on the prism surface to reduce the reflection at
the glass surface. Then the SPR chip was placed in the receptacle as shown in figure
4.9(a). Afterwards, the flow cell was clamped on top of the chip, with a schematic
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sideview and a photo from the top shown in figure 4.9(b)-(c). A close-up of two
channels is shown in figure 4.9(d). These two channels were used for the reagents
passing through the surface of SPR chip.
Figure 4.9: SPR flow cell (Reichert, Inc.). (a) The SPR chip is placed into the receptacle. (b)-(c) Sideview
(schematic) and topview (photo) of the fluidics cell for biosensing. The target biomolecule, buffer
solution, and agents to regenerate the biosensor surface are injected at the inlet and flow towards the
outlet. The flow time and flow rates are controlled to optimize the biosensor performance. (d) The fluid
cell contains 2 distinct channels and both serve as working channels in this study.
The (r)GO SPR platforms were prepared by the three following steps, while the
detailed schematic of the preparation is shown in figure 4.10:
i) The −COOH groups on the surface of the (r)GO thin
films were activated by mixed aqueous solutions of 100 mM
N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC)
and 25 mM N-hydroxysuccinimide (NHS) for 30 min at room temperature.
Afterwards, the chips were cleaned three times by DIW.
ii) The PSA receptor biomolecules were covalently immobilized on the surface of
the (r)GO functional layers at 4 ◦C overnight. The concentration of PSA for the
immobilization was 50 µg ml−1, prepared in 10 mM acetate acid buffer solution,
which was at a pH value of 5. This pH value was chosen to achieve the optimal
surface charge of PSA for the immobilization [44]. The incubation of PSA was
carried out outside of the flow cell overnight instead of a short-term injection
in the flow cell, in order to achieve the maximum amount of −COOH on the
surface.
iii) After the PSA incubation, the chip was mounted into the SPR setup and
stabilized in phosphate buffered saline with tween-20 (PBST) for 2 h. 1 mM
carbo-free blocking agent in 10 mM PBST was then injected for 10 min to saturate
the freestanding −COOH groups.
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The SPR biosensor platforms with (r)GO thin films as functional layers established
with this protocol are called Au/GO/PSA and Au/rGO/PSA in the following
sections.
Figure 4.10: (r)GO thin film based SPR biosensor preparation. The −COOH groups of the (r)GO thin
films are activated by EDC/NHS chemistry to covalently immobilize the PSA receptor biomolecules.
Afterwards, the carbon-free blocking agents are applied to saturate the free-standing −COOH groups
to prevent non-specific binding. The established biosensor is ready to detect target biomolecule: ConA
lectin.
The specific test was carried out with a series of ConA concentrations: 0.5 µg ml−1,
1 µg ml−1, 5 µg ml−1, 10 µg ml−1, 50 µg ml−1 and 100 µg ml−1. The detection overview
of the SPR output signal for the ConA concentration experiments is shown in figure
4.11(a). Each concentration was injected 2 times in each channel. The measurements
in the flow cell started from the addition of the carbo-free blocking agent, because
the first two steps of the biosensor preparation took place outside the SPR setup.
The figure 4.11(b) is a close-up showing the detection process of two specific ConA
concentrations (50 µg ml−1 and 100 µg ml−1).
The biosensing measurements are shown in figure 4.12(a). Between two subsequent
ConA injections, 0.2 M NaCl and 10 mM NaOH were used to regenerate the sensor
surface. For all the agents (ConA, NaCl and NaOH), the injection (also called
association) started from the blue vertical line and terminated at the orange line. PBST
cleaning (also called dissociation) followed up until the red line. Generally, between
the red line and next blue line was also PBST cleaning so that the biosensor surface
was cleaned and ready for the injection of the next agent. The exact values for the
association and dissociation phases are summarized in figure 4.12(b).
The biosensing kinetics is represented by a sensorgram which displays the changes in
refractive index unit (RIU) with respect to time. The relationship of refractive index
unit and the angle shift ∆α of the incident light which corresponds to the minimum
reflectance follows: 0.1°∆α = 1000 µRIU. The obtained sensorgrams of the ConA
concentrations for (r)GO based SPR platforms are given in figure 4.13(a)-(b). It is
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Figure 4.11: Output signal of the Reichert SPR setup. (a) Overview for ConA concentration experiments.
The 1 mM carbo-free blocking agent was injected for 10 min to block the free-standing −COOH groups.
A series of ConA concentrations were detected. (b) A close-up of the detection of 50 µg ml−1 and
100 µg ml−1 ConA. Each concentration of ConA has been injected 2 times. Between measurements, the
biosensor surface was cleaned by a regeneration agent.
shown that the rGO thin film enhances the SPR signal compared to the GO thin film.
The amplification factor was 1.70± 0.25. This result confirms the SPs enhancement
effect of rGO functional layers as already predicted by the simulation results in section
4.2.
Specific and non-specific tests were compared to analyze the sensing selectivity of the
(r)GO based SPR platforms. The biosensor surface was prepared as described in figure
4.10 without PSA immobilization for non-specific tests. Each ConA concentration for
specific and non-specific tests was injected three times on two different chips, so that
the performance of both platforms could be investigated statistically. The obtained
results were fitted by pharmacology DoseResp in origin software as shown in figure
4.14(a)-(b). The correlation of specific and non-specific bindings was analyzed by
Student’s unpaired t-test. It manifests the significant difference between specific and
non-specific binding for the GO platform (???P < 0.001, ????P < 0.0001, n = 4− 14)
and for the rGO platform (??P < 0.01, ???P < 0.001, n = 4− 12). The limit of detection
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Figure 4.12: SPR biosensing measurements and parameters. (a) A close-up of the detection of a
single concentration of ConA (50 µg ml−1). 0.2 M NaCl and 10 mM NaOH were used to regenerate the
biosensor surface. For each agent (ConA, NaCl, and NaOH), three phases are observed: the injection
(association), the PBST cleaning (dissociation) and the PBST cleaning so that the biosensor surface
was cleaned for the injection of the next agents. (b) The flow time and rate of the association and
dissociation phases for each agent: carbo-free blocking agent, ConA, NaCl and NaOH.
Figure 4.13: Sensorgrams of GO and rGO thin film based SPR biosensor platforms. PSA as receptor
biomolecules were covalently immobilized on (r)GO thin film by EDC/NHS chemistry. To avoid
non-specific binding, the freestanding−COOH groups were saturated by the carbo-free blocking agent.
The target biomolecule ConA were detected with a concentration range of 0.01 µg ml−1 to 100 µg ml−1.
(LOD) of the rGO biosensor platform was one order of magnitude lower than that
of the GO based platform, with values of 0.5 µg ml−1 and 5 µg ml−1, respectively.
Moreover, the signal-to-noise ratio of the rGO platform was approximately three times
larger than that for the GO platform with statistical values 6.56± 3.63 and 2.16± 1.64,
respectively. When compared with GO thin films, rGO thin films restore a larger
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area of the carbon lattice after the thermal reduction treatment. This enables the SPs
to propagate over longer distances without being scattered. This could be responsible
for the improved LOD and signal-to-noise ratio in the ConA biosensing process. These
results indicate a significant influence of the thermal reduction on the SPR biosensors
with GO and rGO as functional layers.
Figure 4.14: Statistical comparison of GO and rGO thin film based SPR biosensor performance for
specific and non-specific detection of ConA. The results were analyzed using Student’s unpaired
t-test. Significant differences between specific and non-specific binding are shown for the GO platform
(???P < 0.001, ????P < 0.0001, n = 4 − 14), and for the rGO platform (??P < 0.01, ???P < 0.001,
n = 4− 12).
4.3.2 Electronic rGO Based SPR Platforms
In this section, the tuning effect of SPR signals by external electronic fields is discussed
for rGO thin film based SPR biosensor platforms. Prior to the biosensing process, the
bipolar properties of the rGO thin films were characterized in an ESFET configuration,
as shown in figure 4.15(a). The rGO thin film was prepared on IDEs by the fabrication
process as described in chapter 2. The IDEs consisted of a common source electrode
which is located at the center of the chip and is shared by 16 drain electrodes in a 4× 4
array layout. There are 10 fingers for each channel with an effective channel length
of 5 µm, an effective channel width of 900 µm and a separation distance between
neighboring fingers of 5 µm. A SEM image of a close-up of a single channel with a
patterned rGO thin film is shown in figure 4.15(b).
The ESFET measurements were carried out with a Keithley 4200-SCS parameter
analyzer. To obtain the curves without any drifting, the rGO devices were stabilized
beforehand in 10 mM PBS for 2 h at room temperature. An Ag/AgCl electrode
immersed in 10 mM PBS served as the gate electrode to apply sweep voltages from
−0.8 V to 0.8 V against the source electrode, while the step voltages are applied
between the drain and source electrodes ranging from −0.1 V to 0.1 V with 0.1 V as the
step size. The detailed explanation of the bipolar curve can be found in section 3.2.3.
The measured bipolar characteristic curves are shown in figure 4.16. They indicate that
the rGO thin film is initially n-doped, because the Dirac points are shifted to the left
compared to Vgs = 0 V. Besides, a stronger tuning effect is observed for a drain-source
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Figure 4.15: Electronic characterization of rGO thin films on IDEs. (a) Schematic of an ESFET
configuration with the rGO thin film as a transducer layer. (b) SEM image of an rGO thin film on
an IDEs structure used for ESFET characterization.
voltage Vds = −100 mV compared to Vds = 100 mV. This bipolar property can be
utilized for modulating the dielectric parameters of the rGO functional layers and,
hence, possibly tune the sensitivity for rGO based SPR biosensors [205].
Figure 4.16: Bipolar characteristics of the rGO thin film as transducer layer in an ESFET configuration.
The electronic SPR measurements that intended to employ the bipolar property of
rGO thin films were carried out in a flow cell, which is shown in figure 4.17(a)-(b).
An Ag/AgCl electrode was immersed from the top of the flow cell into the analyte
solution, while a metal pillar was in contact with the Au/rGO/PSA SPR biosensor
surface. More details of this flow cell are given in the Reichert handbook [200, 206]. In
this study, a bias voltage was applied to the Au/rGO/PSA biosensor surface through
the metal pillar against the Ag/AgCl electrode. The close-up of this two-electrode
configuration is depicted in figure 4.17(c).
The tuning effect was tested initially in the PBST buffer solution, by applying a voltage
staircase to the rGO thin film: 0 V, 0.5 V, 0.8 V, 0 V, −0.5 V, −0.8 V and 0 V. Each
voltage step was applied for 30 s. The corresponding SPR signals are shown in figure
71
Figure 4.17: Flow cell setup for electronic SPR measurements. (a)-(b) Top view and side view of the
electronic flow cell with an Ag/AgCl RE inserted from the top (the images are adapted from the user
guide of the Reichert SPR setup [206]). (c) Close-up of the side view of the electronic flow cell: the
voltage bias was applied to the rGO surface through a metal pillar (yellow color) against an Ag/AgCl
electrode.
4.18(a). It demonstrates that only the positive but not the negative voltages modulate
the SPR signals with a response delay time of 12-15 s. Then, the comparison of the SPR
responses of Au/rGO/PSA biosensors and bare Au chips were carried out in PBST
running buffer, by applying the sweeping voltages (0 V to 0.8 V to −0.8 V to 0 V) with a
sweeping rate of 0.1 V s−1. After compensating with a 12 s delay for the Au/rGO/PSA
biosensor platform, the obtained voltage modulation curves were measured as shown
in figure 4.18(b). The SPR signals of the Au/rGO/PSA chips showed no response
to the applied negative voltages but they showed a response to the applied positive
voltages (gray curve). This is consistent with the previously presented results in case
of the applied voltage staircase. This result indicates that the running PBST buffer
solution provides a stable baseline for the ConA detection when negative voltages are
applied.
In contrast, the SPR signals of the bare Au chips are tuned with the applied voltages
(orange curve) with a peak-to-peak delay between 8 s and 10 s. It is also seen that
the modulation intensity of the SPR signals was slightly higher for the negative
voltages than for the positive voltages. The reason for this might be due to the
asymmetric modulation of the refractive indices [207], which is induced by cation or
anion accumulations in the Helmholtz double layer [163], changes of charge density
[208], and a reduction-oxidation process at the Au-liquid interface [209].
In the following, the tuning effect of the applied voltages on the biosensor
performance to detect ConA was investigated. The voltages were applied to the
Au/rGO/PSA SPR biosensor surface against the Ag/AgCl electrode, with a constant
ConA concentration of 50 µg ml−1.
• Positive voltages (0.4 V, 1 V and 1.6 V) were applied to the Au/rGO/PSA
biosensor surface from t = 0 s for 210 s. It was observed that the maximum
intensities of the output SPR signals increased proportionally with the positive
voltages while the association time was longer than the injection time of 210 s,
as shown in figure 4.19(a). This could be because the positive voltages polarized
the PSA receptor molecules and ConA target molecules were still being attracted
and bonded after the bias terminated. It is in a clear contrast with the reference
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Figure 4.18: Electronically tunable SPR biosensor with an rGO thin film as a functional layer. (a) SPR
response of an Au/rGO/PSA chip within PBST flow. The applied voltage staircase to the rGO thin
film was 0 V, 0.5 V, 0.8 V, 0 V, −0.5 V, −0.8 V and 0 V and each step was lasting for 30 s. A response to
positive voltages is observed with a delay of 12-15 s. (b) The sweeping voltages (0 V to 0.8 V to −0.8 V
to 0 V, 4 cycles, red curve) were applied to an Au chip and an Au/rGO/PSA chip. The corresponding
SPR response of the Au/rGO/PSA chip (gray curve) is displayed after compensating with a 12 s delay
and can only be modulated by positive voltages. In contrast, the SPR response of an Au chip (orange
curve) shows the voltage modulation corresponding to both positive and negative sweeping voltages.
test in PBST, during which the SPR signal intensity was also tuned by the
applied positive voltage (V = 1.6 V) but dropped immediately when the voltage
supply terminated at t = 210 s.
• With negative voltage modulations, the biosensing performance presented very
distinctive characteristics. The SPR signal in figure 4.19(b) shows no influence of
the PBST when negative voltages were applied. Therefore, the negative voltage
was applied from 0 s to 630 s, which covers both association and dissociation
periods. The baseline refers to the sensorgram which was measured in 10 mM
PBST running buffer at V = −0.8 V. The sensorgrams for 50 µg ml−1 ConA
injections were measured in the condition of the applied negative voltages of 0 V,
−0.8 V and−1.6 V. The obtained results are shown in figure 4.19(b). As expected,
the negative voltage introduces no SPs changes to the running PBST buffer
solution. Therefore, it can be used as the baseline to analyze the tuning effect of
the bipolar property of rGO thin film for detecting the target biomolecule. The
SPR signals increased with the absolute value of the applied voltages, proving
the tunability of the SPs on rGO based SPR biosensors with negative voltages.
In the following, the sensing limit of ConA biomolecules was investigated for the
rGO based electronic SPR platform in three different conditions: no bias, positive bias
(V = 1.6 V) and negative bias (V = −0.8 V). A concentration of 0.01 µg ml−1 ConA
was chosen for the test, because it is not detectable by conventional Au SPR chips. The
sensorgrams of 50 µg ml−1 ConA and PBST buffer solution serves as the references.
The ConA injection was performed from 0 s to 630 s and the applied voltages were
the same as described in the last session. The obtained results are shown in Figure
4.20(a)-(c).
• When no bias was applied on the rGO surface, there is no detection signal for
the 0.01 µg ml−1 concentration.
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Figure 4.19: Biosensing performance of the electronically tunable SPR platform using rGO thin films
as functional layers. (a) A ConA concentration of 50 µg ml−1 was detected while different bias voltages
were applied on the Au/rGO/PSA sensor surface (0 V, 0.4 V, 1 V and 1.6 V). This confirmed the
sensitivity increase. However, the SPR signal also responded to PBST as control experiment. (b) This
can also be confirmed when 50 µg ml−1 ConA were detected when voltages of 0 V, −0.8 V and −1.6 V
were applied on the Au/rGO/PSA sensor surface. The reference curve is given by 10 mM PBST at
V = −0.8 V because the biasing into the negative direction generates a stable baseline for PBST.
• At a fixed positive voltage V = 1.6 V, the SPs intensity for 0.01 µg ml−1 is
detectable with a lower intensity compared to that of PBST. The reason could be
that the SPs intensity caused by the accumulated ions on the Au/rGO/PSA
sensor surface in PBST is higher than that induced by the bound ConA
molecules. In future, more detailed experiments are required to precisely clarify
this issue.
• At a fixed negative voltage V = −0.8 V, the detection limit was as low as
0.01 µg ml−1 with the SPs intensity at 30 µRIU (as shown in the figure 4.20(d)),
which can be distinguished from the baseline obtained from the pure PBST
buffer solution.
These results show that the sensing LOD of rGO based SPR platforms can be
improved by negative voltages applied to the thin films.
This electronic tuning effect with the application of negative biases makes the rGO
thin films even more interesting compared to the GO thin films for SPR biosensing
as previously shown (see performances in figure 4.13). The binding of incoming,
negatively charged ConA (neutral pH of 6.3-7) onto the Au/rGO/PSA biosensor
surface is equivalent to a negative bias, which tends to enhance the SPs intensity.
Thereby, in a normal SPR setup without external bias, rGO based SPR platforms
display a higher sensitivity compared to GO based SPR platforms.
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Figure 4.20: Sensitivity limit of the electronically tunable SPR biosensors using rGO thin films as
functional layers. (a) When no bias voltage was set to the rGO thin film, the LOD was approximately
1 µg ml−1. A concentration of 0.01 µg ml−1 had no effect on the signal. (b) When biased with positive
voltages, the SPR signal responded to a ConA concentration as low as 0.01 µg ml−1. However, also
a PBST flush as control showed a significant response. The bias voltage was fixed at V = 1.6 V while
0.01 µg ml−1 and 50 µg ml−1 ConA were detected. (c) When biasing with negative voltages, 0.01 µg ml−1
caused a detectable response, which could be clearly distinguished from the PBST control. (d) A
close-up of 0.01 µg ml−1 ConA detection at V = −0.8 V.
4.4 Conclusion
In this chapter, a wafer-scale method to prepare (r)GO based SPR biosensor platforms
was successfully established, by using (r)GO thin films prepared with the LTEDS
method and the TRP. Such a method is of a promising potential to allow a mass
production of SPR devices towards commercialization due to its simplicity and
robustness of the (r)GO coatings. The biosensing performance of these two SPR
platform was simulated and compared with the WinSpall software. The required
parameters, thicknesses and dielectric parameters of (r)GO thin films, were extracted
by AFM and ellipsometry characterizations. The AFM characterization revealed that
the thin-film thicknesses of GO were 8 nm and of rGO were 6.8 nm. The dielectric
parameters extracted by ellipsometry measurement at a wavelength of 780 nm were
εGO = 1.72 + 0.55j, εrGO = 1.59 + 1.10j.
The simulated results indicated that the rGO based SPR biosensors exhibited higher
sensitivity than GO based devices. Experimentally, (r)GO based SPR biosensors were
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prepared with PSA as receptor biomolecules to detect ConA target biomolecule.
The experimental biosensing results concretely confirmed the simulation results. The
specific and non-specific biosensing results demonstrated that rGO based devices
exhibit improved LOD and signal-to-noise ratio compared to GO based ones. The
LOD of the rGO biosensor platforms was one order of magnitude lower than that of
the GO based platforms, with values of 0.5 µg ml−1 and 5 µg ml−1, respectively.
Moreover, the signal-to-noise ratio of the rGO platform was approximately three
times larger than that of the GO platform with statistical values 6.56± 3.63 and
2.16± 1.64, respectively. This result implies that the thermal reduction effectively
tuned the dielectric parameters of rGO thin films, which led to the enhanced SPR
signals and reduced signal loss. More importantly, in contrast to the insulating GO
thin films, the rGO devices showed bipolar characteristics. This electronic property
allows influencing the dielectric parameters of the rGO thin films with the assistance
of external bias voltages. This enables the SPs modulation and especially improved
the LOD of the rGO based SPR platforms. Indeed, the LOD has been decreased
significantly to 0.01 µg ml−1, which is not attainable by conventional Au based SPR
platforms.
Therefore, to achieve even better biosensing performance, the bipolar property of rGO
thin films can be improved with a better restoration of the carbon lattice, either by
employing initial GO flakes of higher quality or more efficient reduction methods.
This study provides the basis and extends the frontiers of rGO as functional material
for advanced SPR biosensing.
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5 | rGO Based Impedance
Spectroscopy Biosensor
In this chapter, an impedimetric biosensor with an rGO thin film as transducer layer
on IDEs structures is presented and discussed. This biosensor was used for the
label-free detection of PSA. Firstly, the general principle and the state-of-the-art of
impedance spectroscopy are introduced. Secondly, the out-of-line and in-line EIS with
rGO thin films as transducers are presented. Theoretical equivalent circuits for both
out-of-line and in-line EIS are proposed. Thirdly, the biosensing mechanism for the
detection of PSA with rGO based in-line EIS is investigated. Based on a comparison of
the biosensing performances with variable sizes of receptor molecules and different
buffer concentrations, the sensing capability of rGO based in-line EIS in different
frequency regimes is discussed in detail.
5.1 Fundamentals of EIS
Impedance spectroscopy is dedicated to the extraction of the complex impedance Z
of a system within a pseudo-linear range. An alternating perturbation voltage V(t)
of small amplitude (generally in mV regime) in a certain frequency range is used as
input and the alternating output current I(t) is measured, as indicated in figure 5.1(a).
The impedance is expressed as the quotient of the input voltage V(t) and the output
current I(t):
Z(t) =
V(t)
I(t)
(5.1)
In the polar form, the impedance is given by the impedance amplitude |Z| and the
phase change ϕ, and in Cartesian form by the real part Z1 and the imaginary part Z2,
as shown in figure 5.1(b)-(c).
Z = |Z|ejϕ = Z1 + jZ2 (5.2)
where
|Z| =
√
Z21 + Z
2
2 , ϕ = arctan
(
Z2
Z1
)
(5.3)
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Figure 5.1: The basic principle of impedance spectroscopy. (a) The input signal of the measured system
is the alternating current (AC) voltage V(t) and the output signal is the AC current I(t). (b)-(c) The
impedance Z(t) is defined as V(t)/I(t). It can be represented in polar or cartesian form, which can be
displayed in a Bode or Nyquist plot, respectively.
The EIS has been used to investigate the coating quality and the corrosion degree in
the painting industry, to characterize the properties of products in the food industry,
and to monitor the health status of human beings [210–215]. EIS is specially utilized as
a sensitive, selective, and label-free biosensor platform to detect cells, microorganism,
and various biomolecules [216]. The device configuration of a conventional EIS
consists of an electrochemical cell with an aqueous RE, a CE and a WE immersed into
an electrolyte solution. The RE is made of a metal encapsulated in a glass capillary,
which is filled with an electrolyte solution to stabilize the metal. The potential of the
RE is set at a fixed value. The CE is usually made of inert metals, for instance gold,
stainless steel or platinum, which feeds current to the electrolyte solution. The WE is
normally made up of metals, metal oxides, carbons and/or semiconductors. The size
of the WE ranges from nano- to microscale. For biomolecules detection, either the WE
or both the CE and WE can be further functionalized with biorecognition molecules.
The biorecognition molecules can be antibodies, antigens, proteins, aptamers or
single-stranded DNA (ssDNA). The target biomolecule should specifically bind to
the biorecognition molecules in order to obtain a high biosensor selectivity.
For the two EIS approaches, either with only the WE or with both the CE and the
WE for immobilizing the biorecognition molecules, the corresponding measurement
setups are depicted in figure 5.2(a)-(b). A voltage V(ω) that is composed of an AC
voltage Vin_AC and a constant voltage Vin_DC is applied through the WE against the
RE to CE, while the output current between WE and CE is measured as I(ω). The
impedance spectrum is plotted as V(ω)/I(ω) along the frequency ω. The binding
activity of biomolecules between the WE and CE is reflected by the impedance
changes, therefore EIS can be utilized as a platform for biosensing.
EIS measurements can be carried out either in the faradaic mode or in the non-faradaic
mode. For both of these modes, it is interesting to establish an equivalent circuit that
reflects the behavior of the system. The final circuits are built from different elements,
which model different physical phenomena and are described below.
In the faradaic mode, EIS measurements take place in an electrolyte solution
containing a couple of redox markers. A typical couple is the ferri/ferrocyanide
solution K3/K4 (K3Fe(CN)6/K4Fe(CN)6), also used for the cyclic voltammetry
measurements presented in chapter 3. When a voltage is applied between the WE and
the CE, the charge transfer takes places between the biosensor surface and the redox
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Figure 5.2: The typical three-electrodes configuration of the EIS measurement setups: V(ω) (Vin_AC +
Vin_DC) is the input voltage, which is applied at the WE against the RE to CE, while the output current
I(ω) is measured between WE and CE. (a) The CE is made of Pt and only the WE is functionalized
with biorecognition molecules. The typical WE is an Au electrode of circular shape. (b) The two arms of
IDEs can also serve as CE and WE. Both electrodes are functionalized with biorecognition molecules.
This EIS configuration was used in this work.
markers. The charges must then pass through the electrolyte solution of resistance
Rsol. When the potential is positive, the WE acts as an oxidant and the K4 is oxidized:
Fe(CN) 4−6 −−→ Fe(CN) 3−6 + e−
When the potential is negative, the WE acts as a reductant and the K3 is reduced:
Fe(CN) 3−6 + e
− −−→ Fe(CN) 4−6
The electrons go through the WE to the CE, resulting in the so-called faradaic current
that relates to a charge transfer resistance Rct given by:
Rct =
RT
nFi0
ZR = Rct
(5.4)
where T is the temperature; R and F are the gas and Faraday constants, respectively;
n is the number of involved electrons; i0 is the exchange current density. i0 and Rct
vary corresponding to the electronic properties of the biosensor surface, which is
influenced by the access area of the WE and the density of bound target biomolecules.
At the solid-liquid interface, the ions are attracted by the surface potential of the solid
surface and this forms an EDL. A detailed explanation of the EDL and the calculation
of the Debye length can be found in section 3.2.3.2. The EDL can be treated as an
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ideal, parallel plates capacitor with a capacitance Cint and impedance ZC. Its changes
can also reflect the biosensing process.
Cint =
ε0εr A
d
ZC =
1
jωC
=
1
ωC
e−jpi/2
(5.5)
where ε0 is the permittivity of free space; εr is the relative dielectric constant of the
electrolyte solution; A is the surface area of the WE; d is the Debye length. When a
potential is applied between the bulk analyte and the solid surface, the ions will flow
along the electric field. This indicates that the EDL can be represented by a resistor
Rint in direct current (DC) mode.
Additionally, an abstract constant phase element (CPE) is used to describe a
non-ideal capacitor for the EIS measurement. This CPE is defined by its exponent
n (dimensionless) and factor Q (in snΩ−1) and can be expressed with [211]:
ZCPE =
1
jωnQ
(5.6)
Only when n = 1, this element is equivalent to an ideal capacitor. The CPE is a
non-linear element and cannot be found in standard electronics.
A Warburg diffusion element, a special case of the CPE, can also be used to model
the diffusion current from the bulk buffer solution to the solid-liquid interface, when
the interface capacitor Cint is not ideal. The Warburg impedance W can be expressed
as [211]:
W =
σ√
ω
(1− j) (5.7)
with
σ =
1√
2
RT
n2e AF2
(
1
cO
√
DO
+
1
cR
√
DR
)
(5.8)
where ω is the frequency of the input AC voltage; T is the temperature; R and F
are the gas and Faraday constants; cO and cR are the concentrations of oxidant and
reductant in the bulk solution; DO and DR are the diffusion coefficient of oxidant
and reductant, respectively; A is the surface area of the WE; ne is the number of
involved electrons. The Warburg impedance is normally used in the faradaic EIS. At
high frequencies, the diffusion speed of reactants cannot follow the frequency of the
AC signal, resulting in a small Warburg impedance. In contrast, at low frequencies,
they can follow and it generates a high Warburg impedance value.
With these different elements, it is possible to build different electrical circuits to
model the spectra recorded in EIS. The faradaic EIS measurements can be described
by the equivalent circuit shown in figure 5.3(a) using the above-mentioned electronic
elements: the electrolyte solution resistance Rsol, the charge transfer resistance Rct
between the redox markers and the WE, the EDL capacitance Cint which is generated
at the solid-electrolyte interface, and the Warburg element W, which represents
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the diffusion activity between the bulk electrolyte solution and the solid-electrolyte
interface. However, the usage of a redox system may limit the repeatability of the EIS
measurements. For instance, the typical K3/K4 redox markers release the CN– ions
which tend to etch the gold electrodes even in the optimized experimental condition
[217]. The etching process increases the surface roughness and surface area, resulting
in inaccurate EIS measurements. Therefore, the EIS measurement in faradaic mode is
not suitable for long-term monitoring of consecutive surface modification.
The non-faradaic mode of the EIS measurements are carried out in the absence of
redox markers, so that no faradaic current is generated. These measurements are only
based on the principle of capacitive biosensing, using the EDL built on the electrodes.
In this case, the WE and CE may be two arms of an IDEs. The binding of target
biomolecules to the biosensor surface lead to changes in the dielectric parameters
and the charge distribution, and this can be measured [218, 219]. The corresponding
equivalent circuit is built with a combination of different electronic elements shown in
figure 5.3(b). The exact choice of elements must reflect the physical phenomena taking
place during the EIS measurements. This newly built circuit replaces the equivalent
circuit in faradaic mode marked with the red dashed square in 5.3(a).
Figure 5.3: Equivalent circuits for EIS measurements: (a) Faradaic mode with redox markers. (b)
Non-faradaic mode without redox markers. The equivalent circuits can be built by using a special
combination of the shown electronic elements: a capacitor Cint, a resistor Rint, and/or a CPE.
For the faradaic mode, the typical equivalent circuit for the EIS measurements is given
in figure 5.4(a). The corresponding Bode and Nyquist plots can be obtained when
the parameters for the different electronic components are known. In the following,
values were arbitrary chosen to compute typical Bode and Nyquist plots: solution
resistance R1 = 20Ω, charge transfer resistance R2 = 250Ω, capacitance of the EDL
C = 40 µF and the Warburg impedance W = 150(1 − j)ω−1/2. The resulting plots
are shown in figure 5.4(b)-(c). The 45° slope of the tail in the Nyquist plot (5.4(c)) is
characteristic of the existence of a Warburg element in the equivalent circuit. For the
non-faradaic mode, the equivalent circuit can be simplified as a resistor R and an EDL
capacitor C in series as shown in figure 5.4(d). With a solution resistance R = 20Ω
and an capacitance C = 40 µF, the corresponding Bode and Nyquist plots are as
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figure 5.4(e)-(f). In this case, the Nyquist plot is typically a straight line. When adding
an EDL resistor R2 = 250Ω in parallel to the EDL capacitor, as shown in figure 5.4(g),
the Bode and Nyquist plots become as presented in figure 5.4(h)-(i). In this example,
the Bode and Nyquist plots were drawn based on the values of the parameters. In
the actual case, experimental data from EIS measurements are plotted and then the
parameters are determined by fitting to equivalent circuits.
Figure 5.4: Typical Bode and Nyquist plots of the faradaic and non-faradaic EIS measurements. (a)-(c)
Faradaic mode with redox markers, the values of the corresponding electronic elements are chosen
arbitrarily: solution resistance R1 = 20Ω, charge transfer resistance R2 = 250Ω, EDL capacitance C =
40 µF, Warburg impedance W = 150(1− j)ω−1/2. (d)-(f) Non-faradaic mode without redox markers.
The electronic circuit contains a resistor R = 20Ω connecting with a capacitor C = 250Ω in series
(arbitrary values). (g)-(i) Non-faradaic mode without redox markers. The electronic circuit is built up
by adding an EDL resistor R2 = 250Ω in parallel to the EDL capacitor in (d).
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5.2 rGO Based EIS
The sensitivity of the faradaic and non-faradaic EIS based on bare electrodes for
biosensing is often limited. To amplify the impedance signals and, hence, to increase
the sensitivity, transducer layers can be deposited between the WE and CE. Such
transducer layers can be, for example, a biomolecular or a polymer layer, a graphene
or reduced graphene oxide thin film. Conventional EIS with rGO as transducer layer
on macro-sized WE has been reported for biosensor applications to increase the
sensing area [220, 221]. Besides, IDEs were used as capacitive biosensors with high
sensitivity due to the locally confined electronic field [222–226]. In this section, a novel
EIS device is presented by combining rGO thin films and IDEs structures. Its electronic
performance was characterized with the non-faradaic mode (without redox markers)
and the corresponding working mechanisms were investigated.
The GO thin films were prepared on top of IDEs on glass substrates and without being
patterned by following the fabrication process described in chapter 2. The spin-coating
times were eight and the obtained thickness of GO thin films was approximately 8 nm.
The GO thin films were transformed into rGO thin films by the TRP presented in
chapter 3. The device configuration is shown in figure 5.5. A fluidic setup was printed
out by a 3D printer with a top and a bottom part. The top part had a container in
the middle and a sealing rubber ring at its one side. The chip was clamped between
these two parts, while the rGO array was exposed to the liquid [227]. All device
characterizations, surface functionalizations and sensor measurements discussed in
the following section were carried out in this fluidic cell.
Figure 5.5: Device configuration for EIS measurements. GO thin films on top of 10-fingers IDEs to
enhance the biosensing response in EIS.
The EIS measurements were carried out in two different configurations by connecting
the electrodes to an impedance analyzer as shown in figure 5.6(a)-(b):
1. The drain electrode and the common-source electrode of the rGO-IDEs devices
were connected to the WE, while an electrochemical Ag/AgCl electrode served
as RE and a Pt wire as CE. This configuration is called out-of-line EIS (5.6(a)).
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2. The drain electrode and the common source electrode were connected to the WE
and the CE, respectively, while an electrochemical Ag/AgCl electrode served as
RE. This configuration is called in-line EIS (5.6(b)).
The electronic performances of these two configurations in 10 mM PBS were compared
under the following conditions: a DC offset potential and an AC signal were applied
through the WE against a constant potential at the RE to CE, the standard potential
of which is 230 mV in 3 M KCl at room temperature. The measurement started after
30 s to reach an equilibrium. The DC potential offset was 0.05 V while the AC input
had an amplitude of 0.01 V and the frequency range was from 100 kHz to 0.1 Hz. The
AC output Iout(t) flowing from the WE to the CE was then measured.
Figure 5.6: Electrode connections for the EIS measurements. (a) The out-of-line EIS configuration uses
the drain IDEs arm as WE, a Pt wire as CE and an electrochemical Ag/AgCl electrode as RE. (b) The
in-line EIS configuration uses the drain IDEs as WE, the source IDEs as CE and an electrochemical
Ag/AgCl electrode as RE.
5.2.1 Out-of-Line rGO Based EIS
For the device configuration of the out-of-line EIS, the current travels from the WE
through the EDL, modeled with a resistance Rint and a capacitance Cint in parallel
at the solid-liquid interface. Then the current flows through the solution with a
resistance Rsol to reach the CE. In the condition of a uniform EDL building on the
WE, the equivalent circuit can be assumed as displayed in figure 5.4(g). However, the
Bode and Nyquist plots of the rGO-IDEs devices in the out-of-line EIS configuration
are shown in figure 5.7(a)-(b). Instead of a parabolic curve, the Nyquist plot appears
as a straight line and its slope is not 45°. This result indicates that the combination of
the EDL and the rGO thin film behaves neither as a pure capacitor nor as a Warburg
element in the equivalent circuit.
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An explanation could be that the more ions were accumulated around the oxygen
functional groups than around the sp2 C−C lattice. Therefore, the formed EDL was
not uniformly distributed on the rGO surface, which is different from the typical EDL.
Such behavior can be modeled with a more general CPE, and its two parameters
Q and n, instead of a Warburg element. Therefore, an equivalent circuit was built
up as represented in figure 5.7(c). The fitting was carried out with the software of
Ivium COMPACTSTAT.e. Both Bode and Nyquist plots were fitted successfully by
using this equivalent circuit within the 1 Hz to 10 kHz frequency range, which is
the most interesting range for the later biosensing experiments. The corresponding
values of the electronic elements are as follows: Rsol = 2830Ω, Rint = 2.685 · 107Ω,
Q = 1.2 · 10−6, n = 0.7. These parameters are also useful to describe the signal pass
for the in-line EIS measurement as discussed in the following section.
Figure 5.7: Out-of-line rGO based EIS measurement in PBS: (a)-(b) Nyquist and Bode plots, which were
fitted by the equivalent circuit in the frequency range of 1 Hz to 10 kHz. (c) The equivalent circuits and
the extracted values of the electronic elements.
5.2.2 In-Line rGO Based EIS
For the in-line EIS measurements, the stimulation signal travels from one IDEs arm
to the other by passing through the buffer solution and the rGO thin film. To know
the exact electronic elements of the rGO thin film, an I-V sweep in DC mode and
capacitance-voltage (C-V) measurement in AC mode were carried out by a Keithley
4200-SCS parameter analyzer [228].
The exemplary I-V characteristic curve displayed in figure 5.8(a) shows that the rGO
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thin film is in an ohmic contact instead of a Schottky contact with the IDEs structure.
In DC mode, the rGO thin film acts as a resistor, whose conductivity comes from
the charge carriers hopping along the restored carbon lattice. Afterwards, a C-V
measurement in AC mode was carried out with the same rGO-IDEs channel.
For the AC mode measurement, the configuration is as shown in figure 5.8(b). Two
signals, a small AC voltage (mV range) and a DC voltage, were simultaneously
applied at the rGO thin film. The applied DC voltage allows sampling of the material
at different depths in the rGO-IDEs device, while the AC voltage bias of small
amplitude enables the capacitance measurement at a given depth in the device. The
resulting current is measured and integrated over time to obtain the charges Q. Then,
the capacitance is calculated by the quotient of the integrated charge and the applied
voltage as follows:
C =
∆Q
∆V
(5.9)
An AC signal with a fixed amplitude of 10 mV was applied at three different
frequencies (1 kHz, 10 kHz and 100 kHz), while the DC voltage was swept from −1 V
to 1 V. One exemplary result of a C-V measurement with the rGO-IDEs devices in
dry status is shown in figure 5.8(c)-(d). For 1 kHz and 10 kHz, the noise was too high
to properly read the capacitance value. At 100 kHz, the measured capacitance of the
rGO thin film was approximately 4.2 pF.
Since the electronic biosensing experiments are performed in PBS, the rGO thin films
were characterized after an overnight incubation in 10 mM PBS at room temperature.
The incubation was done overnight in order to saturate and stabilize the rGO surface
with ions from the buffer solution. The C-V measurements were done by applying
an AC stimulation voltage with an amplitude of 10 mV at three different frequencies
(1 kHz, 10 kHz and 100 kHz). The DC offset voltage was swept from −0.7 V to 0.7 V.
The absolute value of the applied voltages need to be maintained below 0.7 V to avoid
water electrolysis.
The measurements were carried out with an rGO-IDEs device in 10 mM PBS. The
result obtained for the C-V characterization is shown figure 5.9(a). The average
capacitance values were 44.38± 1.84 nF for 1 kHz, 10.79± 0.15 nF for 10 kHz, and
1.35± 0.02 nF for 100 kHz. The same rGO-IDEs channel was also characterized in
10 mM PBS by an I-V measurement with a dual sweep voltage, ranging from −0.7 V
to 0.7 V. The obtained I-V curve, shown in figure 5.9(b) (green curve), passes through
the origin point. However, the hysteresis behavior is typical for a capacitor with a
charge/discharge happening over time. Additional experiments were conducted to
further clarify the origin of the capacitor in or on the rGO thin films.
The same rGO-IDEs device was characterized in dry status after cleaning with DIW
and drying with a N2 flow. The experimental conditions of C-V and I-V measurements
were the same as for the measurements in 10 mM PBS. The obtained C-V results are
shown in figure 5.9(c)-(d). At the frequencies 10 kHz and 100 kHz, the capacitance of
the rGO thin films was approximately 4-5 pF, which is in the same value range as for
the rGO-IDEs devices before PBS incubation. The I-V characterization curve, shown in
figure 5.9(b) (orange curve) is again linear. This means that the capacitor is caused by
the ions on rGO thin films in the PBS and the non-capacitive behavior can be restored
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by washing the device with DIW. The results obtained from the C-V characterizations
prove that the signal path through rGO thin films in buffer solutions can be treated as
a resistor RrGO and a capacitor CrGO in parallel in the EIS measurement. Such behavior
could be attributed to the overlapping regions of the rGO flakes, which on the one
hand enables the carrier transport but on the other hand also constrains its direction.
Figure 5.8: rGO thin films characterization in DC and AC mode achieved by I-V and C-V
characterization in dry status. (a) The linear I-V characterization curve shows that the rGO thin films
form an ohmic contact instead of a Schottky contact with the IDEs structures. (b) C-V measurement
setup of rGO-IDEs devices in dry status. (c)-(d) The rGO-IDEs device shows a capacitive behavior at
100 kHz with a capacitance measured at 4.2 pF and a noise value of 0.1238 pF.
The focus of the previous discussion was on the modeling of the electronic elements of
rGO thin films. With these elements determined, the in-line EIS measurements based
on rGO-IDEs device were carried out. The WE and the CE were connected to the
common source electrode and drain electrode of the rGO-IDEs device, respectively.
The obtained Bode and Nyquist plots are shown in figure 5.10(a)-(b). The current
flows through two distinct paths in parallel from WE to CE: path 1 is made of the
two EDLs and the ohmic solution Rsol in series; path 2 consists only of the rGO thin
film. As discussed for the out-of-line EIS, the EDL on the rGO surface is not an ideal
capacitor. It can be represented by a CPE for both the WE and the CE. By including
the resistance and the capacitance of the rGO thin films into the pre-developed circuits
for bare IDEs [222], the equivalent circuit of rGO based in-line EIS can be extracted
as presented in figure 5.10(c). Both Bode and Nyquist plots were fitted successfully
by using this equivalent circuit for frequencies ranging from 1 Hz to 10 kHz. This is
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the most interesting range for the biosensing processes and it is presented in the next
section. The values of the same electronic elements were adapted from the out-of-line
EIS fitting results. The corresponding values of additional electronic elements are:
RrGO = 900 kΩ, CrGO = 1.37 nF, Rint2 = 2.196 · 107Ω, Qint2 = 1.2 · 10−6, nint2 = 0.718.
Figure 5.9: rGO thin films characterization by C-V and I-V measurements in PBS and in dry status.
(a) C-V measurement after incubation overnight in 10 mM PBS. (b) I-V characterization was carried
out with a dual sweep scanning from −0.7 V to 0.7 V. In 10 mM PBS, the I-V green curve shows a
hysteresis behavior. In the dry status, the resistive behavior can be recovered. (c)-(d) C-V measurement
in dry status, after cleaning by DIW and drying by N2, the capacitance was similar to the value obtained
before the 10 mM PBS overnight incubation.
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Figure 5.10: In-line rGO-IDEs based EIS measurement in PBS. (a)-(b) Nyquist and Bode plots can be
fitted by the equivalent circuit in the frequency range of 1 Hz to 10 kHz. (c) The equivalent circuit and
the computed values of the electronic elements.
5.3 rGO Based EIS for PSA Detection
After the electronic characterization, the rGO-IDEs devices were utilized in the in-line
EIS configuration to detect the target biomolecule PSA. Two different impedimetric
biosensor platforms were established, one with PSA-specific aptamers and the
other with PSA-specific antibodies as receptor biomolecules. The PSA biosensing
experiments were carried out in different buffer concentrations to compare the
influence of different ionic strengths and the associated Debye lengths. In this
section, the corresponding working mechanism is discussed in detail. The focus is
set on the biosensing capability beyond the Debye-screening length in physiological
buffer solution (ionic strength around 150 mM) towards the vision of future device
commercialization.
5.3.1 rGO Based Biosensors Preparation
In the framework of this thesis, two types of receptor biomolecules, a PSA-specific
DNA aptamer and PSA-specific antibody, were chosen to detect PSA. An aptamer
usually consists of short oligonucleotide strands [229, 230]. It is of a small size, highly
stable and cost-effective. The structure of aptamers is typically folded as a hairpin
loop, because two complementary regions of the strand form local Watson-Crick base
pairs. Such a structure provides a high affinity to bind specific target molecules like
small organic compounds, proteins, or cells. In recent years, aptamers have been
widely employed in the field of biosensing [231, 232] and also for PSA detection
[233, 234]. In this study, the aptamer sequence was TTT TTA ATT AAA GCT CGC
CAT CAA ATA GCT TT (5’ to 3’ direction). The 5’ end was modified by a 6-carbon
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chain as a spacer and terminated with an amino group to enable a covalent binding
to the sensor surface. The aptamer size is approximately 3-5 nm [235]. An antibody
is a Y-shaped protein which recognizes a unique antigen [236, 237]. The size of
an antibody is approximately 10 nm [238]. The PSA-specific antibody has also been
popularly used in biosensor platforms for PSA detection [33].
The different steps of the bio-functionalization process to prepare the rGO-IDEs based
biosensors are shown in figure 5.11. In all steps, a 10 mM PBS solution with pH 7.4
was used. The detailed biosensor preparation protocol was as follows:
i) The amino-terminated aptamers, not the antibodies, were treated as following to
gain an optimum position to capture the PSA. This treatment started by taking
the microcentrifuge tube, which contained 10 µl of 100 µM amino-terminated
aptamer, out of the freezer. The tube stood at the room temperature
for approximately 10 min until thawed. Fast spinning was applied for 5 s
to centrifuge down the residual droplets from the sidewall. Then the
microcentrifuge tube was immersed up to its half height into a flask containing
milliQ water at 90 ◦C. When the temperature reached the room temperature
naturally, the microcentrifuge tube was taken out and centrifuged for 5 s. Then
the solution of 100 µM amino-terminated aptamer was diluted with 10 mM PBS
to a final concentration of 2 µM.
ii) The rGO chips were incubated in 10 mM PBS overnight to stabilize the surface
at room temperature. 80 mM EDC mixed with 20 mM NHS in milliQ water was
used to activate the −COOH groups on the rGO surface and to ensure a robust
immobilization of the receptor biomolecules [239]: amino-terminated aptamers
and antibodies. 100 µl of EDC/NHS solution was applied onto the rGO surface
for 30 min at room temperature.
iii) Immediately after the EDC/NHS activation, the chips were incubated in the
solution of 2 µM receptor molecules overnight at 4 ◦C. Afterwards, the chips
were cleaned 10 times by pipetting 100 µl of 10 mM PBS.
iv) For the aptamers case, 1 mM ethanolamine was prepared by diluting 10 mM
ethanolamine (pH = 8.5) in 10 mM PBS and then applied on the rGO thin
film for 30 min. For the antibodies case, 10 mM ethanolamine (pH = 8.5) was
applied onto the rGO thin film for 1 h. This step was to saturate the freestanding
−COOH groups on the rGO surface and to avoid the non-specific binding of
target biomolecules.
v) The concentrations of PSA were prepared by diluting 100 µM stock solution
in 10 mM PBS, with final concentrations of 33 fM, 330 fM, 3.3 pM, 33 pM,
330 pM, 3.3 nM, 33 nM and 330 nM in order to perform concentration-response
measurements.
It must be noted that the 10 mM PBS (pH = 7.4) buffer solution should be the same
for the overnight incubation of the devices and for the dilution of ethanolamine and
PSA. This prevents the rearrangement of the ionic layer built on the rGO due to the
difference in PBS. Otherwise, non-specific signals could be induced.
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The concentration-response measurements started from the lowest concentration of
PSA towards the highest concentration. The incubation of PSA for each concentration
was done for 30 min at room temperature. After each incubation, the chips were
cleaned 10 times with 10 mM PBS (pH = 7.4) by pipetting. It was then measured in
the in-line EIS configuration by an Ivium COMPACTSTAT.e impedance analyzer. The
biosensing mechanism of rGO-IDEs based in-line EIS biosensors for PSA detection is
intensively studied in the following sections.
Figure 5.11: Preparation schematic for the rGO-IDEs based biosensors (clockwise). The−COOH groups
on the rGO surface were activated by EDC/NHS chemistry, so that the amino-terminated receptor
biomolecules can be immobilized. Afterwards, the free-standing −COOH groups were saturated by
ethanolamine to avoid non-specific binding. The target biomolecule PSA was added and detected in
the last step.
5.3.2 Aptamers as Receptor Molecules for PSA Detection
In this section, the PSA recognition process at the surface of rGO-IDEs based biosensor
with PSA-specific aptamers as receptor biomolecules is discussed. The measurement
setup was the in-line EIS configuration, as shown in 5.12(a). The two arms of the
IDEs structures served as WE and CE, while an electrochemical Ag/AgCl electrode
acted as RE. An AC signal of amplitude 10 mV, a frequency ranging from 1 Hz to
100 kHz and a DC bias voltage of 50 mV were applied through WE against the RE
to the CE. PSA concentration-response experiments were carried out in 10 mM PBS
(pH = 7.4). The resulting salt concentration (ionic strength) was 162 mM and the
corresponding Debye length of EDL was approximately 0.76 nm. Both values are
similar to that of physiological solutions. A detailed explanation of the EDL and the
Debye length can be found in section 3.2.3.2. The Debye length and salt concentration
(ionic strength) at room temperature for different PBS concentrations were calculated
using the equations 3.2 and 3.3, as shown in the table 5.1. The target molecule PSA had
a mass of 33 kDa and its corresponding size was approximately 4.5 nm, implying that
the PSA biomolecules were located out of the Debye length of the EDL. The schematic
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in figure 5.12(b) shows the principle of the PSA detection with aptamers as receptor
biomolecules on a rGO thin film including the corresponding Debye length.
Table 5.1: PBS concentration, dilution, ionic strength, and Debye length
[mM] pH = 7.4
PBS concentration PBS dilution
(ionic strength) [mM]
Salt concentration
length [nm]
Debye
10 1 · PBS 162 0.76
1 0.1 · PBS 16.2 2.41
0.1 0.01 · PBS 1.62 7.6
0.01 0.001 · PBS 0.162 24.1
Figure 5.12: (a) Schematics of an rGO thin film in EIS configuration, where the two arms of the
IDE structures and an electrochemical Ag/AgCl electrode served as WE, CE and RE. (b) Descriptive
schematic of rGO based biosensor with aptamers as receptor biomolecules for PSA in 10 mM PBS. The
corresponding Debye length was 0.76 nm. The diameters of the aptamers and PSA were 3-5 nm and
approximately 10 nm. In theory, both biomolecules should be located outside of the Debye length.
The baselines of biosensors should be measured to prove the device stability before the
PSA concentration-response experiments. For this purpose, the channels of rGO-IDEs
based biosensors were measured in 10 mM PBS (pH = 7.4) 1 time after switching
the connection cables of the measurement setup and 3 times after changing the
PBS solution. The baselines of biosensors were statistically obtained according to
these 4 measurements. Afterwards, the PSA concentrations 33 fM, 330 fM, 3.3 pM,
33 pM, 330 pM, 3.3 nM, 33 nM and 330 nM were sequentially measured. The PSA
concentration-response curves of an exemplary channel obtained using the in-line
EIS configuration are shown in figure 5.13(a)-(b). The results show that the output
impedance sensitively varied with the PSA concentration at the frequencies of 1-10 Hz
and 1 kHz, compared to the baseline (black curve). The close-up of the real and
imaginary parts of the output impedance around 1-10 Hz is given in figure 5.13(c)-(d).
At low frequencies, the resistive path through the rGO thin film mainly contributes
to the output impedance signal. As indicated by the experimental results, the real
part of the impedance increased with an increase of the PSA concentration. The
amplitude and phase of the output impedance at 1 kHz, figure 5.13(e)-(f), indicate
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that the phase is decreasing with increasing PSA concentration, while the amplitude
shows no clear tendency of PSA biosensing. In this case, the capacitive path from one
IDEs arm to another through the buffer solution plays a dominant role for the output
impedance signal. In contrast to the conventional IDEs based capacitive biosensor
[226], the capacitive path of rGO-IDEs sensor is measuring the biomolecular layer
between the CE and the WE. The capacitive detection of PSA with rGO-IDEs seems
to be more pronounced at a frequency of 1 kHz.
To confirm the biosensing mechanism of rGO-IDEs based in-line EIS devices in low
frequency regime, the PSA concentration-response experiments were also carried
out by performing an I-V dual characterization, which can be considered as an
ESFET measurement with a zero gate voltage. The sweeping voltage was applied
between the two arms of IDEs from −0.8 V to 0.8 V. The results are shown in figure
5.14(a). It can be seen that the binding of PSA leads to a resistance increase in the
rGO thin film. This result is in agreement with the biosensing tendency of PSA
concentration-response curves obtained using the in-line EIS device configuration.
This is explained considering that the isoelectric point of PSA is 6.9-7.2 [240], so PSA
is negatively charged in 10 mM PBS with a pH 7.4. The attachment of PSA onto
the rGO thin films is equivalent to an additional negative voltage. The modulation
effect of the negative voltage to the rGO thin films can be explained in the ESFET
configuration, in which rGO thin films serve as transducers, as shown in figure 5.14(b).
The corresponding bipolar characteristic curves are given in figure 5.14(c). The ESFET
measurements were performed as follows: the sweeping voltages were applied to the
gate electrode against the source electrode and ranged from −0.8 V to 0.8 V, while
the step voltages were applied between the drain and source electrodes ranging from
−0.1 V to 0.1 V with a step size of 0.1 V. The Dirac points in the bipolar curves were
shifted to the left compared to the axis Vgs = 0, therefore the rGO thin films were
initially n-doped. The negative voltage, that is caused by the PSA attachment, tended
to modify the Fermi level and carrier concentrations within the rGO thin film. During
the biosensing, the voltage applied by the gate electrode on the rGO thin film was
zero. The negatively charged PSA biomolecules were equivalent to a negative voltage
applied on the rGO thin film. As indicated in figure 5.14(b), the drain-source current
Ids decreased while a negative gate voltage Vgs was applied, and the drain source
voltage Vds maintained constant. Therefore, an increase of PSA molecules led to a
larger negative gate voltage, which induced a decrease of the conductivity and an
increase of the resistance.
In the application field of biosensors, the concentration of an unknown sample
is extracted by comparing to a calibration curve which is obtained from
concentration-response experiments. The calibration curves of the rGO based
biosensors were generated for the amplitude of the impedance at 1 Hz and the phase
of the impedance at 1 kHz from the PSA concentration-response experiments with
5 channels. The corresponding results are displayed in figure 5.15(a)-(b). For the
amplitude calibration curve, the LOD the rGO-IDEs biosensor was 33 pM, while it
was 33 fM for the phase calibration curve. The clinically relevant PSA concentration
range of 4-10 ng ml−1, which corresponds to a concentration range of 115-290 pM, is
completely covered by the linear response regime of these two calibration curves.
Besides, the results also indicate that it is possible to detect even lower concentrations
with the presented biosensor. This makes the platform also interesting and promising
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Figure 5.13: PSA concentration-response experiments with aptamers as receptor molecules, using
rGO thin film based in-line EIS configuration. The measurements were carried out in 10 mM PBS.
An input AC signal of 10 mV amplitude in a frequency range of 1 Hz to 100 kHz and a DC offset
of 50 mV were applied. Before PSA detection, the baseline (black curve) of the biosensors was
obtained by measuring the devices 4 times in 10 mM PBS (pH = 7.4) (1 time after switching the
connection cables of the measurement setup and 3 times after changing the 10 mM PBS solution).
(a)-(b) Plots of amplitude, phase, real part and imaginary part of the output impedance from PSA
concentration-response experiments. (c)-(d) Real part and imaginary part of the output impedance for
1-10 Hz. (e)-(f) Amplitude and phase of the output signal impedance around 1 kHz.
for applications to detect smaller concentration of target molecules.
Additionally, non-specific control experiments were carried out to detect 1 µM human
serum albumin (HSA) instead of PSA. 1 µM HSA was prepared by diluting the 100 µM
stock solution in 10 mM PBS (pH = 7.4). The 100 µM HSA was beforehand filtered by
a filter with pore size 0.2 µm. The sensor surface was prepared as described for the
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Figure 5.14: (a) PSA concentration-response measurements by I-V dual sweep. A sweeping voltage
from −0.8 V to 0.8 V was used as bias between source and drain electrodes. (b) Schematic of the ESFET
based on rGO thin film IDEs device. (c) Electronic characterization of the rGO thin film IDEs biosensor
platform: bipolar characteristic curves of ESFET with rGO thin film as transducer layer in 10 mM PBS.
aptamer immobilization. Then the sensor was incubated with 1 µM HSA for 30 min
at room temperature. The baseline was determined as reported before. After the HSA
incubation, 3 channels were measured 2 times to obtain the non-specific control signal.
As one can see in figure 5.15, the incubation with 1 µM HSA led to no significant signal
change, which means that only the PSA is selectively bound to the aptamers.
To prove that the resistive path at 1 Hz is caused by the tuning effect of the Fermi level
of the rGO thin film, a higher PBS concentration of 200 mM was chosen to carry out
the PSA concentration-response experiments. The corresponding Debye length in this
case is only 0.17 nm. The experimental condition for the in-line EIS measurements was
the same as for the previous experiments in 10 mM PBS. The baseline of rGO-IDEs
based biosensors was statistically obtained by measuring the channels in 200 mM PBS
(pH = 7.4) 1 time after switching the connection cables of the measurement setup and
3 times after changing the PBS solution. The rGO-IDEs device incubation, aptamer
immobilization and ethanolamine blocking process were all carried out in 200 mM
PBS. Because of solubility issues, the PSA concentrations were measured only from
33 fM to 3.3 nM. The obtained plots of the amplitude, phase, real part and imaginary
part of the output impedance are shown in figure 5.16(a)-(b). The results indicate
that there was no response in the amplitude, real and imaginary parts of the output
impedance for the low frequency range from 1-10 Hz. The resistive path through the
rGO thin film was screened out due to the Debye length of only 0.17 nm. This means
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Figure 5.15: (a)-(b) Amplitude and phase calibration curve of PSA concentration-response experiments
by rGO based in-line EIS with aptamers as receptor molecules in physiological 10 mM PBS (channel
number n = 5). In red, the non-specific binding of 1 µM HSA is shown as a control.
that the surface potential of the rGO thin film is completely compensated by the
ions from buffer solution. The PSA molecules were located farther than the Debye
length of the EDL and their charge were not able to induce an effective voltage to the
rGO thin film. Therefore, there is no change in the channel resistance. In contrast, the
impedance amplitude and phase around 1 kHz, shown in figure 5.16(c)-(d), is changed
after binding of the analyte, which indicates the PSA sensing capability. This means
that the capacitive path from one IDEs arms to the other seems to be modulated by
the attached PSA charges in such a high buffer concentration. It could be that the
capacitive biosensing of PSA took place within the electric field depth, which equaled
to the finger separation distance of the IDEs 5 µm.
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Figure 5.16: PSA concentration-response experiments with aptamers as receptor molecules, using rGO
thin film based in-line EIS configuration. The measurements were carried out in a high ionic strength
solution of 200 mM PBS. An input AC signal of 10 mV amplitude in a frequency range from 1 Hz to
100 kHz and a DC offset of 50 mV were applied. Before PSA detection, the baseline of rGO-IDEs based
biosensors was statistically obtained by measuring the channels in 200 mM PBS (pH = 7.4) 1 time
after switching the connection cables of the measurement setup and 3 times after changing the PBS
solution. (a)-(b) Plots of amplitude, phase, real part and imaginary part of the output impedance from
the PSA concentration-response experiments. (c)-(d) Amplitude and phase of the output impedance
around 1 kHz.
5.3.3 Antibodies as Receptor Molecules for PSA Detection
In this section, antibodies instead of aptamers were used as receptor biomolecules
to detect PSA. The biosensors were prepared by following the process introduced in
section 5.3.1. The aim of these experiments was to reveal if the capacitive sensing is
positively influenced by the rGO transducer layer compared to the sole effect of bare
IDEs structures. The descriptive schematic of an antibody-based biosensor is shown
in figure 5.17.
The experimental procedure for the rGO-IDEs based in-line EIS measurements and
the baseline determination of PSA concentration-response experiments were the same
as in the case with aptamers as receptor biomolecules in 10 mM PBS (pH = 7.4).
The obtained plots of amplitude, phase, real part and imaginary part of the output
impedance from the PSA concentration-response experiments in 10 mM PBS (pH =
7.4) are shown in figure 5.18(a)-(b). The corresponding Debye length is 0.76 nm. The
Bode plot indicates that the capacitive sensing effect around 1 kHz was completely
screened out. The diameter of the antibodies (10 nm) is bigger than that of the
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Figure 5.17: Descriptive schematic of an rGO-based biosensor with antibodies as receptor biomolecules
in 10 mM PBS. The corresponding Debye length is indicated by the dashed plane.
aptamers (3-5 nm). Eventually, in the case of antibodies, the PSA biomolecules were
located out of the vertical range of the effective electrical field, which is created
between the rGO covered IDEs arms. Therefore, the capacitance change might not be
sensible and cannot be used for the measurements. These results demonstrated that
the depth of the electric field induced by IDEs and rGO thin films should be less than
10 nm, which was much smaller than that of the bare IDEs. However, the biosensors
still responded to the PSA attachment in the low frequency range from 1-10 Hz, as
shown in figure 5.18(c)-(d). The real part of the output impedance increased with
the increasing PSA concentration. This result indicates that the resistive path through
the rGO thin films is responsible for sensing the PSA, even with a Debye length of
0.76 nm.
In summary, the rGO-IDEs based in-line EIS biosensor is capable to detect PSA in
10 mM and even in very high ionic strength buffer 200 mM PBS with a similar or
even higher Debye length as typical physiological solutions. The presented results
concretely confirm that the established biosensor device with aptamers or antibodies
overcomes the Debye-screening effect, which is the major challenge for charge based
label-free biosensing towards clinical applications.
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Figure 5.18: PSA concentration-response experiments with antibodies as receptor molecules, using rGO
thin film based in-line EIS configuration. The measurement was carried out in physiological 10 mM
PBS. An input AC signal of 10 mV amplitude in a frequency range from 1 Hz to 100 kHz with a DC
offset of 50 mV was applied. Before PSA detection, the baseline of rGO-IDEs based biosensors was
statistically obtained by measuring the channels in 10 mM PBS (pH = 7.4) 1 time after switching
the connection cables of the measurement setup and 3 times after changing the PBS solution. (a)-(b)
Plots of amplitude, phase, real part and imaginary part of the output impedance from the PSA
concentration-response experiments. (c)-(d) Real and imaginary parts of the output impedance at low
frequencies from 1 Hz to 10 Hz.
5.4 Conclusion
In this chapter, the equivalent circuits for rGO-IDEs based out-of-line and in-line EIS
were established. The results imply that the interface of the rGO thin film and the
electrolyte solution can be represented by a resistor connected to a CPE in parallel,
instead of a perfect capacitor.
The biosensing mechanisms with rGO as transducer layer on IDEs were investigated
by using PSA-specific aptamers (length 3-5 nm) and antibodies (diameter 10 nm) as
receptor biomolecules to detect PSA (diameter 4.5 nm) target biomolecules in PBS of
different ionic strengths and, hence, different Debye lengths. In the case of aptamers
as receptor biomolecules, the sensing in 10 mM PBS was visible in the impedance
amplitude and phase in Bode plots. At around 1 Hz, an increase of the impedance
amplitude was observed with PSA concentrations from 33 pM to 330 nM. At around
1 kHz, a decrease of the impedance phase was observed for PSA ranging from 33 fM
to 330 nM. Such biosensors with the aptamers as receptor molecules can directly
detect PSA target molecules in their clinical concentration range in 10 mM PBS,
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where the ionic strength (162 mM) and Debye length (0.76 nm) are similar to the
values of physiological buffer solution (150 mM and 0.78 nm). Even in rather high
concentrations of 200 mM PBS, the impedance phase still displays sensing capability
at 1 kHz. Also, the biosensors with antibodies as receptor biomolecules in 10 mM PBS
still displayed biosensing capability.
These results demonstrate that both resistive and capacitive mechanisms are most
likely responsible for the biosensing in different frequency regimes. It could be
attributed to the sp2 hybridized carbon lattice of rGO thin films, because the
electrochemical functionalization of graphene was proven to change the surface
charge and result in capacitance and resistance changes [241]. The sensing
performance was not influenced by the so-called Debye-screening effect, which is
the major challenge that conventional charge-based label-free biosensing devices
are facing towards their clinical implementation. The rGO-IDEs based biosensors
developed in this thesis concretely demonstrated their biosensing capability beyond
the Debye-screening effect. Therefore, they have a great potential to directly analyze
real clinic samples, with no need of sample pretreatment.
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6 | rGO Based ESFET
In this chapter, ESFET biosensors based on rGO thin films for label-free detection of
PSA are presented and discussed. Firstly, the state-of-the-art of ESFETs for biosensing
is introduced. The characteristics of the ESFETs with rGO thin films as transducers
are discussed. Secondly, Au nanoparticles (NPs) were immobilized onto the surface of
the rGO thin films in order to immobilize thiol-terminated aptamers. The biosensing
performance of ESFET aptasensors for PSA detection is presented and analyzed in
detail. Thirdly, Cu NPs were grown on the rGO thin films by a chronoamperometry
technique. The modulation effect of Cu NPs on the electronic characteristics of rGO
thin films is investigated.
6.1 rGO Based ESFET
The principle of the ESFETs biosensor is utilizing FETs to detect biomolecules
in a buffer solution. The transducing channel of the FETs, used to detect ions
or biomolecules, can be doped Si [242], GaN [243], poly polystyrene sulfonate
(PEDOT:PSS polymer) [244] and other semiconducting materials. Since the discovery
of graphene in 2004, graphene-based materials drew tremendous attention and have
been extensively investigated as transducer layers in ESFETs for biosensing [245–251].
In this section, the GO thin films were prepared using GO aqueous solutions,
which were chemically synthesized by following the LTEDS method without the
centrifugation in the last step. This results in a GO solution with larger flake sizes.
The details are given in section 2.3. The preparation process of GO thin films was the
same as introduced in section 2.5.1. The GO thin films were transformed into rGO thin
films after following the TRP. The obtained rGO thin films were utilized as transducer
layers on the top of IDEs in the ESFET configuration to detect PSA, as depicted in
figure 6.1(a). The two arms of the IDEs act as source and drain electrodes, while
an electrochemical Ag/AgCl RE is placed above the rGO thin film and immersed
inside the buffer solution to apply a gate voltage through the electrolyte to the rGO
thin film. A single rGO-IDEs chip consists of 16 channels in a 4× 4 array layout
with a common-source electrode located in the middle of the chip. Each channel has
10 IDEs fingers, while the effective channel length and width are 5 µm and 900 µm,
respectively. The separation distance of the neighboring fingers is 5 µm. The structure
of a single channel is shown in figure 6.1(b).
The ESFET characterization measurements were carried out in 10 mM PBS using a
Keithley 4200-SCS parameter analyzer. The gate voltage Vgs was swept from −0.7 V to
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Figure 6.1: (a) Schematic of ESFET configuration with an rGO thin film as a transducer layer and an
Ag/AgCl RE immersed into the buffer solution as the electrolyte gate contact. (b) A single chip consists
of 16 channels in a 4× 4 array layout with a common-source electrode located in the middle of the chip.
Each channel has 10 IDEs fingers, while the effective channel length and width are 5 µm and 900 µm,
respectively. The separation distance of the neighboring fingers is 5 µm.
1.2 V and the drain-source step voltage Vds was varied from −100 mV to 100 mV with
a 50 mV step size. The obtained characteristic curves, figure 6.2(a), show that the rGO
thin films of the exemplary device preserve the bipolar property similar to pristine
graphene and intrinsically possess electrons and hole as carriers. This is a promising
property compared to typical monopolar materials, which can be conductive in the
means of doping with either electrons or hole as the carriers. The right side and left
side of the Dirac point (detailed explanation can be found in sections 2.1 and 3.2.3)
in the bipolar characteristic curves correspond to the carrier type as electron and hole
in the rGO thin films, respectively. The Ids drastically increases when the difference
between the gate voltage and the Dirac points increases. It is because the higher Vgs
shifts the Fermi level deeper into the conductance (or valence) band, resulting in a
higher carrier concentration and a larger drain-source current Ids.
Ideally, for a fixed drain-source voltage Vds, the drain-source current Ids of each
bipolar characteristic curve reaches its minimum at zero gate voltage (Vgs = 0 V). This
minimal Ids corresponds to the Dirac point where the valence and conductance bands
meet. However, the obtained bipolar characteristic curves show that the Dirac point
is shifted away from the zero gate voltage (Vgs = 0 V) and slightly varies with the
applied drain-source voltage Vds. The detailed information is summarized in figure
6.2(b) for this exemplary device. The minimal Ids of each Ids-Vgs characteristic curves
with Vds = −100 mV, −50 mV, 50 mV and 100 mV correspond to Vgs = 0.47 mV,
0.46 mV, 0.5 mV and 0.53 mV, respectively. This result is possibly due to impurity
doping induced by the substrate, surface contaminations and/or the modulation of
the residual oxygen functional groups [84, 156]. In principle, each arm of the bipolar
curve can be described in a first approximation by the characteristic equation of a
MOSFET in its linear regime [252], as given in equation 3.1 of section 3.2.3.1.
In the biosensing process, the binding of target biomolecules onto the sensing area of
ESFET lead to changes of the characteristic curves [155]. This is due to the charges of
the target biomolecules, which modulate the capacitance on the transducer layer. This
leads to a change in the source-drain current Ids. As indicated by the equation 3.1, a
higher change in capacitance Cg induces a bigger change in Ids. The concentration of
incoming target biomolecules is directly correlated to the changes of Ids. Therefore,
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Figure 6.2: The characteristic properties of rGO thin films as the transducer layers of an ESFET device.
(a) The bipolar behavior of rGO thin films shows high similarity to that of the pristine graphene. This
ESFET measurement was carried out in 10 mM PBS. The gate-source voltage Vgs was swept from −0.7 V
to 1.2 V and the drain-source voltage Vds was varied from −100 mV to 100 mV with a 50 mV step. (b)
The table lists the corresponding Vgs of Dirac points at different Vds. These values were extracted from
the bipolar characteristic curves as shown in (a).
the sensitivity of the biosensing process is defined as the transconductance gm, which
is the first derivative of Ids with respect to Vgs for a constant Vds. It corresponds to the
slope of the characteristic curve Ids-Vgs. Deduced from equation 3.1, gm is expressed
as the product of the capacitance per unit area of the gate structure Cg, the field-effect
mobility of the transducer layer µ, the ratio of effective width W and length L of the
gate area, and the gate-source voltage Vds:
gm =
∂Ids
∂Vgs
∣∣∣∣
Vds=const
= µCg
W
L
Vds (6.1)
A high sensitivity of an ESFET biosensor device is represented by a high gm. For
the above exemplary rGO ESFET, the geometry factor W/L and gate capacitance per
area Cg are constants so that gm is linearly proportional to the field-effect mobility of
the transducer layer µ and Vds. For the bipolar rGO thin film, the slope (gm), as seen
from the curves in figure 6.2(a), are different for both sides of a bipolar curve in the
condition of a constant Vds. This result shows that the gm is dependent on the type
of the carriers, because the field-effect mobilities of electrons and holes are different.
Besides, the slopes on either side of the bipolar curves at different Vds are distinctly
different. This demonstrates that gm is influenced by the applied drain-source voltage
Vds as well. Before performing the biosensing experiments, the voltages Vds and Vgs
corresponding to the maximum gm were selected and used as the working point of the
rGO based ESFET biosensor. During the biosensing, the capacitance of the gate Cg is a
critical parameter to influence the biosensing performance, since the other parameters
Vds, Vgs, µ, W , and L are constant at this working point.
For a typical ESFET, the capacitance Cg is dominantly modulated by the attachment
of the biomolecules and directly related to the ionic layer EDL (details can be found in
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section 3.2.3.2). In a buffer solution, the gate surface of the ESFET is typically charged
and the ions are accumulating on the gate surface to form the EDL. As demonstrated
in equation 3.2, the thickness of the EDL (so-called Debye length) is dependent on the
solvent permittivity, concentration of the solution ions and valence of solute ions. The
Debye length influences the biosensing performance of the ESFET. Indeed, only the
attachment of the biomolecules that takes place within the Debye length can lead to
a change in the characteristic curves of the ESFET, because the charged biomolecules
beyond the Debye length are not sensitive to the electrostatic field generated by
the charged gate surface. Therefore, the charges of the biomolecules outside of the
Debye length have no influence on the capacitance of the surface of the gate area,
resulting in no change in Ids of the ESFET. This effect is the so-called Debye-screening
effect. The typical charge-based FET biosensor are restricted by this effect towards real
applications [253]. Since the clinical fluid sample is of high ionic strength (150 mM)
and the corresponding Debye length is approximately 0.8 nm, a pre-dilution of the
clinical fluid sample is required. This enables the detection of the biomolecules (of
diameter larger than several nanometers) in a lower buffer concentration with a higher
Debye length. The PSA biosensing capability of rGO based ESFET related to the
Debye-screening effect is of great interest and is investigated in the following sections.
6.2 rGO Based ESFET for PSA Detection
In this section, rGO based ESFET devices were prepared with aptamers as receptor
biomolecules towards PSA detection. Au NPs were proposed to be functionalized
onto the surface of rGO thin films to increase the surface area. Thus, thiol terminated
aptamers were chosen as receptor biomolecules to bind onto Au NPs. A descriptive
schematic of the aptasensors preparation process is shown in figure 6.3. In this study,
the aptamer sequence used for PSA detection was TTT TTA ATT AAA GCT CGC CAT
CAA ATA GCT TT (5’ to 3’ direction). The 5’ end was modified by a 6-carbon chain as
a spacer and terminated with a thiol group. The detailed preparation of a biosensor
was as follows:
i) A mixture solution containing 80 mM EDC and 20 mM NHS in milliQ water was
used to activate the −COOH groups on the surfaces of the rGO thin films for
30 min.
ii) The ATP linker molecules with a concentration of 2 mg ml−1 in ethanol were
incubated on the rGO surfaces for 30 min. In this process, the amino groups of
the ATP linker molecules covalently bound to the −COOH groups of the rGO
thin films, while the thiol groups of ATPs were standing towards the ambient
air.
iii) Au NPs (Gold (III) chloride hydrate, HAuCl4 · x H2O)) diluted in milliQ water
were incubated overnight at 4 ◦C to bind to the thiol groups of ATP.
iv) The microcentrifuge tube which contained 10 µl of 100 µM thiol-terminated
aptamers was taken out of the freezer and left at the room temperature
for approximately 10 min until thawed. Fast spinning was applied for 5 s to
centrifuge down the residual droplets from the sidewall.
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v) Then the microcentrifuge tube was half-immersed into a flask containing milliQ
water at 90 ◦C. When the milliQ water temperature returned to the room
temperature naturally, the microcentrifuge tube was taken out and fast spun
for 5 s.
vi) A stock solution 10 mM 6-mercapto-1-hexanol (MCH) was prepared in ethanol.
Then a solution 50 µM MCH was prepared in 10 mM PBS with the stock solution.
Finally, the solution 100 µM thiol-terminated aptamers was mixed with the
solution 50 µM MCH to obtain 1 µM aptamers.
vii) This prepared solution was subsequently incubated on the rGO device for 4 h at
4 ◦C to immobilize the thiol-terminated aptamer on the Au NPs. In this step, the
concentration of MCH was chosen to obtain an optimized arrangement of the
aptamers [254].
viii) The rGO device was incubated for 1 h at 4 ◦C in a blocking solution, which
contains 1 mM MCH and 10 % ethanol (volume percentage) in 10 mM PBS. This
step was to block the free space on the Au NPs to avoid non-specific bonding.
The established rGO aptasensor was stabilized in 10 mM PBS overnight at 4 ◦C
as a final step before PSA detection.
Figure 6.3: Descriptive schematic of the biosensor preparation protocol with thiol-terminated aptamers
as receptor biomolecules. The rGO surface was functionalized with ATP linker molecules via
EDC/NHS chemistry to immobilize Au NPs, to which afterwards thiol-terminated aptamers are
binding. The free sites on Au NPs were blocked by MCH molecules. These aptasensors were established
to detect PSA target biomolecules by the ESFET transducing mechanism with an increased density of
receptor biomolecules.
105
Different PSA concentrations were prepared in 10 mM PBS. The
concentration-response measurements started by incubating the chip in 100 µl
PSA with a concentration of 33 fM for 30 min. Afterwards, the chip was cleaned
10 times with 10 mM PBS using pipette and measured by an Agilent 4156C
semiconductor analyzer. The same process was repeated by adding different PSA
concentrations on the rGO aptasensor surface: 330 fM, 3.3 pM, 33 pM, 330 pM, 3.3 nM,
33 nM and 330 nM.
The gate voltage Vgs was swept from −0.8 V to 0.8 V for a constant drain-source step
voltage Vds = 100 mV. The obtained bipolar characteristic curves are shown in figure
6.4(a). The results clearly show that a higher concentration of PSA molecules leads
to a smaller drain-source current Ids. This indicates an increase of resistance within
the rGO sensing area with the attachment of PSA. The cause is that the PSA target
biomolecules are negatively charged and an equivalent negative voltage is applied
on the rGO thin films. Indeed, the Dirac points are left-shifted away from the axis
Vgs = 0 V and the right arm of the bipolar curve indicates that the electrons, as the
majority of carriers, are responsible for the detection. Thus, the higher negative gate
voltage generated on the rGO biosensor surface suppresses the Fermi level to lower
levels in conductance band, resulting in a lower carrier concentration in the rGO thin
films and a higher resistance.
To verify the specificity of the rGO biosensing performance, 1 µM non-specific HSA
biomolecules were tested on the established rGO biosensor surface. The drain-source
current Ids showed no change induced by 1 µM HSA, as indicated in figure 6.4(b).
These measurements of specific binding of PSA and non-specific binding of HSA
demonstrate an outstanding selectivity of the rGO aptasensor platform.
Figure 6.4: (a) PSA concentration-response curves measured for an exemplary rGO based ESFET. (b)
A high concentration of HSA (1 µM) was used as a non-specific control.
It is noteworthy that the concentration-response were carried out in 10 mM PBS.
The corresponding Debye length is 0.76 nm, which is much smaller than the total
diameter of the aptamer (3-5 nm) and the PSA (10 nm). Also in this approach, the rGO
based ESFETs exhibit an outstanding sensing capability beyond the Debye-screening
effect. It could be because of the attachment of biomolecules which influenced the ion
arrangement on the rGO transducer layer and induced the changes of Ids.
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6.3 Modification of rGO Based ESFET Devices with Cu
Nanoparticles
6.3.1 Growth of Cu Nanoparticles
The oxygen functional groups on the surface of carbon basal plane of rGO
thin films offer various possibilities for receptor biomolecules immobilization.
The rGO thin films can be functionalized with Cu NPs, which serve as
catalysts of a click chemistry NPs [255–257] to immobilize alkyne terminated
receptor biomolecules for detecting prostate-specific biomarkers. A three-electrodes
electrochemical configuration connected with an Ivium potentiostat was used to
grow Cu NPs on the rGO surfaces. Electrodeposition methods are a typical way
to synthesize nanoparticles, nanorods, nanowires and nanoclusters metals [258].
Chronoamperometry, one type of electrodeposition, is generally used to apply step
voltages on a WE, while the resulting faradaic current is monitored over time. This
technique can be utilized for Cu NPs growth [259]. In this study, Cu NPs were
deposited onto rGO thin films by using the chronoamperometry technique. The
conversion solution used was prepared by mixing 10 mM copper acetate and 100 mM
lithium chloride with a volume ratio 1:5. Both solutions were prepared in DIW. The
used chronoamperometry setup is shown in figure 6.5(a). The WE was connected to
the common source of the rGO chip. A Pt wire, which acted as a CE, was twisted
and placed around the inner wall along the bottom of the electrochemical cell. An
electrochemical Ag/AgCl electrode acted as RE. A chronoamperometry voltage of
−1.1 V was applied to the WE for 10 s. It is noteworthy that the lithium ions were
used to increase the solution conductivity as well as precisely control the size, shape
and size distributions of the Cu NPs [260]. The Cu NPs density can be modified by
the concentrations, the growth time, and the volume ratio of the copper acetate and
lithium chloride. A descriptive schematic of Cu NPs growth on rGO thin films is given
in figure 6.5(b)-(c).
The applied negative potential on the WE reduced the Cu2+ into Cu NPs at the
defective sites of the rGO thin films. The Cu NPs formation process is monitored
with the current values across the rGO thin films dropping from microampere to
nanoampere. The rGO thin films, before and after Cu growth, were characterized by
SEM and shown in figure 6.6(a)-(b). This indicates that the Cu NPs were successfully
grown with a high density and a uniform distribution.
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Figure 6.5: Cu NPs growth on rGO thin films. (a) The experimental setup for the Cu NPs growth
using an Ivium potentiostat. The WE was connected to the common source bar of the rGO chip
while the Pt wire in the chemical cell served as CE and the electrochemical Ag/AgCl as RE. (b)
The chronoamperometry condition for Cu NPs growth in the conversion solution, which consisted
of copper acetate and lithium chloride. The applied voltage on the WE was V = −1.1 V for 10 s. (c)
Schematic of the Cu NPs on a rGO thin film.
Figure 6.6: (a)-(b) SEM characterizations of the rGO thin films before and after the Cu NPs growth.
6.3.2 Electronic Characterization of rGO Based ESFET with Cu
Nanoparticles
The bipolar characteristic curves of the rGO ESFETs were measured in 10 mM PBS
before and after the growth of Cu NPs. The results are shown in figure 6.7(a)-(b).
The measurements were carried out with the gate-source voltage Vgs sweeping from
−0.7 V to 1.2 V and the drain-source voltage Vds from −100 mV to 100 mV with a
50 mV step size. The obtained results show that the drain-source current Ids decreased
after the Cu NPs growth. This is most likely caused by a scattering effect of the carriers
induced by Cu NPs on the rGO thin films. The transconductance gm, that represents
the sensitivity of the rGO ESFET, is calculated from the bipolar curves before and after
the growth of the Cu NPs. The results are shown in figure 6.7(c)-(d), in which gm for
electrons (the right arm of the bipolar curves) is generally higher when comparing to
the holes (the left arm of the bipolar curves). In addition, it shows that the maximum
value of gm with electrons as majority carrier on the right arm of bipolar curves
are slightly enhanced after Cu NPs modification, while the maximum value of gm
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decreases in the case of the holes.
Figure 6.7: Characterization curves of rGO ESFETs before and after the growth of Cu NPs. (a)-(b)
Bipolar characteristic curves. (c)-(d) The transconductance gm.
Taking a closer look at the bipolar curve of Vds = 100 mV, it can be observed that
the Dirac point is left-shifted after Cu NPs decoration, as shown in figure 6.8. This is
because the Cu NPs act as electron donors for the rGO thin films and modulate the
Femi-level even deeper into the conductance band.
Figure 6.8: Close-up of the bipolar curve of an exemplary rGO ESFET before and after Cu decoration, in
the condition of Vds = 100 mV. The Dirac point is left-shifted and the transconductance gm is increasing 
with electrons as the major carriers.
The performances of the rGO ESFETs were highly dependent on the treatment of
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the GO aqueous solution for the rGO thin films preparation. As an experimental
comparison, the GO aqueous solution used for GO thin film preparation was treated
with the last centrifugation step of LTEDS protocol. This only selected GO flakes of
smaller sizes for the formation of rGO thin films. After the same reduction condition
in TRP, the characteristic curves of rGO based ESFET are shown in figure 6.9(a)-(b).
The Ids is one thousand times smaller than that of the devices prepared by GO
aqueous solution without the last centrifugation step. Nevertheless, for both rGO
ESFET devices, the enhancement effect of the Cu NPs on the bipolar curves was
consistent.
Figure 6.9: The rGO device was prepared with mesh graphite as original material. In the preparation
protocol the last centrifugation step was used. Close-up of the bipolar curve of rGO ESFET before
and after Cu decoration, with Vds =−100 mV, 0 mV and 100 mV. The current is here expressed in
nanoampere against microampere previously (figure 6.7(a)-(b).)
Towards biosensing, azide molecules can be initially anchored on the surface of rGO
thin films. The receptor biomolecules are terminated with alkyne groups to react with
the azide, while the grown Cu NPs serve as catalysts. This reaction is so-called click
chemistry. It is fast and quantitative as well as biocompatible. The reaction process
is easy to handle, since it can happen in various solutions, such as buffers, dimethyl
sulfoxide, and water. A wide range of pH value from 1 to 4 can be used. Furthermore,
it takes place only between azide and alkyne terminated components and does
not react with other organic groups, which are contained in native biomolecules,
for instance amino and carboxyl groups. Therefore, this immobilization mechanism
of receptor biomolecules is of high specificity and can be investigated to detect
prostate-specific biomarkers in a future work.
6.4 Conclusion
The GO thin films that were prepared using GO solutions by the LTEDS method
without the centrifugation in the last step showed a superior bipolar property
and a higher transconductance gm compared to the case of the GO solution with
the centrifugation step. This result demonstrates the bigger GO flakes preserve
more similar electronic properties to the pristine graphene. Remarkably, with the
immobilized Au NPs on the rGO thin films, the rGO based ESFET biosensor can detect
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PSA with thiol-terminated aptamers as receptor biomolecules in 10 mM PBS which
has a similar ionic strength (162 mM) and corresponding Debye length (0.76 nm) as
physiological solutions. The concentration-response curves of an exemplary device
exhibit PSA detection with a wide sensing range from 33 fM to 330 nM, beyond the
Debye-screening effect.
Additionally, Cu NPs were successfully grown on the surface of rGO thin films by
chronoamperometry technique. rGO transducer layer with Cu NPs functionalization
showed improved transconductance gm of the rGO ESFETs. Click chemistry could be
used with Cu NPs as catalysts for assisting the immobilization of alkyne-terminated
ssDNA receptors to detect prostat-specific complementary DNA (cDNA) sequences.
This immobilization mechanism of receptor biomolecules needs to be further
optimized to conclude quantitatively about the biosensing capability.
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7 | Conclusions and Outlook
Conclusions
In conclusion, the newly developed LTEDS synthesis process, which is an upgraded
version of the IHM with lower process temperature and additional purification steps,
offers a unique opportunity to preserve larger areas of carbon lattice with less defects
and contaminations from ions and molecules. The chemically exfoliated GO flakes
synthesized by the LTEDS process were utilized as the source material to establish a
wafer-scale flow process of GO thin films. Afterwards, thermal reduction treatments
were chosen to transform the insulating GO to conductive rGO thin films. The (r)GO
thin films were utilized as transducers in the SPR ((r)GO), EIS (rGO) and ESFET (rGO)
based biosensor platforms for PSA detection. In the following, the properties of (r)GO
flakes and thin films as well as the sensing mechanisms and performance of (r)GO
based biosensor platforms are summarized, compared and discussed. In addition, the
potential applications of these biosensor platforms are assessed.
Wafer-scale fabrication of GO devices
The properties of GO flakes produced by the LTEDS synthesis process were
characterized by SEM, TEM, UV-VIS spectroscopy, fluorescence spectroscopy, XRD
and FT-IR spectroscopy. Low exfoliation temperature and additional purification
steps of the LTEDS method proved to generate GO flakes of high quality in terms
of larger and cleaner carbon lattice. With the GO aqueous solution as the original
material, a top-down wafer-scale fabrication process of GO thin films was established,
making use of gas-phase silanization, spin-coating, photolithography and O2 reactive
etching techniques. The GO thin films were formed on 4-inch SiO2/Si (or glass)
substrates with APS as linker layers, which were of thicknesses 1.01± 0.40 nm.
Characterized by ellipsometry spectroscopy and AFM, the thickness of the wafer-scale
GO thin films were 2.95± 0.35 nm and 6.43± 0.40 nm in the condition of 1 time
and 4 times spin-coating, respectively. The results indicated that GO thin films were
topographically uniform in wafer-scale and their thicknesses were controllable by the
number of spin-coating.
Electronic properties after reduction treatments
To characterize the electronic properties on wafer-scale, the GO thin films were
prepared on top of IDEs, which consisted of a bilayer stack of 30 nm Ti and 270 nm Au.
Each IDEs channel had a total of 10 finger electrodes with a finger length of 100 µm,
a finger width and a separation distance of neighboring electrodes of 5 µm. The TRP
113
with a reduction at 350 ◦C for 10 h in a vacuum oven and subsequent 600 ◦C for 20 s
in ambient conditions was used throughout this thesis to obtain rGO thin films.
Confirmed by cyclic voltammetry measurements and I-V characterizations, the
generated rGO thin films were dense and complete without pinholes and formed
ohmic contacts with the IDEs. After the TRP, approximately 98.7 % of the working
channels of an exemplary 4-inch wafer were conductive with a resistance ranging from
104Ω to 107Ω. More remarkably, 87.9 % of all the conductive rGO channels showed a
uniform electrical resistance varying within only one order of magnitude (1.14 · 106Ω
to 9.54 · 106Ω). The resistance uniformity demonstrated that the formed rGO thin
films can be integrated into electronic devices for further applications. Four-point
measurements were carried out to extract the sheet resistivity from Greek-cross VDP
structures with a diagonal electrodes’ distance of 5 µm. The obtained sheet resistivities
ranged from 0.3Ωm to 0.06Ωm. In addition, bipolar characteristic curves of rGO
based ESFET devices in 10 mM PBS were used to deduce the field-effect mobility:
0.326 cm2 V−1 s−1 for holes and 0.092 cm2 V−1 s−1 for electrons. Furthermore, the
evolution of the functional groups on the carbon basal plane were revealed by Raman
spectroscopy and XPS characterization. These results showed the reduction degree
of rGO thin films by TRP and can serve as an important reference for the further
optimization of reduction treatments.
(r)GO based SPR biosensor
The rGO based SPR chips were prepared by metal evaporation and gas-phase
silanization techniques. With the metal evaporation technique, bilayer stacks of 3 nm
Ti and 47 nm Au were prepared in sequence on top of 4-inch glass wafers. Afterwards,
the Au thin films were functionalized with ATP linker molecules by the gas-phase
silanization technique to covalently immobilize GO flakes, which formed uniform
GO thin films. The obtained GO thin films were then transformed into rGO thin
films using the TRP. The (r)GO thin films were utilized as the functional layers on
conventional Au based SPR chips for PSA detection while ConA served as receptor
biomolecule. The biosensing mechanism and capability of rGO based SPR biosensors
were analyzed and cross-checked by simulations, using a standard WinSpall software
to simulate the SPR spectra. The simulation principle was to repeatedly apply the
Fresnel equations to the established six-layer stack, namely prism, glass substrate, Au
thin film, (r)GO thin film, ConA/PSA biomolecule layer and analyte solution. From
this perspective, the sensitivity of the (r)GO based SPR biosensor is dependent on the
thin film thickness and dielectric parameters of (r)GO. The AFM characterizations
revealed that the thin-film thickness of GO was 8 nm and rGO was 6.8 nm. The
dielectric parameters extracted by ellipsometry measurements at a wavelength of
780 nm were εGO = 1.72 + 0.55j, εrGO = 1.59 + 1.1j. By substituting these parameters
into the established layer model, the simulated data demonstrated that rGO thin films
as functional layers lead to a higher sensitivity than GO thin films for SPR biosensing.
The real-time biosensing results manifested that the SPR signal intensities were
amplified by a factor of 1.70± 0.25 for the rGO compared to the GO layers. Moreover,
the statistical results from the specific and non-specific biosensing data showed that
the signal-to-noise ratio for the rGO functional layers was approximately 3 times
higher than that of the GO functional layers, with exact values of 6.56± 3.63 for rGO
and 2.16± 1.64 for GO. The rGO thin films as transducers in SPR device exhibited
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superior biosensing capability than GO thin films, which was concretely confirmed
with the simulation results. Besides, the LOD was reduced to 0.01 µg ml−1 PSA when
negative voltages were applied across the rGO thin films-liquid interface. This is
attributed to the bipolar characteristic of the rGO thin films, which enables a Fermi
level modulation to tune the SPs. Such a tuning effect is not reachable by conventional
Au based SPR platforms.
rGO based impedance spectroscopy biosensor
The rGO thin films prepared on top of IDEs were utilized as the transducer layers
of in-line EIS biosensors, in which the two arms of IDEs acted as CE and WE
with electrochemical Ag/AgCl electrode as RE. The input signal was a DC signal
of 0.05 V combined with an AC signal of an amplitude 0.01 V while the frequency was
swept from 100 kHz to 0.1 Hz. The biosensing activity was revealed by the changes
of the amplitude, phase, real part and imaginary part of the output impedance.
The biosensing mechanisms with rGO thin films as transducer layers on IDEs
were investigated by using PSA-specific aptamers (diameter 3-5 nm) and antibodies
(diameter 10 nm) as receptor biomolecules to detect PSA (diameter 4.5 nm) target
biomolecules in PBS of different ionic strengths and Debye lengths. Besides, the
influence of the rGO thin films on the electric field across the IDEs fingers was
evaluated.
With PSA-specific aptamers as receptor molecules, the PSA detection was carried out
in 10 mM PBS with an ionic strength of 162 mM and a Debye length of 0.76 nm.
The biosensing activity was indicated by the impedance amplitude and phase in
the Bode plots. Around 1 Hz, an increase in the impedance amplitude was observed
with the PSA concentration increasing from 33 pM to 330 nM. The charges of bound
PSA biomolecules are equivalent to a variable voltage on the bipolar rGO thin film
which can tune the Fermi level, carrier mobility and channel resistance. Therefore,
the bindings of PSA lead to an increase in the impedance amplitude. This tendency
was confirmed by the experimental results of dual I-V sweep concentration-response.
At around 1 kHz, a decrease in the impedance phase was observed with the PSA
concentration increasing from 33 fM to 330 nM. The differences in the response
frequency regimes of impedance amplitude and phase indicate that the corresponding
electronic elements for biosensing are different. As a control, non-specific binding
experiments were carried out to detect HSA in 10 mM PBS. The result showed almost
no signal and thus demonstrated the excellent selectivity of this biosensor platform.
Therefore, the biosensors, that were utilizing rGO thin films as transducer layers
on IDEs and aptamers as receptor biomolecules, were capable of detecting PSA in
buffer solution with an ionic strength of 162 mM and a corresponding Debye length
of 0.76 nm, which is similar to physiological solutions (150 mM and 0.78 nm). This
result indicated that the rGO based EIS biosensors overcame the Debye-screening
effect which significantly obstructs the charged based label-free biosensing devices
towards real clinical applications.
To understand the sensing mechanism of rGO thin films for biosensing, the same
experiments were carried out in 200 mM PBS, with a corresponding Debye length of
0.17 nm. The difference in the impedance amplitude around 1 Hz vanished because
the target biomolecules were bound beyond the Debye length. The rGO thin films
were not able to sense the charges of the binding PSA biomolecules. As a result, the
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Fermi level, the carrier concentration, and the channel resistance were also not altered.
In contrast, the impedance phase still displayed a sensing capability around 1 kHz. A
decrease in impedance phase was observed with PSA concentration increasing from
33 fM to 3.3 nM. This biosensing activity is attributed to the existing electric field
confined by the IDEs and rGO thin films. The recognition process of PSA biomolecules
on rGO thin films was reflected by a capacitance change between the IDEs.
Technically, the electric field decays perpendicularly away from the plane of bare IDEs
structures, with a depth approximately equal to the finger width of the IDEs, which
is 5 µm. In our case, rGO thin films were prepared on top of the IDEs and most likely
significantly reduced the depth of the electric field created by the IDEs to only a few
nm. To estimate the value of this parameter, the PSA detections were carried out in the
10 mM PBS and antibodies, larger than the aptamers in terms of diameter, were used
as receptor biomolecules. The results showed that both impedance amplitude and
phase exhibit no sensing behavior throughout the whole tested frequency regime.
The PSA molecules bound to the antibodies with large diameters, and as a result the
charged PSA biomolecules were outside the Debye-screening length and outside the
electric field created by the IDEs and rGO thin films. The resistive path (real part
of the output impedance) at 1 Hz was altered with the increased PSA concentration.
However, the capacitive path across IDEs at 1 kHz showed no response for the PSA
binding. These results demonstrated that the depth of the electric field induced by
IDEs and rGO thin films should be less than 10 nm, which was much smaller than
that of the bare IDEs.
rGO based ESFET biosensor
The rGO thin films prepared on top of IDEs were utilized as the transducer layers of
ESFET biosensor platforms. The two arms of IDEs acted as drain and source electrodes
with an electrochemical Ag/AgCl electrode as RE. The drain-source voltage Vds was
swept within a range from −0.7 V to 1.2 V. In this experiment, the GO flakes used for
the GO thin films were prepared without the last centrifugation step of the LTEDS
protocol. Thus, the thin films contained a larger portion of bigger flakes. The GO thin
films were transformed into rGO thin films using the TRP. The obtained field-effect
characteristic curves demonstrated that the bipolar properties were very promising
with high transconductances gm for both carriers: electrons and holes. A right shift of
the Dirac point in the firstly prepared devices indicated that the rGO thin films were
p-doped, which is opposite to the case of rGO thin films (n-doped) quilted with the
GO flakes prepared by the complete LTEDS protocol.
With the assistance of ATP linker molecules, Au NPs were functionalized on the rGO
transducer layer to immobilize the thiol terminated aptamers as receptor biomolecules
for PSA. The concentration-response (33 fM to 300 nM) in 10 mM PBS buffer solution
demonstrated that the binding activity of PSA led to a decrease in the channel
current and an increase in the resistance of the rGO thin films. This result was
also in accordance with the concentration-response experiments of I-V and EIS
measurements. Also, the biosensing was not obstructed by the Debye-screening
effect. In addition, Cu NPs were successfully grown by a chronoamperometry
technique. They could serve as the catalysts for click chemistry, which should facilitate
the immobilization of the alkyne terminated receptor biomolecules to detect PSA.
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Remarkably, the Cu NPs improved the transconductance gm of rGO based ESFET
devices and thus were capable to enhance the sensitivity of biosensing.
Outlook
Properties of (r)GO flakes and thin films
In a future work, even lower exfoliation temperature could be applied to restore the
carbon lattice of GO flakes, in favor of further tuning their properties as similar to the
pristine graphene as possible. However, the decreased exfoliation temperature directly
reduces the yield of GO flakes. The trade-off between the flake quality and yield is
an important issue that needs to be addressed during the later optimization of the
exfoliation process. Besides, more efficient reduction treatments of GO is another path
worth exploring to restore larger areas of the carbon lattice. It would be interesting
to combine both thermal and hydrogen reductions to remove the oxygen functional
groups and restore the carbon lattice simultaneously, such that the electronic and
optical properties of the rGO thin films can be substantially improved.
As one of the important electronic parameter, the Hall mobility of rGO thin films can
be further extracted by Hall measurements [168] to confirm the field-effect mobility
deduced from the field-effect measurement as discussed in chapter 3. Continuing from
the section 3.2.4, the Hall mobility µ can be calculated by the following equations:
µ =
|RH|
ρ
(7.1)
where ρ is the magnetoresistivity and RH the hall coefficient expressed by:
RH =
t
B
V+31,42 (+B)−V−31,42 (+B) + V−31,42 (−B)−V+31,42 (−B)
I+31 (+B)−V−31 (+B) + V−31 (−B)−V+31 (−B)
(7.2)
with the thickness of the material t and the applied magnetic field B.
Even larger rGO based Greek cross and 8-arms Hall bar structures (shown in figure
7.1(a)-(b)) were designed and fabricated to investigate the carrier mobilities and
electronic performance of the ESFET devices with different channel lengths after
different reduction treatments. It is noteworthy that the 8-arms VDP structures
are capable to provide more precise measurements of carrier mobilities. The
above-mentioned measurements require a specific Hall effect setup, which was not
available during the course of this thesis.
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Figure 7.1: SEM images of VDP structures realized in this thesis: (a) Greek cross. (b) 8 arms Hall bar
structure.
(r)GO based biosensors
The wafer-scale fabrication and patterning technique established in this work enable
(r)GO thin films to act as transducers in SPR, EIS and ESFET based biosensors. All
proof of concept experiments showed promising biosensing capability towards PSA
detection. For rGO based SPR biosensors, the above two aspects in optimizing the
exfoliation process and reduction conditions can be further investigated to generate
a better bipolar property to enhance the SPR signals. The related electro-optical
tuning effect of the rGO thin films can be elaborated precisely by combining a
more sophisticated theoretical layer configuration. For both rGO based in-line EIS
and ESFET based biosensors, the sensing mechanism of rGO thin films beyond
Debye-screening effect should be further investigated and discussed with the support
of better modeling and simulations.
In terms of improving the reliability and reproducibility of (r)GO based biosensors,
surface activation protocols of (r)GO thin films should be employed in an optimized
manner to specifically immobilize receptor biomolecules or structures. The click
chemistry, as well as other functionalization possibilities of NPs, provides an
alternative approach to immobilize higher density of receptor biomolecules and it can
be further investigated in a future work. For instance, the grown Cu NPs can function
as catalysts of click chemistry, assisting the immobilization of prostate-specific
receptor ssDNA sequences for biosensing. The detailed steps to establish the biosensor
surface are described in figure 7.2(a)-(d) and as follows:
i) After the growth of Cu NPs, the −COOH groups were activated by EDC for 1 h
to functionalize the rGO thin films with azide molecules. The concentration of
EDC and azide were 15 mM and 50 nM prepared in milliQ water, respectively.
ii) The residual −COOH groups after coupling with EDC and azide were blocked
by 10 nM ethanolamine for 20 min.
iii) With the grown Cu NPs as catalysts, 10 nM alkyne-terminated receptor
biomolecules were immobilized on the chip surface for 30 min.
This protocol is a first proposal and was tested with inconclusive results in the
biosensing experiments. It is believed that different chemicals and concentrations
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could improve the biosensing performances. This proposed biosensing scheme
could be an alternative approach to the EDC/NHS chemistry to immobilize the
prostate-specific ssDNA sequences.
Figure 7.2: The working principle of the click chemistry protocol to immobilize the prostate-specific
receptor molecules after Cu NPs growth on rGO thin films (anticlockwise). (a) Azide molecules bind to
the −COOH groups on the rGO thin films, which are beforehand activated by EDC. The free −COOH
groups are blocked by ethanolamine molecules. (b)-(c) The alkyne at the 5’ end of ssDNA receptors
reacts with the azide, forming a triazole ring with the Cu NPs as catalysts. (d) The prostate-specific
cDNA can theoretically be detected by the established rGO biosensor surface.
In an overall view, this thesis represents an elementary work to comprehend the
basic properties of GO and rGO thin films. The established biosensor platforms
based on the (r)GO thin films are all very promising towards the label-free detection
of PSA. In a future work, combined with a microspotter technique, a multiplexing
array with various receptor biomolecules on the same rGO based biosensor could be
developed to offer multi-variable information of the biosensing results. The biosensing
mechanism of the rGO based biosensors can be further analyzed and provide an
opportunity for future healthcare applications, especially for future POC devices.
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A | (r)GO Based Devices Preparation
A.1 Preparation of the Electrodes
The bottom IDEs are fabricated by standard photolithography (negative photoresist
ARU4030), metal evaporation and lift-off process on 4-inch substrate, for instance
SiO2/Si or glass. The electrode is a bilayer stack: top layer is 270 nm Au and bottom
30 nm Ti as an adhesion layer.
Chip cleaning (note: this process can be applied to clean the wafers for preparing SPR
chips):
• Spin dry: DIW, 700 rpm/3 min+2000 rpm/4 min, N2
• Caro’s acid tank: H2SO4 (98 %), H2O2(30 % by weight, 20-40 ml), 115 ◦C, 10 min
• DIW cleaning, 2-3 min
• Spin dry: DIW, 700 rpm/3 min + 2000 rpm/4 min, N2
• Plasma stripper, 40 % O2, 350 W, 5 min
Cr/Au Bottom electrodes: negative photoresist patterning
• 3 ml photoresist ARU4030, spin coat 100 rpm/7 s + 2000 rpm/60 s
• Soft bake 85 ◦C/120 s, 10 min cool down in the air
• Hard contact mode, exposure 10 s, UV energy dose 6.5 mW
• Post bake 115 ◦C/5 min, 10 min cool down in the air
• Development, AR300-26: DIW = 1:3, 15 s
• Spin-dry, 3000 rpm/30 s
• Microscope, check the structures
Cr/Au evaporation
• 270 nm Cr/Au evaporation (Au, 5 Å s−1, Power 51 %)
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Lift-off process
• In container, lift off in Acetone/20 min,
• In container, fresh Aceton/1 min
• In container, isoproponal/1 min
• Clean the wafer with DIW
• Spin-dry machine, program 1, 700 rpm/3 min; DIW; 200 rpm/4 min; N2
• O2 stripper, 40 % O2, 350 W, 5 min
A.2 Gas-Phase Silanization
4-inch SiO2 and glass wafer surface activation:
• Plasma stripper: 2.5 min, 240 W, 40 % O2
• Or Piranha acid: H2SO4(95-97 %)/20 ml+H2O2(30 %)/1 ml, clean the wafer with
pipette/5 min
4-inch SiO2 and glass wafer APTES silanization
• After surface activation, immediately transfer the wafer to glove box, 2 µl APTES
in petri dish/60 ◦C/2.5 h, the contact angle is around 60-70 ◦C
A.3 GO Spin-Coating
• pH ≈ 2.9 GO solution
• 500 rpm/90 s or 100 rpm/120 s+2000 rpm/60 s, 90 ◦C/60 s between each spin
coating
A.4 Etching of GO Thin-Films
GO patterning
• Positive photoresist ARU4030, spin coat 500 rpm/30 s+2000 rpm/60 s
• soft baking 85 ◦C/120 s
• contact mode, exposure 10 s, UV energy does 6.5 W
• Development, AR300-26: DIW = 1:3, 15 s
• O2 plasma etching, 33 sccm O2, 10 Pa chamber pressure, 10 W, 250
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A.5 Wafer Dicing
Chip dicing (note: this process can be applied to dice the wafers for preparing SPR
chips):
• Spin coat positive photoresist ARU4030, spin coat 500 rpm/30 s+2000 rpm/60 s
• Cut 4-inch wafer in to 7 mm× 7 mm chips (SPR chip size: 1.25 cm× 1.25 cm)
Chip cleaning:
• Aceton/5 min
• Fresh aceton/5 min
• Isoproponal/5 min
• N2 dry
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B | Equipment List
Table B.1: Equipment list.
Equipment Model Company Country
Spin coater/Hot plate Delta 30 T2 Süss Germany
Mask aligner MA/BA 6 Süss Germany
Reactive ion etching
(RIE)
SI 591 M SENTECH Instruments
GmbH
Germany
Plasma stripper 300-E Technics Plasma USA
Electron Beam Evapo-
rator
BAK500 Oerlikon Balzers Liechtenstein
High temperature
oven
DS-3900-PC-150 INOTHERM Germany
Vacuum oven VT5042 EKP Heraeus Germany
Wafer dicing saw DAD-2H/6T Disco Japan
Optical microscopy Olympus BX51 Olympus UK
Atomic Force Mi-
croscopy (AFM)
DEMENSION icon
with ScanAsyst
Bruker Corporation Germany
Scanning Electron Mi-
croscopy (SEM)
Zeiss Supra 40 SEM Carl Zeiss AG Germany
Transmission Electron
Microscopy (TEM)
JEOL JEM 2010 Michigan TECH USA
Fluorescence spec-
troscopy
FP 8300 Jesco Corporation Japan
Ultraviolet-visible (UV-
VIS) spectroscopy
PerkinElmer Lambda
40
PerkinElmer USA
X-ray diffraction
(XRD)
PANanlytical X’Pert
PRO MPD Diffrac-
tometer
Philips Netherland
Fourier-transform in-
frared spectroscopy
(FTIR)
PerkinElmer Frontier PerkinElmer USA
Goniometers Contact angle system
OCA
Dataphysics Germany
Spectroscopic Ellip-
someter
SE850 SENTECH Instruments
GmbH
Germany
Raman spectroscopy LabRAM HR Evolu-
tion
Horiba Japan
X-ray photoelectron
spectroscopy (XPS)
D8Advance Bruker AXS GmbH Germany
Continued on next page
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Table B.1 – continued from previous page
Equipment Model Company Country
Surface Plasmon Reso-
nance (SPR) system
SR7000DC Reichert Technologies USA
Semiconductor ana-
lyzer
Keithley 4200-SCS Keithley Instruments USA
Semiconductor ana-
lyzer
Agilent 4156C Keysight Techologies USA
Impedance analyzer Ivium COMPACT-
STAT.e
Ivium Techologies Netherland
Silver/Silver chloride
(Ag/AgCl) RE
DRIREF-2SH World Precision Instru-
ments
Germany
Three-dimensional
(3D) material printer
Objet350 Connex Stratays Ltd. Israel
Localized Surface Plas-
mon Resonance (LSPR)
system
Home-made equip-
ment
University of Bath UK
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C | Chemical List
Table C.1: Chemical list.
Name of chemical Company Country
Graphite Alfa Aeser Germany
(3-Aminopropyl) triethoxysilane (APTES) Sigma Aldrich Germany
4-aminothiopheol (4-ATP) Sigma Aldrich Germany
K3Fe(CN)6/K4Fe(CN)6 (K3/K4) Sigma Aldrich Germany
Phosphate buffered saline (PBS) Sigma Aldrich Germany
Phosphate buffered saline with Tween 20
(PBST)
Sigma Aldrich USA
Glycin Sigma Aldrich USA
NaOH Sigma Aldrich Germany
N-(3-Dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (EDC)
Sigma Aldrich Germany
N-Hydroxysuccinimide (NHS) Carbo-free
blocking agent
Sigma Aldrich Germany
Concanavalin A (ConA) Vector Laboratories USA
Maackia Amurensis lectin ii (MAA ii) Vector Laboratories USA
Biotin labeled MAA ii Vector Laboratories USA
PSA (SPR experiments) Fitzgerald Industries Inter-
national
USA
PSA specific aptamer (amino-, thiol ter-
minated)
Sigma Aldrich Germany
Anti-PSA antibody Abcam UK
Ethanolamine Sigma Aldrich Germany
Human serum albumin (HSA) Sigma Aldrich UK
PSA (all experiments except SPR) Merck USA
Au NPs (Gold (III) chloride hydrate,
HAuCl4 · x H2O)
Sigma Aldrich UK
6-mercapto-1-hexanol (MCH) Sigma Aldrich UK
Ethanol Sigma Aldrich UK
Copper acetate Sigma Aldrich Germany
Lithium chloride Sigma Aldrich Germany
200 stainless sieves Spoerl OHG
25.4 mm dialysis membrane Th. Geyer GmhH&Co.KG
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